[{"entities":{"urls":[{"start":60,"end":83,"url":"https://t.co/cBBxSH3TQE","expanded_url":"http://bit.ly/2l0IVYH","display_url":"bit.ly/2l0IVYH"}],"hashtags":[{"start":18,"end":36,"tag":"AdvancedTherapies"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"832587979717746689","text":"Our Committee for #AdvancedTherapies elected its new chair: https://t.co/cBBxSH3TQE","id":"832587979717746689","lang":"en","created_at":"2017-02-17T13:50:17.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/1lWPybjfsK","expanded_url":"http://bit.ly/2ksbCKA","display_url":"bit.ly/2ksbCKA"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":49,"end":58,"tag":"medicine"},{"start":108,"end":120,"tag":"raredisease"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"831490426821554177","text":"The #agenda of this week's meeting of our orphan #medicine committee (COMP) is out: https://t.co/1lWPybjfsK #raredisease","id":"831490426821554177","lang":"en","created_at":"2017-02-14T13:09:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/AmaZdBOpU3","expanded_url":"http://bit.ly/2lLgfB6","display_url":"bit.ly/2lLgfB6"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"831480615698628608","text":"Work programme for 2017 is out: check out EMA's priorities and objectives for the year ahead: https://t.co/AmaZdBOpU3","id":"831480615698628608","lang":"en","created_at":"2017-02-14T12:30:01.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/sQV4YtaWsa","expanded_url":"http://bit.ly/2lLfnfT","display_url":"bit.ly/2lLfnfT"}],"hashtags":[{"start":41,"end":52,"tag":"veterinary"},{"start":53,"end":63,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"831469842117062656","text":"The agenda of this week's meeting of our #veterinary #medicines committee (CVMP) has been published: https://t.co/sQV4YtaWsa","id":"831469842117062656","lang":"en","created_at":"2017-02-14T11:47:12.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":80,"end":103,"url":"https://t.co/eebqKQqAfy","expanded_url":"http://bit.ly/2kiQyej","display_url":"bit.ly/2kiQyej"}],"hashtags":[{"start":53,"end":71,"tag":"postauthorisation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":7,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"831072582703128576","text":"Over 1000 studies now recorded in the EU register of #postauthorisation studies https://t.co/eebqKQqAfy","id":"831072582703128576","lang":"en","created_at":"2017-02-13T09:28:38.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/g5PeFCU5bf","expanded_url":"http://bit.ly/2lrg01a","display_url":"bit.ly/2lrg01a"}],"hashtags":[{"start":33,"end":51,"tag":"Pharmacovigilance"},{"start":111,"end":116,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":1,"like_count":6,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"830029528303009792","text":"The highlights from the February #Pharmacovigilance Risk Assessment Committee are out: https://t.co/g5PeFCU5bf #PRAC","id":"830029528303009792","lang":"en","created_at":"2017-02-10T12:23:55.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/2kh9N7XkdH","expanded_url":"http://bit.ly/2kFTd0L","display_url":"bit.ly/2kFTd0L"}],"hashtags":[{"start":51,"end":69,"tag":"pharmacovigilance"},{"start":105,"end":110,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":2},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"828670623119441924","text":"Check out the agenda of this week's meeting of our #pharmacovigilance committee: https://t.co/2kh9N7XkdH #PRAC","id":"828670623119441924","lang":"en","created_at":"2017-02-06T18:24:07.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/2JEPi17ste","expanded_url":"http://bit.ly/2kKgyhw","display_url":"bit.ly/2kKgyhw"}],"hashtags":[{"start":39,"end":44,"tag":"EPAR"},{"start":73,"end":84,"tag":"Coliprotec"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"828626092001001472","text":"The European public assessment report (#EPAR) for the veterinary vaccine #Coliprotec F4/F18 is now published: https://t.co/2JEPi17ste","id":"828626092001001472","lang":"en","created_at":"2017-02-06T15:27:10.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/iLEVJHtzlv","expanded_url":"http://bit.ly/1QIeQ5W","display_url":"bit.ly/1QIeQ5W"},{"start":96,"end":119,"url":"https://t.co/8nlrkEFnuY","expanded_url":"https://twitter.com/EMA_News/status/827094619171221504/photo/1","display_url":"pic.twitter.com/8nlrkEFnuY"}],"hashtags":[{"start":19,"end":29,"tag":"medicines"},{"start":46,"end":52,"tag":"PRIME"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":10,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"827094619171221504","text":"Find out about the #medicines accepted in our #PRIME scheme in January: https://t.co/iLEVJHtzlv https://t.co/8nlrkEFnuY","id":"827094619171221504","lang":"en","created_at":"2017-02-02T10:01:38.000Z","author_id":"116716199","attachments":{"media_keys":["3_827094439197810688"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/RuDI4dVtVr","expanded_url":"http://bit.ly/2juSuLo","display_url":"bit.ly/2juSuLo"}],"hashtags":[{"start":72,"end":88,"tag":"HerbalMedicines"},{"start":90,"end":95,"tag":"HMPC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"826081956374990849","text":"We have published the agenda of this week's meeting of our committee on #HerbalMedicines (#HMPC) https://t.co/RuDI4dVtVr","id":"826081956374990849","lang":"en","created_at":"2017-01-30T14:57:40.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/dH6q5I9mk2","expanded_url":"http://bit.ly/2jwIBQr","display_url":"bit.ly/2jwIBQr"},{"start":96,"end":119,"url":"https://t.co/rnhgPLoM9Z","expanded_url":"https://twitter.com/EMA_News/status/824953775253241856/photo/1","display_url":"pic.twitter.com/rnhgPLoM9Z"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":19,"end":29,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":32,"reply_count":0,"like_count":13,"quote_count":7},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"824953775253241856","text":"#CHMP recommends 8 #medicines for approval at its January 2017 meeting: https://t.co/dH6q5I9mk2 https://t.co/rnhgPLoM9Z","id":"824953775253241856","lang":"en","created_at":"2017-01-27T12:14:41.000Z","author_id":"116716199","attachments":{"media_keys":["3_824946129091571712"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":66,"end":89,"url":"https://t.co/RoZ0HOizJr","expanded_url":"http://bit.ly/2jVIxIK","display_url":"bit.ly/2jVIxIK"}],"hashtags":[{"start":19,"end":30,"tag":"Paediatric"},{"start":60,"end":65,"tag":"PDCO"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"824672661020221441","text":"The agenda for the #Paediatric Committee in January is out. #PDCO https://t.co/RoZ0HOizJr","id":"824672661020221441","lang":"en","created_at":"2017-01-26T17:37:38.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/tXu2jI2lO3","expanded_url":"http://bit.ly/2k5noxU","display_url":"bit.ly/2k5noxU"},{"start":120,"end":143,"url":"https://t.co/WFcW3VQ91b","expanded_url":"https://twitter.com/EMA_News/status/824658741467508740/photo/1","display_url":"pic.twitter.com/WFcW3VQ91b"}],"hashtags":[{"start":71,"end":83,"tag":"biosimilars"}],"mentions":[{"start":109,"end":119,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"824658741467508740","text":"Save the date for the EMA - EDQM event on the regulatory framework for #biosimilars: https://t.co/tXu2jI2lO3 @edqm_news https://t.co/WFcW3VQ91b","id":"824658741467508740","lang":"en","created_at":"2017-01-26T16:42:20.000Z","author_id":"116716199","attachments":{"media_keys":["3_824658582381723648"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/tDDrPTF89v","expanded_url":"http://bit.ly/2ktpaFS","display_url":"bit.ly/2ktpaFS"},{"start":103,"end":126,"url":"https://t.co/n48sBJNdPW","expanded_url":"https://twitter.com/EMA_News/status/824294183137669123/photo/1","display_url":"pic.twitter.com/n48sBJNdPW"}],"hashtags":[{"start":28,"end":39,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"824294183137669123","text":"In 2016, EMA recommended 11 #veterinary medicines for marketing authorisation: https://t.co/tDDrPTF89v https://t.co/n48sBJNdPW","id":"824294183137669123","lang":"en","created_at":"2017-01-25T16:33:42.000Z","author_id":"116716199","attachments":{"media_keys":["3_824294136325033984"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":22,"end":45,"url":"https://t.co/pBtO6u4jCT","expanded_url":"http://bit.ly/2iVYpxw","display_url":"bit.ly/2iVYpxw"},{"start":46,"end":69,"url":"https://t.co/HuNDSwCj6I","expanded_url":"https://twitter.com/EMA_News/status/824223179514249216/photo/1","display_url":"pic.twitter.com/HuNDSwCj6I"}],"hashtags":[{"start":0,"end":21,"tag":"MedicinesEarlyAccess"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":23,"reply_count":0,"like_count":7,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"824223179514249216","text":"#MedicinesEarlyAccess https://t.co/pBtO6u4jCT https://t.co/HuNDSwCj6I","id":"824223179514249216","lang":"und","created_at":"2017-01-25T11:51:33.000Z","author_id":"116716199","attachments":{"media_keys":["3_824223137415987201"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":71,"end":94,"url":"https://t.co/zMDysk8Ior","expanded_url":"http://bit.ly/2jsgGi8","display_url":"bit.ly/2jsgGi8"},{"start":95,"end":118,"url":"https://t.co/7jEv5Rwqzw","expanded_url":"https://twitter.com/EMA_News/status/823839180891521024/photo/1","display_url":"pic.twitter.com/7jEv5Rwqzw"}],"hashtags":[{"start":46,"end":70,"tag":"AntimicrobialResistance"}],"mentions":[{"start":20,"end":28,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":25,"reply_count":0,"like_count":12,"quote_count":2},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"823839180891521024","text":"Check out the EMA - @EFSA_EU joint opinion on #AntimicrobialResistance\nhttps://t.co/zMDysk8Ior https://t.co/7jEv5Rwqzw","id":"823839180891521024","lang":"en","created_at":"2017-01-24T10:25:41.000Z","author_id":"116716199","attachments":{"media_keys":["3_823839101615009793"]},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":42,"end":57,"tag":"antimicrobials"},{"start":102,"end":126,"tag":"AntimicrobialResistance"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"public_metrics":{"retweet_count":54,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"823836272951169025","text":"RT @EFSA_EU: How can we reduce the use of #antimicrobials in animals? Find it out in our infographic. #AntimicrobialResistance https://t.co…","id":"823836272951169025","lang":"en","created_at":"2017-01-24T10:14:08.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"823836031606779909"}]},{"entities":{"urls":[{"start":125,"end":148,"url":"https://t.co/RwMby65ueV","expanded_url":"https://twitter.com/EMA_News/status/823570996204449792/photo/1","display_url":"pic.twitter.com/RwMby65ueV"}],"hashtags":[{"start":103,"end":124,"tag":"MedicinesEarlyAccess"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":26,"reply_count":0,"like_count":14,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"823570996204449792","text":"On average, a conditional marketing authorisation is converted into a standard one in approx. 4 years. #MedicinesEarlyAccess https://t.co/RwMby65ueV","id":"823570996204449792","lang":"en","created_at":"2017-01-23T16:40:01.000Z","author_id":"116716199","attachments":{"media_keys":["3_823560663368957952"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/pBtO6ulUur","expanded_url":"http://bit.ly/2iVYpxw","display_url":"bit.ly/2iVYpxw"},{"start":131,"end":154,"url":"https://t.co/0oeSIhUIk0","expanded_url":"https://twitter.com/EMA_News/status/823565963287113728/photo/1","display_url":"pic.twitter.com/0oeSIhUIk0"}],"hashtags":[{"start":109,"end":130,"tag":"MedicinesEarlyAccess"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":8,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"823565963287113728","text":"Conditional marketing authorisation - What companies need to do post-authorisation? https://t.co/pBtO6ulUur  #MedicinesEarlyAccess https://t.co/0oeSIhUIk0","id":"823565963287113728","lang":"en","created_at":"2017-01-23T16:20:01.000Z","author_id":"116716199","attachments":{"media_keys":["3_823558705794924544"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/pBtO6u4jCT","expanded_url":"http://bit.ly/2iVYpxw","display_url":"bit.ly/2iVYpxw"},{"start":113,"end":136,"url":"https://t.co/mtreBg0tRM","expanded_url":"https://twitter.com/EMA_News/status/823558254466895872/photo/1","display_url":"pic.twitter.com/mtreBg0tRM"}],"hashtags":[{"start":91,"end":112,"tag":"MedicinesEarlyAccess"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":7,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"823558254466895872","text":"Conditional marketing authorisation addresses unmet medical needs. https://t.co/pBtO6u4jCT #MedicinesEarlyAccess https://t.co/mtreBg0tRM","id":"823558254466895872","lang":"en","created_at":"2017-01-23T15:49:23.000Z","author_id":"116716199","attachments":{"media_keys":["3_823558207524245505"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/2AWupAerd5","expanded_url":"http://bit.ly/2j5ijBs","display_url":"bit.ly/2j5ijBs"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":73,"end":78,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"823537094144520192","text":"The #agenda of this week's meeting of our committee for human medicines (#CHMP) is available:\nhttps://t.co/2AWupAerd5","id":"823537094144520192","lang":"en","created_at":"2017-01-23T14:25:18.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":95,"end":107,"tag":"antibiotics"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":57,"end":66,"username":"EMA_News","id":"116716199"}],"annotations":{}},"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"822499200504041472","text":"RT @EFSA_EU: Coming out next week our joint opinion with @EMA_News on possible alternatives to #antibiotics in animal husbandry https://t.c…","id":"822499200504041472","lang":"en","created_at":"2017-01-20T17:41:05.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"822446255464923137"}]},{"entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/e8BPaxXx2P","expanded_url":"http://bit.ly/2jH0QTG","display_url":"bit.ly/2jH0QTG"}],"hashtags":[{"start":46,"end":57,"tag":"veterinary"},{"start":58,"end":68,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"822474845556457472","text":"Highlights of this month's recommendations on #veterinary #medicines have been published: https://t.co/e8BPaxXx2P","id":"822474845556457472","lang":"en","created_at":"2017-01-20T16:04:18.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/j8qdEBw84Y","expanded_url":"http://bit.ly/2jALWic","display_url":"bit.ly/2jALWic"}],"hashtags":[{"start":19,"end":30,"tag":"paediatric"},{"start":130,"end":140,"tag":"medicines"}],"mentions":{},"annotations":[{"start":65,"end":84,"probability":0.7539,"type":"Organization","normalized_text":"Paediatric Committee"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"822036956926345216","text":"Find out about the #paediatric investigation plans agreed by our Paediatric Committee (PDCO) in December: https://t.co/j8qdEBw84Y #medicines","id":"822036956926345216","lang":"en","created_at":"2017-01-19T11:04:17.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/sjHCns5TFA","expanded_url":"http://bit.ly/2jUY0HE","display_url":"bit.ly/2jUY0HE"},{"start":120,"end":143,"url":"https://t.co/GVff6c6Kq8","expanded_url":"https://twitter.com/EMA_News/status/821380143218360320/photo/1","display_url":"pic.twitter.com/GVff6c6Kq8"}],"hashtags":[{"start":23,"end":33,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":62,"reply_count":0,"like_count":28,"quote_count":4},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"821380143218360320","text":"Highlights of 2016: 81 #medicines recommended for approval, including 27 new active substances: https://t.co/sjHCns5TFA https://t.co/GVff6c6Kq8","id":"821380143218360320","lang":"en","created_at":"2017-01-17T15:34:21.000Z","author_id":"116716199","attachments":{"media_keys":["3_821380058656940033"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/2SGsoo6tPh","expanded_url":"http://bit.ly/2ixpK9f","display_url":"bit.ly/2ixpK9f"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":42,"end":49,"tag":"orphan"},{"start":114,"end":126,"tag":"RareDisease"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"821373111849324544","text":"The #agenda of this week's meeting of our #orphan medicine committee (COMP) is available: https://t.co/2SGsoo6tPh #RareDisease","id":"821373111849324544","lang":"en","created_at":"2017-01-17T15:06:24.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/Ywwm1eeOMN","expanded_url":"http://bit.ly/2apzXi9","display_url":"bit.ly/2apzXi9"}],"hashtags":[{"start":15,"end":25,"tag":"medicines"},{"start":35,"end":48,"tag":"tuberculosis"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"821347104610275328","text":"Development of #medicines to treat #tuberculosis: comments on draft guidance invited until 31 January 2017: https://t.co/Ywwm1eeOMN","id":"821347104610275328","lang":"en","created_at":"2017-01-17T13:23:04.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/ue3HqzpaJt","expanded_url":"http://bit.ly/2jLOdYl","display_url":"bit.ly/2jLOdYl"}],"hashtags":[{"start":42,"end":60,"tag":"Pharmacovigilance"},{"start":115,"end":120,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"819884073866948608","text":"Check out the highlights from the January #Pharmacovigilance Risk Assessment Committee: https://t.co/ue3HqzpaJt    #PRAC","id":"819884073866948608","lang":"en","created_at":"2017-01-13T12:29:30.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/e4itIBj9L4","expanded_url":"http://bit.ly/2jIlQue","display_url":"bit.ly/2jIlQue"}],"hashtags":[{"start":43,"end":48,"tag":"EPAR"},{"start":53,"end":61,"tag":"Lusduna"},{"start":84,"end":93,"tag":"medicine"},{"start":103,"end":112,"tag":"diabetes"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"819597867690115073","text":"Read the European public assessment report #EPAR for #Lusduna (insulin glargine), a #medicine to treat #diabetes: https://t.co/e4itIBj9L4","id":"819597867690115073","lang":"en","created_at":"2017-01-12T17:32:13.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/3i5yivyXRK","expanded_url":"http://bit.ly/2jaioYL","display_url":"bit.ly/2jaioYL"}],"hashtags":[{"start":80,"end":85,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":6,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"819496142434025472","text":"See the minutes from the November meeting of our committee for human medicines (#CHMP): https://t.co/3i5yivyXRK","id":"819496142434025472","lang":"en","created_at":"2017-01-12T10:48:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/bodvGrOGRM","expanded_url":"http://bit.ly/2iadzxg","display_url":"bit.ly/2iadzxg"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":42,"end":60,"tag":"pharmacovigilance"},{"start":72,"end":77,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"818459830369259521","text":"The #agenda of this week's meeting of our #pharmacovigilance committee (#PRAC) is available here: https://t.co/bodvGrOGRM","id":"818459830369259521","lang":"en","created_at":"2017-01-09T14:10:04.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/egpu9LGvf4","expanded_url":"http://bit.ly/2hUK3Io","display_url":"bit.ly/2hUK3Io"}],"hashtags":[{"start":113,"end":118,"tag":"ATMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"817003653177507840","text":"Find out about the CAT's recommendations on advanced therapy classification in December: https://t.co/egpu9LGvf4 #ATMP","id":"817003653177507840","lang":"en","created_at":"2017-01-05T13:43:44.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/BQt9ffKC7g","expanded_url":"http://bit.ly/2hXbYsP","display_url":"bit.ly/2hXbYsP"}],"hashtags":[{"start":39,"end":44,"tag":"EPAR"},{"start":54,"end":65,"tag":"veterinary"},{"start":75,"end":83,"tag":"Halagon"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"811981741980258304","text":"The European public assessment report (#EPAR) for the #veterinary medicine #Halagon is now published: https://t.co/BQt9ffKC7g","id":"811981741980258304","lang":"en","created_at":"2016-12-22T17:08:27.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/WexqgGgt8k","expanded_url":"http://bit.ly/2hgqBu2","display_url":"bit.ly/2hgqBu2"}],"hashtags":[{"start":43,"end":48,"tag":"EPAR"},{"start":58,"end":69,"tag":"veterinary"},{"start":79,"end":87,"tag":"Cepedex"},{"start":89,"end":105,"tag":"dexmedetomidine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"811951837796597760","text":"See the European public assessment report (#EPAR) for the #veterinary sedative #Cepedex (#dexmedetomidine): https://t.co/WexqgGgt8k","id":"811951837796597760","lang":"en","created_at":"2016-12-22T15:09:38.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/zrepovtWnw","expanded_url":"http://bit.ly/2hfQAC3","display_url":"bit.ly/2hfQAC3"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"811904896282804225","text":"#Consultation open on product-specific bioequivalence guidance for six medicines: https://t.co/zrepovtWnw","id":"811904896282804225","lang":"en","created_at":"2016-12-22T12:03:06.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/sZSI1CEHw3","expanded_url":"http://bit.ly/2huwvE4","display_url":"bit.ly/2huwvE4"},{"start":91,"end":114,"url":"https://t.co/4l2XXuqgWe","expanded_url":"https://twitter.com/EMA_News/status/811898044262350848/photo/1","display_url":"pic.twitter.com/4l2XXuqgWe"}],"hashtags":[{"start":36,"end":54,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":24,"reply_count":0,"like_count":9,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"811898044262350848","text":"Check out the December issue of our #pharmacovigilance newsletter: https://t.co/sZSI1CEHw3 https://t.co/4l2XXuqgWe","id":"811898044262350848","lang":"en","created_at":"2016-12-22T11:35:52.000Z","author_id":"116716199","attachments":{"media_keys":["3_811897684323864576"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/SRVvAAvBSC","expanded_url":"http://bit.ly/2hcYA4Z","display_url":"bit.ly/2hcYA4Z"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"811895671125057536","text":"#Consultation on guidance on clinical investigation of human normal immunoglobulin for intravenous administration https://t.co/SRVvAAvBSC","id":"811895671125057536","lang":"fr","created_at":"2016-12-22T11:26:26.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/gZrVjrORNu","expanded_url":"http://bit.ly/28ZxUmZ","display_url":"bit.ly/28ZxUmZ"}],"hashtags":[{"start":72,"end":83,"tag":"veterinary"},{"start":119,"end":132,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"811891299875979264","text":"Comments invited on guideline on user safety for topically administered #veterinary medicines: https://t.co/gZrVjrORNu #consultation","id":"811891299875979264","lang":"en","created_at":"2016-12-22T11:09:04.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/4doanRYNRp","expanded_url":"http://bit.ly/2hYkdY3","display_url":"bit.ly/2hYkdY3"}],"hashtags":{},"mentions":{},"annotations":[{"start":33,"end":36,"probability":0.3401,"type":"Organization","normalized_text":"SmPC"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"811882288376123393","text":"Comments invited on guideline on SmPC for human normal immunoglobulin for intravenous administration: https://t.co/4doanRYNRp","id":"811882288376123393","lang":"en","created_at":"2016-12-22T10:33:16.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/iLEVJHtzlv","expanded_url":"http://bit.ly/1QIeQ5W","display_url":"bit.ly/1QIeQ5W"},{"start":96,"end":119,"url":"https://t.co/MJ1S5CgvRw","expanded_url":"https://twitter.com/EMA_News/status/811547672704327680/photo/1","display_url":"pic.twitter.com/MJ1S5CgvRw"}],"hashtags":[{"start":19,"end":29,"tag":"medicines"},{"start":46,"end":52,"tag":"PRIME"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":4,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"811547672704327680","text":"Find out about the #medicines accepted in our #PRIME scheme this month: https://t.co/iLEVJHtzlv https://t.co/MJ1S5CgvRw","id":"811547672704327680","lang":"en","created_at":"2016-12-21T12:23:37.000Z","author_id":"116716199","attachments":{"media_keys":["3_811547283544272896"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/gZrVjrORNu","expanded_url":"http://bit.ly/28ZxUmZ","display_url":"bit.ly/28ZxUmZ"}],"hashtags":[{"start":80,"end":91,"tag":"veterinary"},{"start":127,"end":140,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"811496973060702208","text":"One week left to comment on guideline on user safety for topically administered #veterinary medicines: https://t.co/gZrVjrORNu #consultation","id":"811496973060702208","lang":"en","created_at":"2016-12-21T09:02:09.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/0kzGADv1BC","expanded_url":"http://bit.ly/2hQ6P5W","display_url":"bit.ly/2hQ6P5W"},{"start":135,"end":158,"url":"https://t.co/bsnicC2h67","expanded_url":"https://twitter.com/EMA_News/status/811258653038755841/photo/1","display_url":"pic.twitter.com/bsnicC2h67"}],"hashtags":[{"start":49,"end":60,"tag":"veterinary"},{"start":129,"end":134,"tag":"CVMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"811258653038755841","text":"Together with @IFAHEurope, we are organising the #veterinary info day on 16-17 March 2017. Register now! https://t.co/0kzGADv1BC #CVMP https://t.co/bsnicC2h67","id":"811258653038755841","lang":"en","created_at":"2016-12-20T17:15:09.000Z","author_id":"116716199","attachments":{"media_keys":["3_811258568632659968"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/AtjBieWW62","expanded_url":"http://bit.ly/2h5xTzg","display_url":"bit.ly/2h5xTzg"}],"hashtags":[{"start":63,"end":79,"tag":"HerbalMedicines"},{"start":81,"end":86,"tag":"HMPC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"811199166932287489","text":"See the minutes from the September meeting of our committee on #HerbalMedicines (#HMPC) https://t.co/AtjBieWW62","id":"811199166932287489","lang":"en","created_at":"2016-12-20T13:18:47.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/NBaKVFY5sr","expanded_url":"http://bit.ly/2hRWzK4","display_url":"bit.ly/2hRWzK4"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"810900153192378368","text":"Highlights of last week's meeting of our Management Board have been published: https://t.co/NBaKVFY5sr","id":"810900153192378368","lang":"en","created_at":"2016-12-19T17:30:36.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/96wmqfYFU2","expanded_url":"http://bit.ly/2hM46wP","display_url":"bit.ly/2hM46wP"}],"hashtags":[{"start":16,"end":26,"tag":"medicines"},{"start":71,"end":78,"tag":"orphan"},{"start":127,"end":139,"tag":"RareDisease"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":6,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"810848281676877824","text":"See the list of #medicines that were granted a positive opinion for an #orphan designation this month: https://t.co/96wmqfYFU2 #RareDisease","id":"810848281676877824","lang":"en","created_at":"2016-12-19T14:04:29.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/yCK35Gds2B","expanded_url":"http://bit.ly/2gSgv2C","display_url":"bit.ly/2gSgv2C"}],"hashtags":[{"start":100,"end":112,"tag":"biosimilars"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":13,"quote_count":2},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"809792139458740224","text":"In Feb 2017 we will launch a pilot project on tailored scientific advice for the development of new #biosimilars https://t.co/yCK35Gds2B","id":"809792139458740224","lang":"en","created_at":"2016-12-16T16:07:45.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":74,"end":97,"url":"https://t.co/pvUOCr0uy7","expanded_url":"http://bit.ly/2hO6F1H","display_url":"bit.ly/2hO6F1H"}],"hashtags":[{"start":4,"end":13,"tag":"medicine"},{"start":18,"end":38,"tag":"rheumatoidarthritis"},{"start":67,"end":72,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":1,"like_count":5,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"809734370584043520","text":"New #medicine for #rheumatoidarthritis recommended for approval by #CHMP: https://t.co/pvUOCr0uy7","id":"809734370584043520","lang":"en","created_at":"2016-12-16T12:18:12.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/QxZfZc4Bgg","expanded_url":"http://bit.ly/2gItj6L","display_url":"bit.ly/2gItj6L"},{"start":112,"end":135,"url":"https://t.co/2dBvryIMET","expanded_url":"https://twitter.com/EMA_News/status/809734315932319744/photo/1","display_url":"pic.twitter.com/2dBvryIMET"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":19,"end":29,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":5,"quote_count":4},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"809734315932319744","text":"#CHMP recommends 7 #medicines for approval at its December meeting. 81 overall in 2016: https://t.co/QxZfZc4Bgg https://t.co/2dBvryIMET","id":"809734315932319744","lang":"en","created_at":"2016-12-16T12:17:59.000Z","author_id":"116716199","attachments":{"media_keys":["3_809731231428542464"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/QxUaEu3BDC","expanded_url":"http://bit.ly/295HGxT","display_url":"bit.ly/295HGxT"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":84,"end":94,"tag":"medicines"},{"start":98,"end":113,"tag":"clinicaltrials"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":9,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"809702360276533248","text":"#Consultation on guideline on requirements for quality documentation for biological #medicines in #clinicaltrials: https://t.co/QxUaEu3BDC","id":"809702360276533248","lang":"en","created_at":"2016-12-16T10:11:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/gZrVjrORNu","expanded_url":"http://bit.ly/28ZxUmZ","display_url":"bit.ly/28ZxUmZ"}],"hashtags":[{"start":72,"end":83,"tag":"veterinary"},{"start":119,"end":132,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"809694849654026240","text":"Comments invited on guideline on user safety for topically administered #veterinary medicines: https://t.co/gZrVjrORNu #consultation","id":"809694849654026240","lang":"en","created_at":"2016-12-16T09:41:10.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/icGhNKFHua","expanded_url":"http://bit.ly/2hzdOQr","display_url":"bit.ly/2hzdOQr"}],"hashtags":[{"start":62,"end":73,"tag":"paediatric"},{"start":85,"end":90,"tag":"PDCO"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"809357135473676288","text":"We have published the minutes of the September meeting of our #paediatric committee (#PDCO): https://t.co/icGhNKFHua","id":"809357135473676288","lang":"en","created_at":"2016-12-15T11:19:12.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":85,"end":101,"tag":"together4health"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":57,"end":61,"probability":0.8326,"type":"Place","normalized_text":"Paris"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"808960839210401792","text":"RT @WHO_Europe: Want to catch up on what happened at the Paris conference on working #together4health? Get Day 1 highlights here: https://t…","id":"808960839210401792","lang":"en","created_at":"2016-12-14T09:04:28.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"808945662129803264"}]},{"entities":{"urls":[{"start":77,"end":100,"url":"https://t.co/wHq6OVeTQ4","expanded_url":"http://bit.ly/2hq8Nt6","display_url":"bit.ly/2hq8Nt6"}],"hashtags":[{"start":32,"end":49,"tag":"AdaptivePathways"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":9,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"808649201903161344","text":"A summary of discussions at the #AdaptivePathways workshop is now available: https://t.co/wHq6OVeTQ4","id":"808649201903161344","lang":"en","created_at":"2016-12-13T12:26:08.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/h3PDJq8jVJ","expanded_url":"http://bit.ly/2gxqhXA","display_url":"bit.ly/2gxqhXA"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"808374665043464193","text":"The #agenda of this week's meeting of our Management Board has been published: https://t.co/h3PDJq8jVJ","id":"808374665043464193","lang":"en","created_at":"2016-12-12T18:15:13.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/zs15C1SGNd","expanded_url":"http://bit.ly/2gEEZud","display_url":"bit.ly/2gEEZud"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":74,"end":79,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"808369389980545024","text":"The #agenda of this week's meeting of our committee  for human medicines (#CHMP) is available: https://t.co/zs15C1SGNd","id":"808369389980545024","lang":"en","created_at":"2016-12-12T17:54:16.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/2Ht6SK3RRl","expanded_url":"http://bit.ly/2gss8rG","display_url":"bit.ly/2gss8rG"}],"hashtags":{},"mentions":{},"annotations":[{"start":33,"end":35,"probability":0.4747,"type":"Other","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"808327338291302400","text":"You can now see the recording of EMA's webinar on  regulatory and procedural aspects of type I variations: https://t.co/2Ht6SK3RRl","id":"808327338291302400","lang":"en","created_at":"2016-12-12T15:07:10.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":137,"end":160,"url":"https://t.co/OXa33jj8pg","expanded_url":"https://twitter.com/EMA_News/status/807281539482587136/video/1","display_url":"pic.twitter.com/OXa33jj8pg"}],"hashtags":[{"start":110,"end":127,"tag":"AdaptivePathways"}],"mentions":{},"annotations":[{"start":0,"end":14,"probability":0.9948,"type":"Person","normalized_text":"Chris Sotirelis"},{"start":21,"end":35,"probability":0.5114,"type":"Place","normalized_text":"UK Thalassaemia"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"807281539482587136","text":"Chris Sotirelis from UK Thalassaemia Society @UKThal calls for more collaboration between stakeholders at the #AdaptivePathways workshop https://t.co/OXa33jj8pg","id":"807281539482587136","lang":"en","created_at":"2016-12-09T17:51:32.000Z","author_id":"116716199","attachments":{"media_keys":["7_807278803324170240"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":75,"end":98,"url":"https://t.co/3vNwhatLDG","expanded_url":"http://bit.ly/2gJwxYc","display_url":"bit.ly/2gJwxYc"},{"start":99,"end":122,"url":"https://t.co/EA6nuUhU90","expanded_url":"https://twitter.com/EMA_News/status/807266792955580416/photo/1","display_url":"pic.twitter.com/EA6nuUhU90"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":8,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"807266792955580416","text":"Check out the November issue of our Human medicines highlights newsletter: https://t.co/3vNwhatLDG https://t.co/EA6nuUhU90","id":"807266792955580416","lang":"en","created_at":"2016-12-09T16:52:56.000Z","author_id":"116716199","attachments":{"media_keys":["3_807266713943285760"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/x4ygTlvuja","expanded_url":"http://bit.ly/2h5NM9s","display_url":"bit.ly/2h5NM9s"}],"hashtags":[{"start":123,"end":139,"tag":"pharmacokinetic"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"807264585082408960","text":"See the recording of the workshop on qualification and reporting of PBPK modelling and simulation: https://t.co/x4ygTlvuja #pharmacokinetic","id":"807264585082408960","lang":"en","created_at":"2016-12-09T16:44:09.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/fYOvb7BLlY","expanded_url":"http://bit.ly/2gsKigc","display_url":"bit.ly/2gsKigc"}],"hashtags":[{"start":66,"end":77,"tag":"veterinary"},{"start":88,"end":93,"tag":"CVMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"807263287276687366","text":"See the highlights from this month’s meeting of our committee for #veterinary medicines #CVMP: https://t.co/fYOvb7BLlY","id":"807263287276687366","lang":"en","created_at":"2016-12-09T16:39:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":133,"end":156,"url":"https://t.co/aJWgFBGYQ3","expanded_url":"https://twitter.com/EMA_News/status/807248994166566912/video/1","display_url":"pic.twitter.com/aJWgFBGYQ3"}],"hashtags":[{"start":106,"end":123,"tag":"AdaptivePathways"}],"mentions":[{"start":61,"end":68,"username":"myESMO","id":"69232855"}],"annotations":[{"start":0,"end":12,"probability":0.9851,"type":"Person","normalized_text":"Rosa Giuliani"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":8,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"807248994166566912","text":"Rosa Giuliani from the European Society for Medical Oncology @myESMO appreciates the lively debate at the #AdaptivePathways workshop https://t.co/aJWgFBGYQ3","id":"807248994166566912","lang":"en","created_at":"2016-12-09T15:42:12.000Z","author_id":"116716199","attachments":{"media_keys":["7_807245382220660736"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":125,"end":148,"url":"https://t.co/Aie7FEvKE3","expanded_url":"https://twitter.com/EMA_News/status/807185562327195648/video/1","display_url":"pic.twitter.com/Aie7FEvKE3"}],"hashtags":[{"start":98,"end":115,"tag":"AdaptivePathways"}],"mentions":{},"annotations":[{"start":0,"end":14,"probability":0.9962,"type":"Person","normalized_text":"Ashley Woodcock"},{"start":17,"end":40,"probability":0.7142,"type":"Organization","normalized_text":"University of Manchester"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"807185562327195648","text":"Ashley Woodcock, University of Manchester, explains the different perspectives of patients on the #AdaptivePathways approach https://t.co/Aie7FEvKE3","id":"807185562327195648","lang":"en","created_at":"2016-12-09T11:30:09.000Z","author_id":"116716199","attachments":{"media_keys":["7_807181457387094017"]},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":119,"end":136,"tag":"AdaptivePathways"}],"mentions":{},"annotations":[{"start":0,"end":10,"probability":0.8536,"type":"Person","normalized_text":"S. Vamvakas"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806904757738729472","text":"S. Vamvakas: We will endeavour to address any remaining questions and ensure we meet expectations of all stakeholders. #AdaptivePathways","id":"806904757738729472","lang":"en","created_at":"2016-12-08T16:54:20.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":83,"end":100,"tag":"AdaptivePathways"}],"mentions":{},"annotations":[{"start":0,"end":10,"probability":0.9313,"type":"Person","normalized_text":"S. Vamvakas"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806904531204317185","text":"S. Vamvakas, EMA head of scientific advice: We will continue to gain experience on #AdaptivePathways with the involvement of stakeholders","id":"806904531204317185","lang":"en","created_at":"2016-12-08T16:53:26.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":75,"end":98,"url":"https://t.co/4WP24ycrHt","expanded_url":"https://twitter.com/EMA_News/status/806900169266659329/video/1","display_url":"pic.twitter.com/4WP24ycrHt"}],"hashtags":[{"start":47,"end":64,"tag":"AdaptivePathways"}],"mentions":{},"annotations":[{"start":26,"end":38,"probability":0.6158,"type":"Person","normalized_text":"David Leather"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"806900169266659329","text":"Watch short clip of GSK’s David Leather on the #AdaptivePathways workshop: https://t.co/4WP24ycrHt","id":"806900169266659329","lang":"en","created_at":"2016-12-08T16:36:06.000Z","author_id":"116716199","attachments":{"media_keys":["7_806897706606231552"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":138,"end":161,"url":"https://t.co/UzSb2UcSEa","expanded_url":"https://twitter.com/EMA_News/status/806892911715643392/video/1","display_url":"pic.twitter.com/UzSb2UcSEa"}],"hashtags":[{"start":103,"end":120,"tag":"AdaptivePathways"}],"mentions":[{"start":62,"end":71,"username":"cancereu","id":"140344419"}],"annotations":[{"start":0,"end":16,"probability":0.9585,"type":"Person","normalized_text":"Rafal Swierzewski"},{"start":28,"end":60,"probability":0.4357,"type":"Other","normalized_text":"European Cancer Patient Coalition"}]},"public_metrics":{"retweet_count":12,"reply_count":1,"like_count":12,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"806892911715643392","text":"Rafal Swierzewski, from the European Cancer Patient Coalition @cancereu, shares his perspective on the #AdaptivePathways workshop so far: https://t.co/UzSb2UcSEa","id":"806892911715643392","lang":"en","created_at":"2016-12-08T16:07:16.000Z","author_id":"116716199","attachments":{"media_keys":["7_806891068553887744"]},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":0,"end":17,"tag":"AdaptivePathways"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":12,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806829722915274752","text":"#AdaptivePathways is not a new licencing standard. The focus is on evaluating the benefit/risk in a population where unmet need is highest","id":"806829722915274752","lang":"en","created_at":"2016-12-08T11:56:10.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":120,"end":137,"tag":"AdaptivePathways"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9504,"type":"Person","normalized_text":"Dr Eichler"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":4,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806829112081973248","text":"Dr Eichler: The uncertainty a patient might accept depends on whether he faces a life-threatening or a milder condition #AdaptivePathways","id":"806829112081973248","lang":"en","created_at":"2016-12-08T11:53:45.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":25,"end":34,"tag":"Patients"},{"start":123,"end":140,"tag":"AdaptivePathways"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.988,"type":"Person","normalized_text":"Guido Rasi"}]},"public_metrics":{"retweet_count":24,"reply_count":1,"like_count":13,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806820229384904704","text":"Guido Rasi, head of EMA: #Patients should be informed on how we collect evidence and what the remaining uncertainties are: #AdaptivePathways","id":"806820229384904704","lang":"en","created_at":"2016-12-08T11:18:27.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":112,"end":129,"tag":"AdaptivePathways"}],"mentions":[{"start":18,"end":27,"username":"cancereu","id":"140344419"}],"annotations":[{"start":0,"end":15,"probability":0.8968,"type":"Person","normalized_text":"Rafal Swierzeski"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806799723172483073","text":"Rafal Swierzeski, @cancereu, recommends stronger and sustainable collaboration between regulators and patients. #AdaptivePathways","id":"806799723172483073","lang":"en","created_at":"2016-12-08T09:56:58.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/qTHWyjCFEz","expanded_url":"http://bit.ly/2ggK0Jn","display_url":"bit.ly/2ggK0Jn"},{"start":136,"end":159,"url":"https://t.co/OUQ6LMnpLF","expanded_url":"https://twitter.com/EMA_News/status/806793712164450304/photo/1","display_url":"pic.twitter.com/OUQ6LMnpLF"}],"hashtags":[{"start":94,"end":111,"tag":"AdaptivePathways"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9701,"type":"Person","normalized_text":"Dr Eichler"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":7,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806793712164450304","text":"Dr Eichler, EMA Senior Medical Officer: We have all the necessary tools to address the issues #AdaptivePathways https://t.co/qTHWyjCFEz https://t.co/OUQ6LMnpLF","id":"806793712164450304","lang":"en","created_at":"2016-12-08T09:33:05.000Z","author_id":"116716199","attachments":{"media_keys":["3_806793030237683712"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/qTHWyjCFEz","expanded_url":"http://bit.ly/2ggK0Jn","display_url":"bit.ly/2ggK0Jn"},{"start":137,"end":160,"url":"https://t.co/c6ayTvrMGM","expanded_url":"https://twitter.com/EMA_News/status/806792127539650560/photo/1","display_url":"pic.twitter.com/c6ayTvrMGM"}],"hashtags":[{"start":40,"end":57,"tag":"AdaptivePathways"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.973,"type":"Person","normalized_text":"Dr Eichler"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":8,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806792127539650560","text":"Dr Eichler, EMA Senior Medical Officer: #AdaptivePathways is a response to problems that have always been there: https://t.co/qTHWyjCFEz https://t.co/c6ayTvrMGM","id":"806792127539650560","lang":"en","created_at":"2016-12-08T09:26:47.000Z","author_id":"116716199","attachments":{"media_keys":["3_806791041130991617"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/qTHWyjCFEz","expanded_url":"http://bit.ly/2ggK0Jn","display_url":"bit.ly/2ggK0Jn"}],"hashtags":[{"start":92,"end":109,"tag":"AdaptivePathways"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9838,"type":"Person","normalized_text":"Guido Rasi"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806780714054127616","text":"Guido Rasi, EMA Exec Director: We are here to learn and to see with you how we can improve. #AdaptivePathways https://t.co/qTHWyjCFEz","id":"806780714054127616","lang":"en","created_at":"2016-12-08T08:41:26.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":57,"end":80,"url":"https://t.co/qTHWyjCFEz","expanded_url":"http://bit.ly/2ggK0Jn","display_url":"bit.ly/2ggK0Jn"},{"start":81,"end":104,"url":"https://t.co/Ak8FN3VJOq","expanded_url":"https://twitter.com/EMA_News/status/806776581104336896/photo/1","display_url":"pic.twitter.com/Ak8FN3VJOq"}],"hashtags":[{"start":14,"end":31,"tag":"AdaptivePathways"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":24,"reply_count":0,"like_count":15,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806776581104336896","text":"Watch now the #AdaptivePathways workshop live broadcast: https://t.co/qTHWyjCFEz https://t.co/Ak8FN3VJOq","id":"806776581104336896","lang":"en","created_at":"2016-12-08T08:25:00.000Z","author_id":"116716199","attachments":{"media_keys":["3_806564537629556736"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/V8WjO7j7Re","expanded_url":"http://bit.ly/2hgtH0M","display_url":"bit.ly/2hgtH0M"}],"hashtags":[{"start":33,"end":49,"tag":"EUagenciesforum"},{"start":75,"end":86,"tag":"EUAgencies"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806502375095762944","text":"Two new studies presented at the #EUagenciesforum show the contribution of #EUAgencies to citizens: https://t.co/V8WjO7j7Re","id":"806502375095762944","lang":"en","created_at":"2016-12-07T14:15:24.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/Y06bSnCFip","expanded_url":"http://bit.ly/2hgi5uV","display_url":"bit.ly/2hgi5uV"}],"hashtags":[{"start":53,"end":61,"tag":"Ninlaro"},{"start":63,"end":72,"tag":"ixazomib"},{"start":77,"end":86,"tag":"medicine"},{"start":96,"end":103,"tag":"cancer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806469568793288704","text":"See the European public assessment report (EPAR) for #Ninlaro (#ixazomib), a #medicine to treat #cancer: https://t.co/Y06bSnCFip","id":"806469568793288704","lang":"en","created_at":"2016-12-07T12:05:03.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/qTHWyjCFEz","expanded_url":"http://bit.ly/2ggK0Jn","display_url":"bit.ly/2ggK0Jn"},{"start":117,"end":140,"url":"https://t.co/oAu93hUzDc","expanded_url":"https://twitter.com/EMA_News/status/806469556730368000/photo/1","display_url":"pic.twitter.com/oAu93hUzDc"}],"hashtags":[{"start":33,"end":50,"tag":"AdaptivePathways"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":7,"quote_count":3},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"806469556730368000","text":"Follow the live broadcast of the #AdaptivePathways workshop tomorrow. Agenda available here: https://t.co/qTHWyjCFEz https://t.co/oAu93hUzDc","id":"806469556730368000","lang":"en","created_at":"2016-12-07T12:05:00.000Z","author_id":"116716199","attachments":{"media_keys":["3_806469484433342464"]},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":39,"end":55,"tag":"PhEurCommission"},{"start":74,"end":88,"tag":"AnimalTesting"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806143293708967936","text":"RT @edqm_news: Recent decisions of the #PhEurCommission aimed at reducing #AnimalTesting in the quality control of medicines https://t.co/H…","id":"806143293708967936","lang":"en","created_at":"2016-12-06T14:28:33.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"806142404512206848"}]},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/iDurI847bi","expanded_url":"http://bit.ly/1SMa0Yr","display_url":"bit.ly/1SMa0Yr"},{"start":131,"end":154,"url":"https://t.co/TJO2HEpfIp","expanded_url":"https://twitter.com/EMA_News/status/806121025113124864/photo/1","display_url":"pic.twitter.com/TJO2HEpfIp"}],"hashtags":[{"start":39,"end":48,"tag":"workshop"},{"start":76,"end":94,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"806121025113124864","text":"Follow now live the second part of our #workshop on measuring the impact of #pharmacovigilance activities: https://t.co/iDurI847bi https://t.co/TJO2HEpfIp","id":"806121025113124864","lang":"en","created_at":"2016-12-06T13:00:04.000Z","author_id":"116716199","attachments":{"media_keys":["3_806117271093542913"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/hHBluG79X4","expanded_url":"https://euagencies.eu/","display_url":"euagencies.eu"},{"start":129,"end":152,"url":"https://t.co/siSLA4kOY2","expanded_url":"https://twitter.com/EU_SRB/status/806078530975072259","display_url":"twitter.com/EU_SRB/status/…"}],"hashtags":[{"start":33,"end":49,"tag":"euagenciesforum"}],"mentions":{},"annotations":[{"start":69,"end":79,"probability":0.7589,"type":"Organization","normalized_text":"EU Agencies"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"806115646576742400","text":"Follow the live broadcast of the #euagenciesforum on the benefits of EU Agencies for citizens in the EU: https://t.co/hHBluG79X4 https://t.co/siSLA4kOY2","id":"806115646576742400","lang":"en","created_at":"2016-12-06T12:38:41.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"quoted","id":"806078530975072259"}]},{"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/PgULa7NxW6","expanded_url":"http://bit.ly/2eOY784","display_url":"bit.ly/2eOY784"}],"hashtags":[{"start":57,"end":67,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":9,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"805836424218112001","text":"The video of our November workshop on the development of #medicines for spinal muscular atrophy is available: https://t.co/PgULa7NxW6","id":"805836424218112001","lang":"en","created_at":"2016-12-05T18:09:09.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/eZKN26w7Yu","expanded_url":"http://bit.ly/2gZvuH8","display_url":"bit.ly/2gZvuH8"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"805835429064900608","text":"Watch the video recording of our October workshop on patient registries: https://t.co/eZKN26w7Yu","id":"805835429064900608","lang":"en","created_at":"2016-12-05T18:05:12.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/iDurI847bi","expanded_url":"http://bit.ly/1SMa0Yr","display_url":"bit.ly/1SMa0Yr"},{"start":125,"end":148,"url":"https://t.co/t9uXVs4D6l","expanded_url":"https://twitter.com/EMA_News/status/805760557987065857/photo/1","display_url":"pic.twitter.com/t9uXVs4D6l"}],"hashtags":[{"start":33,"end":42,"tag":"workshop"},{"start":70,"end":88,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"805760557987065857","text":"Follow now our live broadcast of #workshop on measuring the impact of #pharmacovigilance activities: https://t.co/iDurI847bi https://t.co/t9uXVs4D6l","id":"805760557987065857","lang":"en","created_at":"2016-12-05T13:07:41.000Z","author_id":"116716199","attachments":{"media_keys":["3_805759972361588736"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/oeogLruUp0","expanded_url":"http://bit.ly/2gPvUgU","display_url":"bit.ly/2gPvUgU"},{"start":106,"end":129,"url":"https://t.co/I5vdJ6qcMZ","expanded_url":"https://twitter.com/EMA_News/status/804691609946308608/photo/1","display_url":"pic.twitter.com/I5vdJ6qcMZ"}],"hashtags":[{"start":71,"end":81,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":12,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"804691609946308608","text":"See our simpler website navigation for regulatory information on human #medicines https://t.co/oeogLruUp0 https://t.co/I5vdJ6qcMZ","id":"804691609946308608","lang":"en","created_at":"2016-12-02T14:20:04.000Z","author_id":"116716199","attachments":{"media_keys":["3_804691085993922560"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/4hlE0UlwOf","expanded_url":"http://bit.ly/2h1S826","display_url":"bit.ly/2h1S826"}],"hashtags":[{"start":0,"end":5,"tag":"PRAC"},{"start":23,"end":33,"tag":"Hepatitis"},{"start":84,"end":94,"tag":"Hepatitis"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":5,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"804657801062711296","text":"#PRAC warns of risk of #Hepatitis B re-activation with direct-acting antivirals for #Hepatitis C. See recommendation https://t.co/4hlE0UlwOf","id":"804657801062711296","lang":"en","created_at":"2016-12-02T12:05:44.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/C4ugHsuMzQ","expanded_url":"http://bit.ly/2gNQNLz","display_url":"bit.ly/2gNQNLz"}],"hashtags":[{"start":45,"end":63,"tag":"pharmacovigilance"},{"start":75,"end":80,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":1,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"804657369460436992","text":"The highlights of this week’s meeting of our #pharmacovigilance committee (#PRAC) are available: https://t.co/C4ugHsuMzQ","id":"804657369460436992","lang":"en","created_at":"2016-12-02T12:04:01.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/UwMxUsuCwg","expanded_url":"http://bit.ly/2gYv5VF","display_url":"bit.ly/2gYv5VF"},{"start":141,"end":164,"url":"https://t.co/GgwVpIwv2X","expanded_url":"https://twitter.com/EMA_News/status/804327983590809600/photo/1","display_url":"pic.twitter.com/GgwVpIwv2X"}],"hashtags":[{"start":0,"end":17,"tag":"AdaptivePathways"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":3,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"804327983590809600","text":"#AdaptivePathways workshop on 8 Dec: follow discussion on development approach for medicines addressing unmet needs: https://t.co/UwMxUsuCwg https://t.co/GgwVpIwv2X","id":"804327983590809600","lang":"en","created_at":"2016-12-01T14:15:09.000Z","author_id":"116716199","attachments":{"media_keys":["3_804325737427857408"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/SgxI97cn0n","expanded_url":"http://bit.ly/2fh3Npf","display_url":"bit.ly/2fh3Npf"},{"start":141,"end":164,"url":"https://t.co/Xzf7mGXKJG","expanded_url":"https://twitter.com/EMA_News/status/804324178740596736/photo/1","display_url":"pic.twitter.com/Xzf7mGXKJG"}],"hashtags":[{"start":83,"end":93,"tag":"medicines"},{"start":132,"end":140,"tag":"EnprEMA"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"804324178740596736","text":"At 14:30: join webinar on how clinical research networks can support developers of #medicines for children: https://t.co/SgxI97cn0n #EnprEMA https://t.co/Xzf7mGXKJG","id":"804324178740596736","lang":"en","created_at":"2016-12-01T14:00:02.000Z","author_id":"116716199","attachments":{"media_keys":["3_804289739813769220"]},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":15,"end":28,"tag":"WorldAIDSDay"},{"start":54,"end":58,"tag":"HIV"},{"start":122,"end":130,"tag":"WAD2016"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"804286285733101568","text":"RT @EU_Health: #WorldAIDSDay 30k Europeans contracted #HIV in 2015, 1 in 7 unaware they r infected, 1 in 2 diagnosed late #WAD2016 https://…","id":"804286285733101568","lang":"en","created_at":"2016-12-01T11:29:28.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"804286103045947393"}]},{"entities":{"urls":{},"hashtags":[{"start":69,"end":73,"tag":"HIV"},{"start":90,"end":103,"tag":"WorldAIDSDay"},{"start":104,"end":132,"tag":"journeemondialecontrelesida"}],"mentions":[{"start":3,"end":16,"username":"ECDC_HIVAIDS","id":"2182569746"}],"annotations":{}},"public_metrics":{"retweet_count":46,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"804285760681766913","text":"RT @ECDC_HIVAIDS: New data, persistent problem: 1 in 2 Europeans get #HIV diagnosis late. #WorldAIDSDay #journeemondialecontrelesida https:…","id":"804285760681766913","lang":"en","created_at":"2016-12-01T11:27:22.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"804251780603322368"}]},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/4dqVcPWqjW","expanded_url":"http://bit.ly/2gaMdDM","display_url":"bit.ly/2gaMdDM"},{"start":112,"end":135,"url":"https://t.co/6PAoBhLa9T","expanded_url":"https://twitter.com/EMA_News/status/804267201582821376/photo/1","display_url":"pic.twitter.com/6PAoBhLa9T"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":12,"probability":0.9351,"type":"Person","normalized_text":"Kaisa Immonen"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":6,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"804267201582821376","text":"Kaisa Immonen elected as new co-chair of Patients’ and Consumers’ Working Party (PCWP): https://t.co/4dqVcPWqjW https://t.co/6PAoBhLa9T","id":"804267201582821376","lang":"en","created_at":"2016-12-01T10:13:38.000Z","author_id":"116716199","attachments":{"media_keys":["3_804266618708721664"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":58,"end":81,"url":"https://t.co/UECoPKkthJ","expanded_url":"http://bit.ly/2gV7jKp","display_url":"bit.ly/2gV7jKp"},{"start":82,"end":105,"url":"https://t.co/ULIycAS76H","expanded_url":"https://twitter.com/EMA_News/status/803966065860603904/photo/1","display_url":"pic.twitter.com/ULIycAS76H"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"803966065860603904","text":"Apply by 11 January 2017 for a role as a project manager: https://t.co/UECoPKkthJ https://t.co/ULIycAS76H","id":"803966065860603904","lang":"en","created_at":"2016-11-30T14:17:01.000Z","author_id":"116716199","attachments":{"media_keys":["3_803958685236162560"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/mHLkbNIo8v","expanded_url":"http://bit.ly/2gIm5Bh","display_url":"bit.ly/2gIm5Bh"},{"start":132,"end":155,"url":"https://t.co/nmwB4wfMhA","expanded_url":"https://twitter.com/EMA_News/status/803958602759344129/photo/1","display_url":"pic.twitter.com/nmwB4wfMhA"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":7,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"803958602759344129","text":"We are recruiting data scientists experienced in processing pharmacovigilance and/or medicine-related data: https://t.co/mHLkbNIo8v https://t.co/nmwB4wfMhA","id":"803958602759344129","lang":"en","created_at":"2016-11-30T13:47:22.000Z","author_id":"116716199","attachments":{"media_keys":["3_803958537252728832"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/LCGy8C1IlH","expanded_url":"http://bit.ly/2fMkr2H","display_url":"bit.ly/2fMkr2H"}],"hashtags":[{"start":27,"end":37,"tag":"medicines"}],"mentions":{},"annotations":[{"start":88,"end":90,"probability":0.5498,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"803593831132250113","text":"Development challenges for #medicines for central nervous system disorders: analysis by EMA experts published today: https://t.co/LCGy8C1IlH","id":"803593831132250113","lang":"en","created_at":"2016-11-29T13:37:54.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/PnT8faCwjR","expanded_url":"http://bit.ly/2gsbNVs","display_url":"bit.ly/2gsbNVs"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":43,"end":61,"tag":"pharmacovigilance"},{"start":73,"end":78,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"803572935399129088","text":"The #agenda for this week's meeting of our #pharmacovigilance committee (#PRAC) is available here: https://t.co/PnT8faCwjR","id":"803572935399129088","lang":"en","created_at":"2016-11-29T12:14:52.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/6TCE6TdwNT","expanded_url":"http://bit.ly/2gRiK5R","display_url":"bit.ly/2gRiK5R"},{"start":137,"end":160,"url":"https://t.co/DsDgokOVUB","expanded_url":"https://twitter.com/EMA_News/status/803558069737324544/photo/1","display_url":"pic.twitter.com/DsDgokOVUB"}],"hashtags":[{"start":129,"end":136,"tag":"PCWP10"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":12,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"803558069737324544","text":"Ten years of EMA's Patients' and Consumers' Working Party (PCWP) - check out our new anniversary videos: https://t.co/6TCE6TdwNT #PCWP10 https://t.co/DsDgokOVUB","id":"803558069737324544","lang":"en","created_at":"2016-11-29T11:15:47.000Z","author_id":"116716199","attachments":{"media_keys":["3_803556323417849857"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/ocNxH2N9e5","expanded_url":"http://bit.ly/2gzPhc9","display_url":"bit.ly/2gzPhc9"}],"hashtags":{},"mentions":{},"annotations":[{"start":66,"end":67,"probability":0.9036,"type":"Place","normalized_text":"UK"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"803271191934943232","text":"Our website will be briefly unavailable  between 18:00 and 19:00 (UK time) on Tuesday 29 November. More information https://t.co/ocNxH2N9e5","id":"803271191934943232","lang":"en","created_at":"2016-11-28T16:15:50.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/xAn373CrOS","expanded_url":"http://bit.ly/2g9XVS3","display_url":"bit.ly/2g9XVS3"},{"start":141,"end":164,"url":"https://t.co/WEHfRrZSPJ","expanded_url":"https://twitter.com/EMA_News/status/803177684331364352/photo/1","display_url":"pic.twitter.com/WEHfRrZSPJ"}],"hashtags":[{"start":49,"end":58,"tag":"workshop"},{"start":86,"end":104,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":7,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"803177684331364352","text":"5 &amp; 6 December: follow our live broadcast of #workshop on measuring the impact of #pharmacovigilance activities: https://t.co/xAn373CrOS https://t.co/WEHfRrZSPJ","id":"803177684331364352","lang":"en","created_at":"2016-11-28T10:04:16.000Z","author_id":"116716199","attachments":{"media_keys":["3_803174286857015296"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/JMfqzKN6jE","expanded_url":"http://bit.ly/2fMSh50","display_url":"bit.ly/2fMSh50"}],"hashtags":[{"start":57,"end":62,"tag":"EPAR"},{"start":68,"end":76,"tag":"Ibrance"},{"start":80,"end":89,"tag":"medicine"},{"start":94,"end":107,"tag":"breastcancer"}],"mentions":{},"annotations":[{"start":22,"end":54,"probability":0.6294,"type":"Other","normalized_text":"European Public Assessment Report"}]},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"803169220712337408","text":"We have published the European Public Assessment Report (#EPAR) for #Ibrance, a #medicine for #breastcancer: https://t.co/JMfqzKN6jE","id":"803169220712337408","lang":"en","created_at":"2016-11-28T09:30:39.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/HD2FlYyLq2","expanded_url":"http://bit.ly/2fM3Dq7","display_url":"bit.ly/2fM3Dq7"}],"hashtags":[{"start":47,"end":61,"tag":"international"}],"mentions":{},"annotations":[{"start":35,"end":39,"probability":0.8324,"type":"Place","normalized_text":"Japan"}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":7,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"802123268316655617","text":"Active pharmaceutical ingredients: Japan joins #international collaboration on GMP inspections:\nhttps://t.co/HD2FlYyLq2","id":"802123268316655617","lang":"en","created_at":"2016-11-25T12:14:24.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/dzdsLahQuZ","expanded_url":"http://bit.ly/2fR9ugw","display_url":"bit.ly/2fR9ugw"},{"start":109,"end":132,"url":"https://t.co/yXoo7SiMu9","expanded_url":"https://twitter.com/EMA_News/status/802082139470757888/photo/1","display_url":"pic.twitter.com/yXoo7SiMu9"}],"hashtags":[{"start":46,"end":56,"tag":"medicines"},{"start":66,"end":79,"tag":"tuberculosis"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"802082139470757888","text":"Follow our workshop on the development of new #medicines to treat #tuberculosis now: https://t.co/dzdsLahQuZ https://t.co/yXoo7SiMu9","id":"802082139470757888","lang":"en","created_at":"2016-11-25T09:30:58.000Z","author_id":"116716199","attachments":{"media_keys":["3_802081681003966464"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/PueVmYQ74G","expanded_url":"http://bit.ly/2gEpDHh","display_url":"bit.ly/2gEpDHh"},{"start":109,"end":132,"url":"https://t.co/dtAaUOutzl","expanded_url":"https://twitter.com/EMA_News/status/801809528165724163/photo/1","display_url":"pic.twitter.com/dtAaUOutzl"}],"hashtags":[{"start":55,"end":65,"tag":"medicines"},{"start":77,"end":82,"tag":"HMPC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"801809528165724163","text":"Marisa Delbò is elected as the new chair of our herbal #medicines committee (#HMPC): https://t.co/PueVmYQ74G https://t.co/dtAaUOutzl","id":"801809528165724163","lang":"ht","created_at":"2016-11-24T15:27:43.000Z","author_id":"116716199","attachments":{"media_keys":["3_801808294763491328"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/f3CGXGn9Sm","expanded_url":"http://bit.ly/2fvjWcX","display_url":"bit.ly/2fvjWcX"}],"hashtags":[{"start":22,"end":30,"tag":"minutes"},{"start":75,"end":93,"tag":"AdvancedTherapies"},{"start":96,"end":100,"tag":"CAT"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"801807977858658304","text":"We have published the #minutes of the October meeting of our Committee for #AdvancedTherapies\n (#CAT): https://t.co/f3CGXGn9Sm","id":"801807977858658304","lang":"en","created_at":"2016-11-24T15:21:33.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":69,"end":92,"url":"https://t.co/EDTti9Hqqu","expanded_url":"http://bit.ly/2gkxWHV","display_url":"bit.ly/2gkxWHV"}],"hashtags":[{"start":36,"end":46,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"801759664664936448","text":"Clinical study reports for two more #medicines now available online:\nhttps://t.co/EDTti9Hqqu","id":"801759664664936448","lang":"en","created_at":"2016-11-24T12:09:34.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/VG151vrOCE","expanded_url":"http://bit.ly/2gjkroe","display_url":"bit.ly/2gjkroe"}],"hashtags":[{"start":39,"end":44,"tag":"EPAR"},{"start":50,"end":59,"tag":"Glyxambi"},{"start":106,"end":115,"tag":"diabetes"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"801758880304955392","text":"See European public assessment report (#EPAR) for #Glyxambi (empagliflozin / linagliptin), a medicine for #diabetes https://t.co/VG151vrOCE","id":"801758880304955392","lang":"en","created_at":"2016-11-24T12:06:27.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/oj9zxuFE5c","expanded_url":"http://bit.ly/2fpiPbE","display_url":"bit.ly/2fpiPbE"}],"hashtags":[{"start":43,"end":48,"tag":"EPAR"},{"start":54,"end":63,"tag":"Lartruvo"},{"start":65,"end":76,"tag":"olaratumab"},{"start":81,"end":90,"tag":"medicine"},{"start":100,"end":107,"tag":"cancer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":1,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"801480522782351360","text":"See the European public assessment report (#EPAR) for #Lartruvo (#olaratumab), a #medicine to treat #cancer https://t.co/oj9zxuFE5c","id":"801480522782351360","lang":"en","created_at":"2016-11-23T17:40:22.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/tTBkHAZ81Q","expanded_url":"http://bit.ly/2frI2Fu","display_url":"bit.ly/2frI2Fu"}],"hashtags":[{"start":50,"end":60,"tag":"antiviral"},{"start":61,"end":70,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"801479122518212608","text":"See the European public assessment report for the #antiviral #medicine Emtricitabine / Tenofovir disoproxil Zentiva https://t.co/tTBkHAZ81Q","id":"801479122518212608","lang":"ro","created_at":"2016-11-23T17:34:48.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/HGgm4wzD66","expanded_url":"http://bit.ly/2bVwAk7","display_url":"bit.ly/2bVwAk7"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":25,"end":35,"tag":"guideline"},{"start":89,"end":96,"tag":"herbal"},{"start":97,"end":108,"tag":"monographs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"801368446093115392","text":"#Consultation on revised #guideline on assessment of clinical safety and efficacy for EU #herbal #monographs: https://t.co/HGgm4wzD66","id":"801368446093115392","lang":"en","created_at":"2016-11-23T10:15:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/0RxOvL02gJ","expanded_url":"http://bit.ly/1Z5LN1B","display_url":"bit.ly/1Z5LN1B"}],"hashtags":[{"start":20,"end":30,"tag":"guideline"},{"start":61,"end":72,"tag":"veterinary"},{"start":73,"end":83,"tag":"medicines"},{"start":109,"end":122,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"801360897239379968","text":"Comments invited on #guideline on plant testing strategy for #veterinary #medicines: https://t.co/0RxOvL02gJ #consultation","id":"801360897239379968","lang":"en","created_at":"2016-11-23T09:45:01.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/krST8l3tTz","expanded_url":"http://bit.ly/2bZ14DN","display_url":"bit.ly/2bZ14DN"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":30,"end":40,"tag":"guideline"},{"start":91,"end":98,"tag":"herbal"},{"start":99,"end":109,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"801348719287353344","text":"#Consultation on revisions to #guideline on non-clinical documentation in applications for #herbal #medicines  https://t.co/krST8l3tTz","id":"801348719287353344","lang":"en","created_at":"2016-11-23T08:56:37.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/d48nuFeSLf","expanded_url":"http://bit.ly/2gCxeY0","display_url":"bit.ly/2gCxeY0"}],"hashtags":[{"start":59,"end":70,"tag":"paediatric"}],"mentions":{},"annotations":[{"start":28,"end":47,"probability":0.8204,"type":"Organization","normalized_text":"Paediatric Committee"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"800759365829464064","text":"The opinions adopted by our Paediatric Committee (PDCO) on #paediatric investigation plans in October are here: https://t.co/d48nuFeSLf","id":"800759365829464064","lang":"en","created_at":"2016-11-21T17:54:44.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/upQunVtSNx","expanded_url":"http://bit.ly/2fjYUhp","display_url":"bit.ly/2fjYUhp"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"800713644661243904","text":"The #minutes of the October meeting of our committee for human medicines (CHMP) are now available: https://t.co/upQunVtSNx","id":"800713644661243904","lang":"en","created_at":"2016-11-21T14:53:04.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/0xsGXLQMle","expanded_url":"http://bit.ly/2g4iX2d","display_url":"bit.ly/2g4iX2d"}],"hashtags":[{"start":19,"end":23,"tag":"CAT"},{"start":45,"end":61,"tag":"advancedtherapy"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799657674698870784","text":"Find out about the #CAT's recommendations on #advancedtherapy classification in November: https://t.co/0xsGXLQMle","id":"799657674698870784","lang":"en","created_at":"2016-11-18T16:57:01.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/t4VWaUsLYJ","expanded_url":"http://bit.ly/2g2J7kB","display_url":"bit.ly/2g2J7kB"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":63,"end":73,"tag":"medicines"},{"start":75,"end":80,"tag":"HMPC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799645386818232320","text":"The #agenda for next week's meeting of our committee on herbal #medicines (#HMPC) is available: https://t.co/t4VWaUsLYJ","id":"799645386818232320","lang":"en","created_at":"2016-11-18T16:08:11.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/f0xh6mbVEK","expanded_url":"http://bit.ly/2g4XNl8","display_url":"bit.ly/2g4XNl8"},{"start":108,"end":131,"url":"https://t.co/pYRiIu4ynb","expanded_url":"https://twitter.com/EMA_News/status/799605878852751360/photo/1","display_url":"pic.twitter.com/pYRiIu4ynb"}],"hashtags":[{"start":49,"end":59,"tag":"medicines"},{"start":69,"end":82,"tag":"tuberculosis"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"799605878852751360","text":"25 Nov 2016 - Workshop on the development of new #medicines to treat #tuberculosis: https://t.co/f0xh6mbVEK https://t.co/pYRiIu4ynb","id":"799605878852751360","lang":"en","created_at":"2016-11-18T13:31:12.000Z","author_id":"116716199","attachments":{"media_keys":["3_799605638691258368"]},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":73,"end":82,"tag":"EAAD2016"},{"start":83,"end":104,"tag":"AntibioticResistance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799578712425504768","text":"Panelists now taking questions. Watching online? Send your questions via #EAAD2016 #AntibioticResistance","id":"799578712425504768","lang":"en","created_at":"2016-11-18T11:43:15.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":117,"end":126,"tag":"EAAD2016"}],"mentions":{},"annotations":[{"start":0,"end":10,"probability":0.996,"type":"Person","normalized_text":"Helen Jukes"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799577713661120512","text":"Helen Jukes reiterates need for vet medicine manufacturers and regulators to continue working together to tackle AMR #EAAD2016","id":"799577713661120512","lang":"en","created_at":"2016-11-18T11:39:17.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":122,"end":131,"tag":"EAAD2016"}],"mentions":{},"annotations":[{"start":0,"end":10,"probability":0.9942,"type":"Person","normalized_text":"Helen Jukes"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799569266945261568","text":"Helen Jukes, CVMP vice-chair: We propose to investigate if colistin targets have been achieved &amp; impact on resistance #EAAD2016","id":"799569266945261568","lang":"en","created_at":"2016-11-18T11:05:43.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/kypuVHahlG","expanded_url":"https://twitter.com/EMA_News/status/799568877785141248/photo/1","display_url":"pic.twitter.com/kypuVHahlG"}],"hashtags":[{"start":104,"end":113,"tag":"EAAD2016"}],"mentions":{},"annotations":[{"start":0,"end":10,"probability":0.974,"type":"Person","normalized_text":"Helen Jukes"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799568877785141248","text":"Helen Jukes, CVMP vice-chair: EU target is to reduce use of colistin in animals by 66% within 3-4 years #EAAD2016 https://t.co/kypuVHahlG","id":"799568877785141248","lang":"en","created_at":"2016-11-18T11:04:10.000Z","author_id":"116716199","attachments":{"media_keys":["3_799568392629981184"]},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":108,"end":117,"tag":"EAAD2016"}],"mentions":{},"annotations":[{"start":0,"end":10,"probability":0.9724,"type":"Person","normalized_text":"Helen Jukes"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799568250187251712","text":"Helen Jukes, CVMP vice-chair: colistin is last resort medicine to treat infections resistant to antibiotics #EAAD2016","id":"799568250187251712","lang":"en","created_at":"2016-11-18T11:01:40.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/MXSqoUkDAV","expanded_url":"http://bit.ly/2gpe87i","display_url":"bit.ly/2gpe87i"}],"hashtags":[{"start":13,"end":18,"tag":"CVMP"},{"start":82,"end":103,"tag":"AntibioticResistance"},{"start":104,"end":113,"tag":"EAAD2016"}],"mentions":{},"annotations":[{"start":0,"end":10,"probability":0.9923,"type":"Person","normalized_text":"Helen Jukes"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799567199103021056","text":"Helen Jukes, #CVMP vice-chair, is one of the speakers to answer your questions on #AntibioticResistance #EAAD2016 https://t.co/MXSqoUkDAV","id":"799567199103021056","lang":"en","created_at":"2016-11-18T10:57:30.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/mI0XMMJReP","expanded_url":"http://bit.ly/2g4CIHg","display_url":"bit.ly/2g4CIHg"}],"hashtags":[{"start":84,"end":105,"tag":"AntibioticResistance"},{"start":130,"end":139,"tag":"EAAD2016"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":[{"start":75,"end":80,"probability":0.9847,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799564904026013696","text":"RT @EAAD_EU: Spread of highly resistant bacteria is at different stages in Europe - #AntibioticResistance https://t.co/mI0XMMJReP #EAAD2016…","id":"799564904026013696","lang":"en","created_at":"2016-11-18T10:48:22.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"799564605202665472"}]},{"entities":{"urls":{},"hashtags":[{"start":76,"end":97,"tag":"AntibioticResistance"},{"start":124,"end":133,"tag":"EAAD2016"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"},{"start":13,"end":21,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":31,"end":45,"probability":0.9821,"type":"Person","normalized_text":"Dominique Monet"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799564719984177152","text":"RT @EAAD_EU: @ECDC_EU AMR head Dominique Monet presents the latest data  on #AntibioticResistance and consumption in humans #EAAD2016","id":"799564719984177152","lang":"en","created_at":"2016-11-18T10:47:39.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"799563465606234116"}]},{"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/FIx4WKPcU6","expanded_url":"http://bit.ly/1Gh85BG","display_url":"bit.ly/1Gh85BG"},{"start":139,"end":162,"url":"https://t.co/OdiYQId5cn","expanded_url":"https://twitter.com/EMA_News/status/799552731581214722/photo/1","display_url":"pic.twitter.com/OdiYQId5cn"}],"hashtags":[{"start":48,"end":59,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799552731581214722","text":"Apply now to represent the civil society at our #paediatric Committee (PDCO). Deadline extended until 21 November: https://t.co/FIx4WKPcU6 https://t.co/OdiYQId5cn","id":"799552731581214722","lang":"en","created_at":"2016-11-18T10:00:00.000Z","author_id":"116716199","attachments":{"media_keys":["3_799368133698027521"]},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":98,"end":107,"tag":"EAAD2016"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"},{"start":108,"end":116,"username":"EFSA_EU","id":"84582815"},{"start":117,"end":126,"username":"EMA_News","id":"116716199"},{"start":127,"end":135,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":13,"end":27,"probability":0.9869,"type":"Person","normalized_text":"Martin Seychell"},{"start":30,"end":31,"probability":0.7465,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799549195480944640","text":"RT @EAAD_EU: Martin Seychell: EU agencies will collaborate to address cross-border threats of AMR #EAAD2016 @EFSA_EU @EMA_News @ECDC_EU","id":"799549195480944640","lang":"en","created_at":"2016-11-18T09:45:57.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"799544635878154240"}]},{"entities":{"urls":{},"hashtags":[{"start":45,"end":48,"tag":"EU"},{"start":131,"end":140,"tag":"EAAD2016"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"},{"start":112,"end":120,"username":"ECDC_EU","id":"204752573"},{"start":121,"end":130,"username":"EMA_News","id":"116716199"}],"annotations":{}},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799548150851792896","text":"RT @EAAD_EU: New EU action plan will support #EU Member States eg strengthen surveillance &amp; monitoring thru @ECDC_EU @EMA_News #EAAD2016","id":"799548150851792896","lang":"en","created_at":"2016-11-18T09:41:48.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"799544148764295168"}]},{"entities":{"urls":[{"start":69,"end":92,"url":"https://t.co/jCzfESvfwY","expanded_url":"http://bit.ly/2g9Zoie","display_url":"bit.ly/2g9Zoie"},{"start":95,"end":118,"url":"https://t.co/HEQl6clrKO","expanded_url":"http://bit.ly/2fQDeKW","display_url":"bit.ly/2fQDeKW"},{"start":129,"end":152,"url":"https://t.co/OWYzTq8dPa","expanded_url":"https://twitter.com/EMA_News/status/799532622162653184/photo/1","display_url":"pic.twitter.com/OWYzTq8dPa"}],"hashtags":[{"start":47,"end":68,"tag":"AntibioticResistance"},{"start":119,"end":128,"tag":"EAAD2016"}],"mentions":{},"annotations":[{"start":30,"end":36,"probability":0.6084,"type":"Product","normalized_text":"twitter"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799532622162653184","text":"Follow now live broadcast and twitter event on #AntibioticResistance https://t.co/jCzfESvfwY - https://t.co/HEQl6clrKO #EAAD2016 https://t.co/OWYzTq8dPa","id":"799532622162653184","lang":"en","created_at":"2016-11-18T08:40:06.000Z","author_id":"116716199","attachments":{"media_keys":["3_799528835679191040"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/PkAqiKlB2b","expanded_url":"http://bit.ly/2gkmbSi","display_url":"bit.ly/2gkmbSi"}],"hashtags":[{"start":80,"end":91,"tag":"veterinary"},{"start":92,"end":102,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799283872462671872","text":"The monthly report on application procedures, guidelines &amp; related docs for #veterinary #medicines is available: https://t.co/PkAqiKlB2b","id":"799283872462671872","lang":"en","created_at":"2016-11-17T16:11:39.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/HEQl6cD2Cm","expanded_url":"http://bit.ly/2fQDeKW","display_url":"bit.ly/2fQDeKW"},{"start":136,"end":159,"url":"https://t.co/nFAwEKblxr","expanded_url":"https://twitter.com/EMA_News/status/799272996556836864/photo/1","display_url":"pic.twitter.com/nFAwEKblxr"}],"hashtags":[{"start":0,"end":21,"tag":"AntibioticResistance"},{"start":117,"end":122,"tag":"EAAD"},{"start":123,"end":130,"tag":"EAAD16"},{"start":131,"end":135,"tag":"AMR"}],"mentions":{},"annotations":[{"start":67,"end":73,"probability":0.5321,"type":"Product","normalized_text":"twitter"}]},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"799272996556836864","text":"#AntibioticResistance concerns everyone. Follow live broadcast and twitter event tomorrow:  https://t.co/HEQl6cD2Cm  #EAAD #EAAD16 #AMR https://t.co/nFAwEKblxr","id":"799272996556836864","lang":"en","created_at":"2016-11-17T15:28:26.000Z","author_id":"116716199","attachments":{"media_keys":["3_799272653924265984"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":66,"end":89,"url":"https://t.co/nM0DGr0rSu","expanded_url":"http://bit.ly/2f0Al5N","display_url":"bit.ly/2f0Al5N"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798939795330187264","text":"See the minutes from the October meeting of our Management Board: https://t.co/nM0DGr0rSu","id":"798939795330187264","lang":"en","created_at":"2016-11-16T17:24:25.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":61,"end":84,"url":"https://t.co/iLEVJHtzlv","expanded_url":"http://bit.ly/1QIeQ5W","display_url":"bit.ly/1QIeQ5W"},{"start":85,"end":108,"url":"https://t.co/zPLa2HYE1r","expanded_url":"https://twitter.com/EMA_News/status/798933154484678656/photo/1","display_url":"pic.twitter.com/zPLa2HYE1r"}],"hashtags":[{"start":19,"end":29,"tag":"medicines"},{"start":42,"end":48,"tag":"PRIME"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798933154484678656","text":"Find out about the #medicines accepted in #PRIME this month: https://t.co/iLEVJHtzlv https://t.co/zPLa2HYE1r","id":"798933154484678656","lang":"en","created_at":"2016-11-16T16:58:02.000Z","author_id":"116716199","attachments":{"media_keys":["3_798928155205660672"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/iXwxcagvkL","expanded_url":"http://bit.ly/2fxdEKw","display_url":"bit.ly/2fxdEKw"},{"start":139,"end":162,"url":"https://t.co/gEQmqUIopo","expanded_url":"https://twitter.com/EMA_News/status/798930364492349440/photo/1","display_url":"pic.twitter.com/gEQmqUIopo"}],"hashtags":[{"start":15,"end":23,"tag":"webinar"},{"start":31,"end":40,"tag":"clinical"},{"start":130,"end":138,"tag":"EnprEMA"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"798930364492349440","text":"Don't miss the #webinar on how #clinical research networks enhance the medicine development for children: https://t.co/iXwxcagvkL #EnprEMA https://t.co/gEQmqUIopo","id":"798930364492349440","lang":"en","created_at":"2016-11-16T16:46:56.000Z","author_id":"116716199","attachments":{"media_keys":["3_798930170568724480"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/MGXUFDJDyw","expanded_url":"http://bit.ly/2ekRXhq","display_url":"bit.ly/2ekRXhq"},{"start":112,"end":135,"url":"https://t.co/w99nnAAbPF","expanded_url":"https://twitter.com/EMA_News/status/798833440359493632/photo/1","display_url":"pic.twitter.com/w99nnAAbPF"}],"hashtags":[{"start":25,"end":30,"tag":"CVMP"},{"start":43,"end":55,"tag":"antibiotics"},{"start":78,"end":87,"tag":"EAAD2016"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798833440359493632","text":"What are the aims of the #CVMP strategy on #antibiotics in animals 2016-2020? #EAAD2016 https://t.co/MGXUFDJDyw https://t.co/w99nnAAbPF","id":"798833440359493632","lang":"en","created_at":"2016-11-16T10:21:48.000Z","author_id":"116716199","attachments":{"media_keys":["3_798833324697366528"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/0RxOvKIqS9","expanded_url":"http://bit.ly/1Z5LN1B","display_url":"bit.ly/1Z5LN1B"}],"hashtags":[{"start":20,"end":30,"tag":"guideline"},{"start":61,"end":72,"tag":"veterinary"},{"start":73,"end":83,"tag":"medicines"},{"start":109,"end":122,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798822493582524416","text":"Comments invited on #guideline on plant testing strategy for #veterinary #medicines: https://t.co/0RxOvKIqS9 #consultation","id":"798822493582524416","lang":"en","created_at":"2016-11-16T09:38:18.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/krST8ll4L7","expanded_url":"http://bit.ly/2bZ14DN","display_url":"bit.ly/2bZ14DN"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":30,"end":40,"tag":"guideline"},{"start":91,"end":98,"tag":"herbal"},{"start":99,"end":109,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798814720589336576","text":"#Consultation on revisions to #guideline on non-clinical documentation in applications for #herbal #medicines https://t.co/krST8ll4L7","id":"798814720589336576","lang":"en","created_at":"2016-11-16T09:07:25.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/t19CFDvUzQ","expanded_url":"http://bit.ly/2ex2k1L","display_url":"bit.ly/2ex2k1L"},{"start":139,"end":162,"url":"https://t.co/IUgww1AwCd","expanded_url":"https://twitter.com/EMA_News/status/798809081641172993/photo/1","display_url":"pic.twitter.com/IUgww1AwCd"}],"hashtags":[{"start":29,"end":38,"tag":"workshop"},{"start":57,"end":64,"tag":"cancer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798809081641172993","text":"Follow the second day of our #workshop on development of #cancer treatments based on genetically modified T-cells: https://t.co/t19CFDvUzQ https://t.co/IUgww1AwCd","id":"798809081641172993","lang":"en","created_at":"2016-11-16T08:45:00.000Z","author_id":"116716199","attachments":{"media_keys":["3_798123590952620032"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/ijdhQpJKRf","expanded_url":"http://bit.ly/2gcNrmj","display_url":"bit.ly/2gcNrmj"}],"hashtags":[{"start":14,"end":22,"tag":"minutes"},{"start":62,"end":72,"tag":"medicines"},{"start":84,"end":89,"tag":"COMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798566190415302656","text":"Check out the #minutes from the October meeting of our orphan #medicines committee (#COMP): https://t.co/ijdhQpJKRf","id":"798566190415302656","lang":"en","created_at":"2016-11-15T16:39:51.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/VwOutIDHc5","expanded_url":"http://bit.ly/2dS0sBh","display_url":"bit.ly/2dS0sBh"},{"start":115,"end":138,"url":"https://t.co/Lhv3xEp8Kk","expanded_url":"https://twitter.com/EMA_News/status/798548629153783808/photo/1","display_url":"pic.twitter.com/Lhv3xEp8Kk"}],"hashtags":[{"start":33,"end":45,"tag":"antibiotics"},{"start":74,"end":80,"tag":"ESVAC"},{"start":81,"end":90,"tag":"EAAD2016"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":6,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798548629153783808","text":"EU Member States continue to use #antibiotics in animals more responsibly #ESVAC #EAAD2016 https://t.co/VwOutIDHc5 https://t.co/Lhv3xEp8Kk","id":"798548629153783808","lang":"en","created_at":"2016-11-15T15:30:04.000Z","author_id":"116716199","attachments":{"media_keys":["3_798544697732067328"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/FIx4WKxBvw","expanded_url":"http://bit.ly/1Gh85BG","display_url":"bit.ly/1Gh85BG"},{"start":134,"end":157,"url":"https://t.co/IKzul9fkDC","expanded_url":"https://twitter.com/EMA_News/status/798533527285338116/photo/1","display_url":"pic.twitter.com/IKzul9fkDC"}],"hashtags":[{"start":53,"end":64,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798533527285338116","text":"Call to appoint civil society representatives at our #paediatric Committee (PDCO) extended until 21 November: https://t.co/FIx4WKxBvw https://t.co/IKzul9fkDC","id":"798533527285338116","lang":"en","created_at":"2016-11-15T14:30:03.000Z","author_id":"116716199","attachments":{"media_keys":["3_798519906845204480"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/K4YCvweGHT","expanded_url":"http://bit.ly/2f0Km6l","display_url":"bit.ly/2f0Km6l"}],"hashtags":[{"start":29,"end":42,"tag":"consultation"},{"start":79,"end":90,"tag":"Paediatric"}],"mentions":[{"start":127,"end":137,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":0,"end":18,"probability":0.6561,"type":"Organization","normalized_text":"European Commission"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798532627028316160","text":"European Commission launches #consultation on the experience acquired with the #Paediatric Regulation: https://t.co/K4YCvweGHT @EU_Health","id":"798532627028316160","lang":"en","created_at":"2016-11-15T14:26:28.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/1VxfJ0WLpt","expanded_url":"http://bit.ly/2fcv6AY","display_url":"bit.ly/2fcv6AY"},{"start":140,"end":163,"url":"https://t.co/cdRgCgFMGB","expanded_url":"https://twitter.com/EMA_News/status/798522262240587777/photo/1","display_url":"pic.twitter.com/cdRgCgFMGB"}],"hashtags":{},"mentions":{},"annotations":[{"start":26,"end":28,"probability":0.4083,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":7,"reply_count":2,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798522262240587777","text":"See the live broadcast of EMA’s webinar on regulatory and procedural aspects of applications for type I variations: https://t.co/1VxfJ0WLpt https://t.co/cdRgCgFMGB","id":"798522262240587777","lang":"en","created_at":"2016-11-15T13:45:17.000Z","author_id":"116716199","attachments":{"media_keys":["3_798521865325133824"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/nBtHH4wSPg","expanded_url":"http://bit.ly/2beZLhL","display_url":"bit.ly/2beZLhL"},{"start":110,"end":133,"url":"https://t.co/fkfdsxlK0R","expanded_url":"https://twitter.com/EMA_News/status/798495778448625664/photo/1","display_url":"pic.twitter.com/fkfdsxlK0R"}],"hashtags":[{"start":54,"end":75,"tag":"AntibioticResistance"},{"start":76,"end":85,"tag":"EAAD2016"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":5,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798495778448625664","text":"How development of new treatments can be accelerated. #AntibioticResistance #EAAD2016 https://t.co/nBtHH4wSPg https://t.co/fkfdsxlK0R","id":"798495778448625664","lang":"en","created_at":"2016-11-15T12:00:03.000Z","author_id":"116716199","attachments":{"media_keys":["3_798493819088105473"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/OQKAnK2rYq","expanded_url":"http://bit.ly/2fBxzW5","display_url":"bit.ly/2fBxzW5"}],"hashtags":[{"start":20,"end":30,"tag":"guideline"},{"start":49,"end":64,"tag":"clinicaltrials"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":1,"like_count":10,"quote_count":4},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798484424535003136","text":"We are revising our #guideline on first-in-human #clinicaltrials; send your comments until end of February 2017: https://t.co/OQKAnK2rYq","id":"798484424535003136","lang":"en","created_at":"2016-11-15T11:14:56.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/CA3H2NZIoc","expanded_url":"http://bit.ly/2ej0aT4","display_url":"bit.ly/2ej0aT4"},{"start":126,"end":149,"url":"https://t.co/l3iL0WFy9w","expanded_url":"https://twitter.com/EMA_News/status/798442920483241984/photo/1","display_url":"pic.twitter.com/l3iL0WFy9w"}],"hashtags":[{"start":28,"end":37,"tag":"workshop"},{"start":41,"end":49,"tag":"bigdata"},{"start":71,"end":81,"tag":"medicines"},{"start":107,"end":125,"tag":"bigdata4medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":24,"reply_count":1,"like_count":12,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798442920483241984","text":"Follow the second day of or #workshop on #bigdata in the regulation of #medicines: https://t.co/CA3H2NZIoc #bigdata4medicines https://t.co/l3iL0WFy9w","id":"798442920483241984","lang":"en","created_at":"2016-11-15T08:30:01.000Z","author_id":"116716199","attachments":{"media_keys":["3_798119030095810560"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/t19CFDNvYq","expanded_url":"http://bit.ly/2ex2k1L","display_url":"bit.ly/2ex2k1L"},{"start":139,"end":162,"url":"https://t.co/D3oK2sYDI7","expanded_url":"https://twitter.com/EMA_News/status/798435373605158912/photo/1","display_url":"pic.twitter.com/D3oK2sYDI7"}],"hashtags":[{"start":29,"end":38,"tag":"workshop"},{"start":57,"end":64,"tag":"cancer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798435373605158912","text":"Follow live broadcast of our #workshop on development of #cancer treatments based on genetically modified T-cells: https://t.co/t19CFDNvYq https://t.co/D3oK2sYDI7","id":"798435373605158912","lang":"en","created_at":"2016-11-15T08:00:01.000Z","author_id":"116716199","attachments":{"media_keys":["3_798122586148405248"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/nBtHH4fhXI","expanded_url":"http://bit.ly/2beZLhL","display_url":"bit.ly/2beZLhL"},{"start":141,"end":164,"url":"https://t.co/Hm6jZMuFKH","expanded_url":"https://twitter.com/EMA_News/status/798199838282280960/video/1","display_url":"pic.twitter.com/Hm6jZMuFKH"}],"hashtags":[{"start":85,"end":106,"tag":"AntibioticResistance"},{"start":107,"end":116,"tag":"EAAD2016"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9794,"type":"Person","normalized_text":"Guido Rasi"}]},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":9,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"798199838282280960","text":"Guido Rasi, EMA Exec Director: We have put up measures to speed up R&amp;D to combat #AntibioticResistance #EAAD2016 https://t.co/nBtHH4fhXI https://t.co/Hm6jZMuFKH","id":"798199838282280960","lang":"en","created_at":"2016-11-14T16:24:05.000Z","author_id":"116716199","attachments":{"media_keys":["7_798199730522177536"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/zdrLyoQ02R","expanded_url":"http://bit.ly/2g7Iv2g","display_url":"bit.ly/2g7Iv2g"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":43,"end":54,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798195840720470016","text":"The #minutes of the October meeting of our #veterinary committee (CVMP) are available: https://t.co/zdrLyoQ02R","id":"798195840720470016","lang":"en","created_at":"2016-11-14T16:08:12.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/iSPmy1oNba","expanded_url":"http://bit.ly/2gaiYo0","display_url":"bit.ly/2gaiYo0"},{"start":135,"end":158,"url":"https://t.co/QCO2rxJOWm","expanded_url":"https://twitter.com/EMA_News/status/798176096743104514/photo/1","display_url":"pic.twitter.com/QCO2rxJOWm"}],"hashtags":[{"start":25,"end":34,"tag":"workshop"},{"start":73,"end":82,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798176096743104514","text":"Follow live broadcast of #workshop on use of modelling and simulation in #medicine development on 21 November: https://t.co/iSPmy1oNba https://t.co/QCO2rxJOWm","id":"798176096743104514","lang":"en","created_at":"2016-11-14T14:49:45.000Z","author_id":"116716199","attachments":{"media_keys":["3_798175630781284352"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/CA3H2OhjMM","expanded_url":"http://bit.ly/2ej0aT4","display_url":"bit.ly/2ej0aT4"},{"start":126,"end":149,"url":"https://t.co/LdmLirmXqG","expanded_url":"https://twitter.com/EMA_News/status/798148483282862081/photo/1","display_url":"pic.twitter.com/LdmLirmXqG"}],"hashtags":[{"start":4,"end":12,"tag":"bigdata"},{"start":43,"end":53,"tag":"medicines"},{"start":66,"end":75,"tag":"workshop"},{"start":107,"end":125,"tag":"bigdata4medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798148483282862081","text":"How #bigdata can be used for regulation of #medicines, follow our #workshop today: https://t.co/CA3H2OhjMM #bigdata4medicines https://t.co/LdmLirmXqG","id":"798148483282862081","lang":"en","created_at":"2016-11-14T13:00:01.000Z","author_id":"116716199","attachments":{"media_keys":["3_798117665420308480"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/nBtHH4fhXI","expanded_url":"http://bit.ly/2beZLhL","display_url":"bit.ly/2beZLhL"},{"start":106,"end":129,"url":"https://t.co/axsDj7om3d","expanded_url":"https://twitter.com/EMA_News/status/798141415989579778/photo/1","display_url":"pic.twitter.com/axsDj7om3d"}],"hashtags":[{"start":50,"end":71,"tag":"AntibioticResistance"},{"start":72,"end":81,"tag":"EAAD2016"}],"mentions":{},"annotations":[{"start":3,"end":8,"probability":0.9892,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":49,"reply_count":0,"like_count":16,"quote_count":5},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798141415989579778","text":"In Europe alone 25000 people die each year due to #AntibioticResistance #EAAD2016 https://t.co/nBtHH4fhXI https://t.co/axsDj7om3d","id":"798141415989579778","lang":"en","created_at":"2016-11-14T12:31:56.000Z","author_id":"116716199","attachments":{"media_keys":["3_798141187051950080"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":57,"end":80,"url":"https://t.co/HEQl6clrKO","expanded_url":"http://bit.ly/2fQDeKW","display_url":"bit.ly/2fQDeKW"},{"start":136,"end":159,"url":"https://t.co/RGCWWGmSag","expanded_url":"https://twitter.com/EMA_News/status/798107368177434625/photo/1","display_url":"pic.twitter.com/RGCWWGmSag"}],"hashtags":[{"start":82,"end":87,"tag":"EAAD"},{"start":88,"end":95,"tag":"EAAD16"},{"start":96,"end":100,"tag":"AMR"},{"start":101,"end":113,"tag":"antibiotics"},{"start":114,"end":135,"tag":"AntibioticResistance"}],"mentions":{},"annotations":[{"start":26,"end":32,"probability":0.4949,"type":"Product","normalized_text":"twitter"}]},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":14,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"798107368177434625","text":"Follow live broadcast and twitter event on 18 November:  https://t.co/HEQl6clrKO  #EAAD #EAAD16 #AMR #antibiotics #AntibioticResistance https://t.co/RGCWWGmSag","id":"798107368177434625","lang":"en","created_at":"2016-11-14T10:16:39.000Z","author_id":"116716199","attachments":{"media_keys":["3_798106574308966401"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/9CZ7x82kbk","expanded_url":"http://bit.ly/2fDJ7c2","display_url":"bit.ly/2fDJ7c2"}],"hashtags":[{"start":66,"end":77,"tag":"veterinary"},{"start":113,"end":118,"tag":"CVMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"797106948030271488","text":"See the highlights from this month’s meeting of our committee for #veterinary medicines: https://t.co/9CZ7x82kbk #CVMP","id":"797106948030271488","lang":"en","created_at":"2016-11-11T16:01:20.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/QoLnE1nbDz","expanded_url":"http://bit.ly/2ePeGk9","display_url":"bit.ly/2ePeGk9"},{"start":92,"end":115,"url":"https://t.co/Fr34yi4ZEl","expanded_url":"https://twitter.com/EMA_News/status/797048907985539072/photo/1","display_url":"pic.twitter.com/Fr34yi4ZEl"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":19,"end":29,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":8,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"797048907985539072","text":"#CHMP recommends 9 #medicines for approval at its November meeting: https://t.co/QoLnE1nbDz https://t.co/Fr34yi4ZEl","id":"797048907985539072","lang":"en","created_at":"2016-11-11T12:10:42.000Z","author_id":"116716199","attachments":{"media_keys":["3_797048505160318977"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/q8jDOvhhay","expanded_url":"http://bit.ly/2e85qZz","display_url":"bit.ly/2e85qZz"},{"start":129,"end":152,"url":"https://t.co/xRpg9q27Ae","expanded_url":"https://twitter.com/EMA_News/status/797046891217293316/photo/1","display_url":"pic.twitter.com/xRpg9q27Ae"}],"hashtags":[{"start":11,"end":19,"tag":"webinar"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"797046891217293316","text":"Follow our #webinar on 15 Nov to learn how to improve the quality of applications for type I variations: https://t.co/q8jDOvhhay https://t.co/xRpg9q27Ae","id":"797046891217293316","lang":"en","created_at":"2016-11-11T12:02:41.000Z","author_id":"116716199","attachments":{"media_keys":["3_797046796350525440"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/AHQFsOCUaA","expanded_url":"https://twitter.com/EMA_News/status/797013779875852289/photo/1","display_url":"pic.twitter.com/AHQFsOCUaA"}],"hashtags":[{"start":51,"end":62,"tag":"antibiotic"},{"start":103,"end":112,"tag":"EAAD2016"}],"mentions":{},"annotations":[{"start":31,"end":37,"probability":0.4272,"type":"Organization","normalized_text":"twitter"}]},"public_metrics":{"retweet_count":12,"reply_count":1,"like_count":7,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"797013779875852289","text":"Follow live broadcast and live twitter event of EU #antibiotic awareness day conference on 18 November #EAAD2016 https://t.co/AHQFsOCUaA","id":"797013779875852289","lang":"en","created_at":"2016-11-11T09:51:07.000Z","author_id":"116716199","attachments":{"media_keys":["3_797011537873539072"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/PgULa7NxW6","expanded_url":"http://bit.ly/2eOY784","display_url":"bit.ly/2eOY784"},{"start":91,"end":114,"url":"https://t.co/U322wMINHl","expanded_url":"https://twitter.com/EMA_News/status/797004527610241024/photo/1","display_url":"pic.twitter.com/U322wMINHl"}],"hashtags":[{"start":15,"end":24,"tag":"workshop"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"797004527610241024","text":"Watch live our #workshop on therapies for spinal muscular atrophy: https://t.co/PgULa7NxW6 https://t.co/U322wMINHl","id":"797004527610241024","lang":"en","created_at":"2016-11-11T09:14:21.000Z","author_id":"116716199","attachments":{"media_keys":["3_797004409993646080"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/haxVZEoAn5","expanded_url":"http://bit.ly/2fULJ92","display_url":"bit.ly/2fULJ92"}],"hashtags":[{"start":8,"end":15,"tag":"agenda"},{"start":47,"end":58,"tag":"paediatric"},{"start":70,"end":75,"tag":"PDCO"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"796762528944689152","text":"See the #agenda of this month's meeting of our #paediatric committee (#PDCO):\nhttps://t.co/haxVZEoAn5","id":"796762528944689152","lang":"en","created_at":"2016-11-10T17:12:44.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/2zYeIVFpHA","expanded_url":"http://bit.ly/2eF51JG","display_url":"bit.ly/2eF51JG"},{"start":109,"end":132,"url":"https://t.co/11lIEZaVL9","expanded_url":"https://twitter.com/EMA_News/status/796696353506201600/photo/1","display_url":"pic.twitter.com/11lIEZaVL9"}],"hashtags":[{"start":39,"end":49,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":40,"reply_count":0,"like_count":14,"quote_count":4},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"796696353506201600","text":"How the European regulatory system for #medicines works. Check out our new brochure: https://t.co/2zYeIVFpHA https://t.co/11lIEZaVL9","id":"796696353506201600","lang":"en","created_at":"2016-11-10T12:49:47.000Z","author_id":"116716199","attachments":{"media_keys":["3_796676739917291520"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/LoEwzoQQ0a","expanded_url":"http://bit.ly/2eAVKCo","display_url":"bit.ly/2eAVKCo"},{"start":131,"end":154,"url":"https://t.co/wkgSoo2jBL","expanded_url":"https://twitter.com/EMA_News/status/796666630982037505/video/1","display_url":"pic.twitter.com/wkgSoo2jBL"}],"hashtags":[{"start":20,"end":32,"tag":"SideEffects"},{"start":92,"end":106,"tag":"PatientSafety"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":48,"reply_count":1,"like_count":23,"quote_count":2},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"796666630982037505","text":"Reporting suspected #SideEffects helps us to better monitor &amp; manage medicines’ safety. #PatientSafety https://t.co/LoEwzoQQ0a https://t.co/wkgSoo2jBL","id":"796666630982037505","lang":"en","created_at":"2016-11-10T10:51:40.000Z","author_id":"116716199","attachments":{"media_keys":["7_796665924862480384"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/HmPjUQqboM","expanded_url":"http://bit.ly/ZoTtg0","display_url":"bit.ly/ZoTtg0"},{"start":109,"end":132,"url":"https://t.co/sIVR3OB8pi","expanded_url":"https://twitter.com/EMA_News/status/796296863326629888/photo/1","display_url":"pic.twitter.com/sIVR3OB8pi"}],"hashtags":[{"start":10,"end":21,"tag":"SideEffect"},{"start":70,"end":84,"tag":"PatientSafety"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":54,"reply_count":0,"like_count":32,"quote_count":2},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"796296863326629888","text":"Suspected #SideEffect? Report it directly to your national authority. #PatientSafety https://t.co/HmPjUQqboM https://t.co/sIVR3OB8pi","id":"796296863326629888","lang":"en","created_at":"2016-11-09T10:22:21.000Z","author_id":"116716199","attachments":{"media_keys":["16_796296748016734208"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/Km7vpZPOP4","expanded_url":"http://bit.ly/2eAWKGC","display_url":"bit.ly/2eAWKGC"},{"start":137,"end":160,"url":"https://t.co/FrzUpBJrC8","expanded_url":"https://twitter.com/EMA_News/status/796044489785806849/photo/1","display_url":"pic.twitter.com/FrzUpBJrC8"}],"hashtags":[{"start":27,"end":36,"tag":"workshop"},{"start":55,"end":62,"tag":"cancer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":6,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"796044489785806849","text":"Follow our 15-16 November  #workshop on development of #cancer treatments based on genetically modified T-cells, https://t.co/Km7vpZPOP4 https://t.co/FrzUpBJrC8","id":"796044489785806849","lang":"en","created_at":"2016-11-08T17:39:30.000Z","author_id":"116716199","attachments":{"media_keys":["3_796042958214676480"]},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":103,"end":111,"tag":"Science"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9824,"type":"Person","normalized_text":"Guido Rasi"},{"start":36,"end":38,"probability":0.3537,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":15,"reply_count":1,"like_count":8,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"796022052486582276","text":"Guido Rasi, EMA Executive Director: EMA is supporting the formation of multinational assessment teams. #Science works best without borders.","id":"796022052486582276","lang":"en","created_at":"2016-11-08T16:10:21.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":53,"end":65,"tag":"SideEffects"},{"start":103,"end":112,"tag":"patients"},{"start":124,"end":138,"tag":"PatientSafety"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9817,"type":"Person","normalized_text":"Guido Rasi"}]},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"796021719773442052","text":"Guido Rasi, EMA Executive Director: The reporting of #SideEffects is constantly↗️; direct reports from #patients ↗️ by 50%” #PatientSafety","id":"796021719773442052","lang":"en","created_at":"2016-11-08T16:09:02.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":90,"end":101,"tag":"openCTdata"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9769,"type":"Person","normalized_text":"Guido Rasi"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":9,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"796020742861287424","text":"Guido Rasi, EMA Executive Director: Researchers, doctors &amp; patients will benefit from #openCTdata; regulators from increased trust.","id":"796020742861287424","lang":"en","created_at":"2016-11-08T16:05:09.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/DzN72B4stl","expanded_url":"http://bit.ly/2eArnvV","display_url":"bit.ly/2eArnvV"}],"hashtags":{},"mentions":[{"start":60,"end":75,"username":"EP_Environment","id":"951333319"}],"annotations":[{"start":0,"end":9,"probability":0.9895,"type":"Person","normalized_text":"Guido Rasi"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"796020045235310592","text":"Guido Rasi, EMA Executive Director, is giving his speech to @EP_Environment now: https://t.co/DzN72B4stl","id":"796020045235310592","lang":"en","created_at":"2016-11-08T16:02:22.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/DzN72B4stl","expanded_url":"http://bit.ly/2eArnvV","display_url":"bit.ly/2eArnvV","status":200,"unwound_url":"https://multimedia.europarl.europa.eu/en/webstreaming?d=20161108&lv=ALL"}],"hashtags":{},"mentions":[{"start":18,"end":33,"username":"EP_Environment","id":"951333319"}],"annotations":[{"start":70,"end":79,"probability":0.9823,"type":"Person","normalized_text":"Guido Rasi"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"796003592771633152","text":"In a few minutes, @EP_Environment will hold an exchange of views with Guido Rasi, EMA Executive Director: https://t.co/DzN72B4stl","id":"796003592771633152","lang":"en","created_at":"2016-11-08T14:57:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/xRiU0UYrCW","expanded_url":"http://bit.ly/2fWEDQK","display_url":"bit.ly/2fWEDQK"},{"start":137,"end":160,"url":"https://t.co/WUnjWrNaSh","expanded_url":"https://twitter.com/EMA_News/status/795939859659706368/photo/1","display_url":"pic.twitter.com/WUnjWrNaSh"}],"hashtags":[{"start":4,"end":12,"tag":"bigdata"},{"start":43,"end":53,"tag":"medicines"},{"start":65,"end":74,"tag":"workshop"},{"start":118,"end":136,"tag":"bigdata4medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":15,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"795939859659706368","text":"How #bigdata can be used for regulation of #medicines, watch our #workshop on 14-15 November: https://t.co/xRiU0UYrCW #bigdata4medicines https://t.co/WUnjWrNaSh","id":"795939859659706368","lang":"en","created_at":"2016-11-08T10:43:45.000Z","author_id":"116716199","attachments":{"media_keys":["3_795938741005258752"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/CyOyTUa4ho","expanded_url":"http://bit.ly/2eO29eq","display_url":"bit.ly/2eO29eq"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":73,"end":78,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"795601585137209344","text":"The #agenda of this week's meeting of our committee for human medicines (#CHMP) is available: https://t.co/CyOyTUa4ho","id":"795601585137209344","lang":"en","created_at":"2016-11-07T12:19:34.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/odio66njcv","expanded_url":"http://bit.ly/2eEGBDk","display_url":"bit.ly/2eEGBDk"},{"start":107,"end":130,"url":"https://t.co/WGQM0HrnFN","expanded_url":"https://twitter.com/EMA_News/status/795573131444420608/photo/1","display_url":"pic.twitter.com/WGQM0HrnFN"}],"hashtags":[{"start":0,"end":9,"tag":"Workshop"},{"start":44,"end":54,"tag":"therapies"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"795573131444420608","text":"#Workshop, 11 November: working towards new #therapies for spinal muscular atrophy https://t.co/odio66njcv https://t.co/WGQM0HrnFN","id":"795573131444420608","lang":"en","created_at":"2016-11-07T10:26:30.000Z","author_id":"116716199","attachments":{"media_keys":["3_795572879127625728"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":63,"end":86,"url":"https://t.co/D2NeRdO8U8","expanded_url":"http://bit.ly/2f264Hn","display_url":"bit.ly/2f264Hn"}],"hashtags":[{"start":23,"end":28,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"794587619724247041","text":"See the agenda for the #CHMP ORGAM meeting on 28 October 2016: https://t.co/D2NeRdO8U8","id":"794587619724247041","lang":"en","created_at":"2016-11-04T17:10:25.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/q8jDOvhhay","expanded_url":"http://bit.ly/2e85qZz","display_url":"bit.ly/2e85qZz"},{"start":129,"end":152,"url":"https://t.co/VXgrm9JZzM","expanded_url":"https://twitter.com/EMA_News/status/794494911009685504/photo/1","display_url":"pic.twitter.com/VXgrm9JZzM"}],"hashtags":[{"start":11,"end":19,"tag":"webinar"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":4,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"794494911009685504","text":"Follow our #webinar on 15 Nov to learn how to improve the quality of applications for type I variations: https://t.co/q8jDOvhhay https://t.co/VXgrm9JZzM","id":"794494911009685504","lang":"en","created_at":"2016-11-04T11:02:02.000Z","author_id":"116716199","attachments":{"media_keys":["3_794494830986588160"]},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":15,"end":28,"tag":"OneHealthDay"},{"start":89,"end":92,"tag":"EU"},{"start":115,"end":125,"tag":"onehealth"},{"start":126,"end":130,"tag":"AMR"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":59,"end":82,"probability":0.3683,"type":"Other","normalized_text":"Antimicrobial Resistance"}]},"public_metrics":{"retweet_count":52,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"794226539240030209","text":"RT @EU_Health: #OneHealthDay We continue the fight against Antimicrobial Resistance: 2nd #EU Action Plan announced #onehealth #AMR https://…","id":"794226539240030209","lang":"en","created_at":"2016-11-03T17:15:37.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"794209633296678916"}]},{"entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/GleInynovB","expanded_url":"http://bit.ly/2eMFMq9","display_url":"bit.ly/2eMFMq9"}],"hashtags":[{"start":42,"end":47,"tag":"Enpr"},{"start":103,"end":114,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"792014988965806080","text":"The minutes of the 2016 annual meeting of #Enpr-EMA members are now published: https://t.co/GleInynovB #paediatric","id":"792014988965806080","lang":"en","created_at":"2016-10-28T14:47:42.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/AVu5RryRde","expanded_url":"http://bit.ly/2eOG3M2","display_url":"bit.ly/2eOG3M2"}],"hashtags":[{"start":70,"end":81,"tag":"Paediatric"},{"start":99,"end":104,"tag":"Enpr"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"792012776931729411","text":"See the report of the 2016 annual workshop of the European Network of #Paediatric Research at EMA (#Enpr-EMA): https://t.co/AVu5RryRde","id":"792012776931729411","lang":"en","created_at":"2016-10-28T14:38:55.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/wmZqQlbtTT","expanded_url":"http://bit.ly/2eU5ji3","display_url":"bit.ly/2eU5ji3"}],"hashtags":[{"start":47,"end":65,"tag":"pharmacovigilance"},{"start":77,"end":82,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"791961458930089985","text":"The highlights from this week's meeting of our #pharmacovigilance committee (#PRAC) are available: https://t.co/wmZqQlbtTT","id":"791961458930089985","lang":"en","created_at":"2016-10-28T11:15:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":119,"end":142,"url":"https://t.co/co9j7adB2w","expanded_url":"http://bit.ly/2ez551i","display_url":"bit.ly/2ez551i"}],"hashtags":[{"start":29,"end":34,"tag":"EFSA"},{"start":94,"end":118,"tag":"AntimicrobialResistance"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":36,"end":45,"username":"EMA_News","id":"116716199"},{"start":52,"end":60,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"791946656589623297","text":"RT @EFSA_EU: New mandate for #EFSA, @EMA_NEWS &amp; @ECDC_EU to jointly develop indicators of #AntimicrobialResistance https://t.co/co9j7adB2w","id":"791946656589623297","lang":"en","created_at":"2016-10-28T10:16:11.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"791634965872177152"}]},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/QRod41SU1e","expanded_url":"http://bit.ly/2dKUmkX","display_url":"bit.ly/2dKUmkX"}],"hashtags":[{"start":34,"end":39,"tag":"EPAR"},{"start":62,"end":71,"tag":"medicine"},{"start":72,"end":79,"tag":"Inhixa"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"791559262933753856","text":"European public assessment report #EPAR for the anticoagulant #medicine #Inhixa (enoxaparin sodium) is now published https://t.co/QRod41SU1e","id":"791559262933753856","lang":"en","created_at":"2016-10-27T08:36:49.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/L6n68Lf2cb","expanded_url":"http://bit.ly/2eIIzne","display_url":"bit.ly/2eIIzne"}],"hashtags":[{"start":42,"end":47,"tag":"EPAR"},{"start":52,"end":62,"tag":"Thorinane"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"791555940583628800","text":"See the European public assessment report #EPAR for #Thorinane (enoxaparin sodium) a medicine to prevent blood clots https://t.co/L6n68Lf2cb","id":"791555940583628800","lang":"en","created_at":"2016-10-27T08:23:37.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/eBEunK5YH9","expanded_url":"http://bit.ly/2eCFMsx","display_url":"bit.ly/2eCFMsx"},{"start":117,"end":140,"url":"https://t.co/8e2YGDV8GO","expanded_url":"https://twitter.com/EMA_News/status/791252329756524544/photo/1","display_url":"pic.twitter.com/8e2YGDV8GO"}],"hashtags":[{"start":62,"end":71,"tag":"clinical"},{"start":81,"end":92,"tag":"openCTdata"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":1,"like_count":9,"quote_count":3},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"791252329756524544","text":"Watch our virtual press conference (20 Oct) on open access to #clinical reports: #openCTdata https://t.co/eBEunK5YH9 https://t.co/8e2YGDV8GO","id":"791252329756524544","lang":"en","created_at":"2016-10-26T12:17:10.000Z","author_id":"116716199","attachments":{"media_keys":["3_791252038793437185"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/eBEunK5YH9","expanded_url":"http://bit.ly/2eCFMsx","display_url":"bit.ly/2eCFMsx"},{"start":117,"end":140,"url":"https://t.co/x1why7qa5T","expanded_url":"https://twitter.com/EMA_News/status/791196070676135937/photo/1","display_url":"pic.twitter.com/x1why7qa5T"}],"hashtags":[{"start":62,"end":71,"tag":"clinical"},{"start":81,"end":92,"tag":"openCTdata"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"791196070676135937","text":"Watch our virtual press conference (20 Oct) on open access to #clinical reports: #openCTdata https://t.co/eBEunK5YH9 https://t.co/x1why7qa5T","id":"791196070676135937","lang":"en","created_at":"2016-10-26T08:33:37.000Z","author_id":"116716199","attachments":{"media_keys":["3_791195873371951104"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":65,"end":88,"url":"https://t.co/eBEunK5YH9","expanded_url":"http://bit.ly/2eCFMsx","display_url":"bit.ly/2eCFMsx"},{"start":89,"end":112,"url":"https://t.co/n5fTp4tJNI","expanded_url":"https://twitter.com/EMA_News/status/790919586904477696/photo/1","display_url":"pic.twitter.com/n5fTp4tJNI"}],"hashtags":[{"start":53,"end":64,"tag":"openCTdata"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":2,"like_count":10,"quote_count":2},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"790919586904477696","text":"Find out more about open access to clinical reports: #openCTdata https://t.co/eBEunK5YH9 https://t.co/n5fTp4tJNI","id":"790919586904477696","lang":"en","created_at":"2016-10-25T14:14:58.000Z","author_id":"116716199","attachments":{"media_keys":["3_790917685802590209"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/Kp4UlNyNem","expanded_url":"http://bit.ly/2enZ2fV","display_url":"bit.ly/2enZ2fV"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":42,"end":60,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"790597387886686209","text":"The #agenda of this week's meeting of our #pharmacovigilance committee (PRAC) is available: https://t.co/Kp4UlNyNem","id":"790597387886686209","lang":"en","created_at":"2016-10-24T16:54:40.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/w72GELKsEZ","expanded_url":"http://bit.ly/2dPkg5H","display_url":"bit.ly/2dPkg5H"}],"hashtags":{},"mentions":[{"start":0,"end":16,"username":"Cormac_Sheridan","id":"308526080"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"789501776072417280","text":"@Cormac_Sheridan Anyone in the world can access the data for general information purposes. See our terms of use: https://t.co/w72GELKsEZ","id":"790581827811639296","lang":"en","created_at":"2016-10-24T15:52:50.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"789501776072417280"}],"in_reply_to_user_id":"308526080"},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/Izuh2wzYNX","expanded_url":"http://bit.ly/2af5lm7","display_url":"bit.ly/2af5lm7"}],"hashtags":[{"start":72,"end":82,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"790579857809772544","text":"Comments invited by 31 October on guidance on clinical investigation of #medicines for bipolar disorder. https://t.co/Izuh2wzYNX","id":"790579857809772544","lang":"en","created_at":"2016-10-24T15:45:01.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/mfDMaUcR4o","expanded_url":"http://bit.ly/2amtu85","display_url":"bit.ly/2amtu85"}],"hashtags":[{"start":0,"end":13,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":1,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"790572310478647297","text":"#consultation on review of EMA guidelines to implement 3Rs (replacement, reduction and refinement of animal testing) https://t.co/mfDMaUcR4o","id":"790572310478647297","lang":"en","created_at":"2016-10-24T15:15:01.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/HsSJtpvWP0","expanded_url":"http://bit.ly/2bV9ppG","display_url":"bit.ly/2bV9ppG"},{"start":141,"end":164,"url":"https://t.co/YPIuUkQJc2","expanded_url":"https://twitter.com/EMA_News/status/790566736244408320/photo/1","display_url":"pic.twitter.com/YPIuUkQJc2"}],"hashtags":[{"start":86,"end":97,"tag":"Paediatric"},{"start":109,"end":114,"tag":"PDCO"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":4,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"790566736244408320","text":"Call for expressions of interest open until 31 Oct. to represent civil society in our #Paediatric Committee (#PDCO): https://t.co/HsSJtpvWP0 https://t.co/YPIuUkQJc2","id":"790566736244408320","lang":"en","created_at":"2016-10-24T14:52:52.000Z","author_id":"116716199","attachments":{"media_keys":["3_790566287407771648"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/ulnV9DBDue","expanded_url":"http://bit.ly/2eDrBEC","display_url":"bit.ly/2eDrBEC"},{"start":137,"end":160,"url":"https://t.co/N8Gbeifjzy","expanded_url":"https://twitter.com/EMA_News/status/790541248700571649/photo/1","display_url":"pic.twitter.com/N8Gbeifjzy"}],"hashtags":[{"start":70,"end":80,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":29,"reply_count":0,"like_count":19,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"790541248700571649","text":"Make better use of patient registries to collect high-quality data on #medicines. Follow our workshop on 28 Oct: https://t.co/ulnV9DBDue https://t.co/N8Gbeifjzy","id":"790541248700571649","lang":"en","created_at":"2016-10-24T13:11:35.000Z","author_id":"116716199","attachments":{"media_keys":["3_790539326362877952"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/06iVudB3Gx","expanded_url":"http://bit.ly/2cWnoc4","display_url":"bit.ly/2cWnoc4"},{"start":118,"end":141,"url":"https://t.co/II6U3iQcIS","expanded_url":"https://twitter.com/EMA_News/status/790507880906625024/photo/1","display_url":"pic.twitter.com/II6U3iQcIS"}],"hashtags":[{"start":41,"end":52,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"790507880906625024","text":"Apply for a role as administrator in our #veterinary medicines division. Deadline 7 November: https://t.co/06iVudB3Gx https://t.co/II6U3iQcIS","id":"790507880906625024","lang":"en","created_at":"2016-10-24T10:59:00.000Z","author_id":"116716199","attachments":{"media_keys":["3_790472792286306304"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/jRbfAVEyi4","expanded_url":"http://bit.ly/2ak1NKg","display_url":"bit.ly/2ak1NKg"}],"hashtags":[{"start":29,"end":39,"tag":"guideline"},{"start":69,"end":78,"tag":"diabetes"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"790500588324790273","text":"Concept paper on revision of #guideline on clinical investigation of #diabetes medicines. Comment until end October: https://t.co/jRbfAVEyi4","id":"790500588324790273","lang":"en","created_at":"2016-10-24T10:30:01.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/w0CEGTwcO5","expanded_url":"http://bit.ly/2cUOxRw","display_url":"bit.ly/2cUOxRw"},{"start":138,"end":161,"url":"https://t.co/J1kUV9OYIU","expanded_url":"https://twitter.com/EMA_News/status/790492530022445057/photo/1","display_url":"pic.twitter.com/J1kUV9OYIU"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":8,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"790492530022445057","text":"We are recruiting experts in stakeholder relations to support our interaction with patients. Deadline 7 November: https://t.co/w0CEGTwcO5 https://t.co/J1kUV9OYIU","id":"790492530022445057","lang":"en","created_at":"2016-10-24T09:58:00.000Z","author_id":"116716199","attachments":{"media_keys":["3_790472535842381824"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/JvcctqOETf","expanded_url":"http://bit.ly/2dxvL13","display_url":"bit.ly/2dxvL13"},{"start":135,"end":158,"url":"https://t.co/nAM2Cmygkt","expanded_url":"https://twitter.com/EMA_News/status/790472458444898304/photo/1","display_url":"pic.twitter.com/nAM2Cmygkt"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"790472458444898304","text":"Apply by 7 Nov for a role as scientific officer on our inspections and human medicines pharmacovigilance team: https://t.co/JvcctqOETf https://t.co/nAM2Cmygkt","id":"790472458444898304","lang":"en","created_at":"2016-10-24T08:38:15.000Z","author_id":"116716199","attachments":{"media_keys":["3_790472316396376064"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/IgkgcmZlK9","expanded_url":"http://bit.ly/2eZ0S8a","display_url":"bit.ly/2eZ0S8a"}],"hashtags":{},"mentions":[{"start":0,"end":9,"username":"redceddy","id":"2233860143"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"789481796459192325","text":"@redceddy for technical assistance, we advise you to contact our service desk at the following link: https://t.co/IgkgcmZlK9","id":"789481796459192325","lang":"en","created_at":"2016-10-21T15:01:42.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{},"in_reply_to_user_id":"2233860143"},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"},{"start":49,"end":58,"username":"EMA_News","id":"116716199"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"789481355226775553","text":"RT @EUombudsman: Step towards more transparency: @EMA_News  launches website - clinical data for newly authorised medicines in the EU https…","id":"789481355226775553","lang":"en","created_at":"2016-10-21T14:59:57.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"789463174021992448"}]},{"entities":{"urls":[{"start":50,"end":73,"url":"https://t.co/TIMRp8pPd9","expanded_url":"http://bit.ly/2dQUL1z","display_url":"bit.ly/2dQUL1z"},{"start":74,"end":97,"url":"https://t.co/qkPfCSMb8w","expanded_url":"https://twitter.com/EMA_News/status/789466276133568518/photo/1","display_url":"pic.twitter.com/qkPfCSMb8w"}],"hashtags":[{"start":25,"end":36,"tag":"openCTdata"},{"start":40,"end":48,"tag":"doctors"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"789466276133568518","text":"What are the benefits of #openCTdata to #doctors? https://t.co/TIMRp8pPd9 https://t.co/qkPfCSMb8w","id":"789466276133568518","lang":"en","created_at":"2016-10-21T14:00:02.000Z","author_id":"116716199","attachments":{"media_keys":["3_789460758778245120"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":64,"end":87,"url":"https://t.co/TIMRp8pPd9","expanded_url":"http://bit.ly/2dQUL1z","display_url":"bit.ly/2dQUL1z"},{"start":88,"end":111,"url":"https://t.co/bF8KuQuySN","expanded_url":"https://twitter.com/EMA_News/status/789452500734795776/photo/1","display_url":"pic.twitter.com/bF8KuQuySN"}],"hashtags":[{"start":9,"end":20,"tag":"openCTdata"},{"start":36,"end":43,"tag":"pharma"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":23,"reply_count":0,"like_count":7,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"789452500734795776","text":"Why does #openCTdata matter for the #pharma industry? See here: https://t.co/TIMRp8pPd9 https://t.co/bF8KuQuySN","id":"789452500734795776","lang":"en","created_at":"2016-10-21T13:05:18.000Z","author_id":"116716199","attachments":{"media_keys":["3_789452239345741824"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":40,"end":63,"url":"https://t.co/TIMRp8pPd9","expanded_url":"http://bit.ly/2dQUL1z","display_url":"bit.ly/2dQUL1z"},{"start":64,"end":87,"url":"https://t.co/VZVlDEztqf","expanded_url":"https://twitter.com/EMA_News/status/789421579650396160/photo/1","display_url":"pic.twitter.com/VZVlDEztqf"}],"hashtags":[{"start":10,"end":21,"tag":"openCTdata"},{"start":29,"end":38,"tag":"patients"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":1,"like_count":6,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"789421579650396160","text":"What will #openCTdata do for #patients? https://t.co/TIMRp8pPd9 https://t.co/VZVlDEztqf","id":"789421579650396160","lang":"en","created_at":"2016-10-21T11:02:25.000Z","author_id":"116716199","attachments":{"media_keys":["3_789421550227296256"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":60,"end":83,"url":"https://t.co/TIMRp8Hq4H","expanded_url":"http://bit.ly/2dQUL1z","display_url":"bit.ly/2dQUL1z"},{"start":84,"end":107,"url":"https://t.co/PD0YB1nlf2","expanded_url":"https://twitter.com/EMA_News/status/789392548322127873/photo/1","display_url":"pic.twitter.com/PD0YB1nlf2"}],"hashtags":[{"start":48,"end":59,"tag":"openCTdata"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":24,"reply_count":0,"like_count":9,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"789392548322127873","text":"How will academics and researchers benefit from #openCTdata https://t.co/TIMRp8Hq4H https://t.co/PD0YB1nlf2","id":"789392548322127873","lang":"en","created_at":"2016-10-21T09:07:04.000Z","author_id":"116716199","attachments":{"media_keys":["3_789392483952189440"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":119,"end":142,"url":"https://t.co/eejf9P3fHH","expanded_url":"http://bit.ly/2emjAEA","display_url":"bit.ly/2emjAEA"}],"hashtags":[{"start":0,"end":11,"tag":"OpenCTData"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":21,"reply_count":1,"like_count":7,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"789116463667933184","text":"#OpenCTData benefits everyone: patients, doctors, academia, researchers &amp; the industry. See what stakeholders say: https://t.co/eejf9P3fHH","id":"789116463667933184","lang":"en","created_at":"2016-10-20T14:50:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/TIMRp8pPd9","expanded_url":"http://bit.ly/2dQUL1z","display_url":"bit.ly/2dQUL1z"},{"start":113,"end":136,"url":"https://t.co/clUC3GqzHp","expanded_url":"https://twitter.com/EMA_News/status/789111434672279552/photo/1","display_url":"pic.twitter.com/clUC3GqzHp"}],"hashtags":[{"start":15,"end":28,"tag":"clinicaldata"},{"start":77,"end":88,"tag":"OpenCTData"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":61,"reply_count":1,"like_count":34,"quote_count":11},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"789111434672279552","text":"Open access to #clinicaldata is good for public health. Share your thoughts! #OpenCTData https://t.co/TIMRp8pPd9 https://t.co/clUC3GqzHp","id":"789111434672279552","lang":"en","created_at":"2016-10-20T14:30:01.000Z","author_id":"116716199","attachments":{"media_keys":["3_789111049538703360"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/ZV2vTdb7qd","expanded_url":"http://bit.ly/2ekfyhp","display_url":"bit.ly/2ekfyhp"}],"hashtags":[{"start":37,"end":47,"tag":"medicines"},{"start":97,"end":108,"tag":"OpenCTData"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":33,"reply_count":1,"like_count":20,"quote_count":12},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"789107714869690368","text":"Open access to clinical data for new #medicines for human use in the EU: https://t.co/ZV2vTdb7qd #OpenCTData","id":"789107714869690368","lang":"en","created_at":"2016-10-20T14:15:14.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/ehqblgc17e","expanded_url":"http://bit.ly/2enhZgr","display_url":"bit.ly/2enhZgr"}],"hashtags":[{"start":20,"end":25,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"789067894990647296","text":"The minutes for the #CHMP meeting on 12-15 September 2016 are also available: https://t.co/ehqblgc17e","id":"789067894990647296","lang":"en","created_at":"2016-10-20T11:37:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/5r9VREBkFZ","expanded_url":"http://ow.ly/o1Jl305mics","display_url":"ow.ly/o1Jl305mics"},{"start":111,"end":134,"url":"https://t.co/zsLSPs4Mue","expanded_url":"https://twitter.com/EU_IPO/status/789018881797021696/photo/1","display_url":"pic.twitter.com/zsLSPs4Mue"}],"hashtags":[{"start":21,"end":32,"tag":"EUAgencies"},{"start":41,"end":50,"tag":"Alicante"},{"start":67,"end":73,"tag":"EUIPO"}],"mentions":[{"start":3,"end":10,"username":"EU_IPO","id":"70650192"}],"annotations":{}},"public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"789058688501817344","text":"RT @EU_IPO: Heads of #EUAgencies meet in #Alicante today under the #EUIPO chairmanship https://t.co/5r9VREBkFZ https://t.co/zsLSPs4Mue","id":"789058688501817344","lang":"en","created_at":"2016-10-20T11:00:25.000Z","author_id":"116716199","attachments":{"media_keys":["3_789018794802966528"]},"referenced_tweets":[{"type":"retweeted","id":"789018881797021696"}]},{"entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/LU1icfvvmM","expanded_url":"http://bit.ly/2emrbpF","display_url":"bit.ly/2emrbpF"}],"hashtags":[{"start":4,"end":9,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"789055310887391232","text":"The #CHMP ORGAM minutes for the meeting on 3 October 2016 have been published: https://t.co/LU1icfvvmM","id":"789055310887391232","lang":"en","created_at":"2016-10-20T10:47:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/cH8XXUmLkZ","expanded_url":"http://bit.ly/2elBasA","display_url":"bit.ly/2elBasA"},{"start":140,"end":163,"url":"https://t.co/yRkoU4X0HH","expanded_url":"https://twitter.com/EMA_News/status/789045636809261056/photo/1","display_url":"pic.twitter.com/yRkoU4X0HH"}],"hashtags":[{"start":80,"end":91,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"789045636809261056","text":"The monthly report on application procedures, guidelines &amp; related docs for #veterinary medicines is available: https://t.co/cH8XXUmLkZ https://t.co/yRkoU4X0HH","id":"789045636809261056","lang":"en","created_at":"2016-10-20T10:08:34.000Z","author_id":"116716199","attachments":{"media_keys":["3_789043693848322048"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/1e25lvdVVU","expanded_url":"http://bit.ly/2ejvfFs","display_url":"bit.ly/2ejvfFs"}],"hashtags":[{"start":40,"end":58,"tag":"AdvancedTherapies"},{"start":91,"end":95,"tag":"CAT"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"789032143020257280","text":"The monthly report of the Committee for #AdvancedTherapies is out: https://t.co/1e25lvdVVU #CAT","id":"789032143020257280","lang":"en","created_at":"2016-10-20T09:14:57.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/iLEVJHtzlv","expanded_url":"http://bit.ly/1QIeQ5W","display_url":"bit.ly/1QIeQ5W"}],"hashtags":[{"start":47,"end":53,"tag":"PRIME"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":1,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"788782605051301888","text":"The complete list of medicines accepted in our #PRIME scheme is now available: https://t.co/iLEVJHtzlv","id":"788782605051301888","lang":"en","created_at":"2016-10-19T16:43:22.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":60,"end":83,"url":"https://t.co/EvkxJg1CfL","expanded_url":"http://bit.ly/2dqHcVq","display_url":"bit.ly/2dqHcVq"},{"start":84,"end":107,"url":"https://t.co/WQB3Jj8aLQ","expanded_url":"https://twitter.com/EMA_News/status/788782091282571264/photo/1","display_url":"pic.twitter.com/WQB3Jj8aLQ"}],"hashtags":[{"start":41,"end":47,"tag":"PRIME"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"788782091282571264","text":"Find out about the medicines accepted in #PRIME this month: https://t.co/EvkxJg1CfL https://t.co/WQB3Jj8aLQ","id":"788782091282571264","lang":"en","created_at":"2016-10-19T16:41:20.000Z","author_id":"116716199","attachments":{"media_keys":["3_788781999989424128"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/4mpCUvZqiG","expanded_url":"http://bit.ly/2eRJZvY","display_url":"bit.ly/2eRJZvY"},{"start":112,"end":135,"url":"https://t.co/uwB3UPySrq","expanded_url":"https://twitter.com/EMA_News/status/788778560429359104/photo/1","display_url":"pic.twitter.com/uwB3UPySrq"}],"hashtags":[{"start":44,"end":49,"tag":"SMEs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"788778560429359104","text":"Check our updated user guide which supports #SMEs to navigate EU legislative framework: https://t.co/4mpCUvZqiG https://t.co/uwB3UPySrq","id":"788778560429359104","lang":"en","created_at":"2016-10-19T16:27:18.000Z","author_id":"116716199","attachments":{"media_keys":["3_788777781333229568"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/SEC2sug7Yz","expanded_url":"http://bit.ly/2dl15SM","display_url":"bit.ly/2dl15SM"}],"hashtags":[{"start":76,"end":85,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"788415484052041728","text":"See the report on a workshop on the extrapolation of efficacy and safety in #medicine development across age groups: https://t.co/SEC2sug7Yz","id":"788415484052041728","lang":"en","created_at":"2016-10-18T16:24:34.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/jRbfAVW99C","expanded_url":"http://bit.ly/2ak1NKg","display_url":"bit.ly/2ak1NKg"}],"hashtags":[{"start":54,"end":64,"tag":"guideline"},{"start":94,"end":103,"tag":"diabetes"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"788024266398707713","text":"Comment by 31 October on concept paper on revision of #guideline on clinical investigation of #diabetes medicines: https://t.co/jRbfAVW99C","id":"788024266398707713","lang":"en","created_at":"2016-10-17T14:30:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/SDiJk4ybEx","expanded_url":"http://bit.ly/2aCV9AP","display_url":"bit.ly/2aCV9AP"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":67,"end":82,"tag":"CysticFibrosis"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"788016719134687233","text":"#Consultation on guidance on the development of medicines to treat #CysticFibrosis. Comments by 31 October: https://t.co/SDiJk4ybEx","id":"788016719134687233","lang":"en","created_at":"2016-10-17T14:00:01.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/HsSJtpNxGy","expanded_url":"http://bit.ly/2bV9ppG","display_url":"bit.ly/2bV9ppG"}],"hashtags":[{"start":86,"end":97,"tag":"Paediatric"},{"start":109,"end":114,"tag":"PDCO"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"788009172981866498","text":"Call for expressions of interest open until 31 Oct. to represent civil society in our #Paediatric Committee (#PDCO): https://t.co/HsSJtpNxGy","id":"788009172981866498","lang":"en","created_at":"2016-10-17T13:30:01.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/Izuh2wRAcx","expanded_url":"http://bit.ly/2af5lm7","display_url":"bit.ly/2af5lm7"}],"hashtags":[{"start":72,"end":82,"tag":"medicines"},{"start":87,"end":95,"tag":"bipolar"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"788001627286437888","text":"Comments invited by 31 October on guidance on clinical investigation of #medicines for #bipolar disorder: https://t.co/Izuh2wRAcx","id":"788001627286437888","lang":"en","created_at":"2016-10-17T13:00:02.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/mfDMaUcR4o","expanded_url":"http://bit.ly/2amtu85","display_url":"bit.ly/2amtu85"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"787989517596782596","text":"Comment review of EMA guidelines to implement 3Rs (replacement-reduction-refinement of animal testing) by 31 Oct: https://t.co/mfDMaUcR4o","id":"787989517596782596","lang":"en","created_at":"2016-10-17T12:11:55.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/uSA9qFpSZW","expanded_url":"http://bit.ly/2ef5AeJ","display_url":"bit.ly/2ef5AeJ"}],"hashtags":[{"start":4,"end":13,"tag":"medicine"},{"start":102,"end":107,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":5,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"786887381823741952","text":"New #medicine for primary biliary cholangitis (primary biliary cirrhosis) recommended for approval by #CHMP: https://t.co/uSA9qFpSZW","id":"786887381823741952","lang":"en","created_at":"2016-10-14T11:12:26.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":71,"end":94,"url":"https://t.co/EY0YWzKca6","expanded_url":"http://bit.ly/2edf0pC","display_url":"bit.ly/2edf0pC"},{"start":95,"end":118,"url":"https://t.co/mzVnBnr6gY","expanded_url":"https://twitter.com/EMA_News/status/786887356439748608/photo/1","display_url":"pic.twitter.com/mzVnBnr6gY"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":23,"end":33,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":3,"quote_count":4},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"786887356439748608","text":"#CHMP recommends eight #medicines for approval at its October meeting: https://t.co/EY0YWzKca6 https://t.co/mzVnBnr6gY","id":"786887356439748608","lang":"en","created_at":"2016-10-14T11:12:20.000Z","author_id":"116716199","attachments":{"media_keys":["3_786886643567525888"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/dVwNbuE9vu","expanded_url":"http://bit.ly/2dgF3f0","display_url":"bit.ly/2dgF3f0"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"786868079254966273","text":"@ElenaEG4A In order to provide you with a detailed response, please send your query to us using this link: https://t.co/dVwNbuE9vu","id":"786873537244037120","lang":"en","created_at":"2016-10-14T10:17:25.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"786868079254966273"}],"in_reply_to_user_id":"517469921"},{"entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/VwOutIDHc5","expanded_url":"http://bit.ly/2dS0sBh","display_url":"bit.ly/2dS0sBh"},{"start":122,"end":145,"url":"https://t.co/RueWFoLrcF","expanded_url":"https://twitter.com/EMA_News/status/786867356475752448/photo/1","display_url":"pic.twitter.com/RueWFoLrcF"}],"hashtags":[{"start":9,"end":20,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":10,"quote_count":7},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"786867356475752448","text":"Sales of #veterinary antibiotics continue to decline in most European countries. Read the report: https://t.co/VwOutIDHc5 https://t.co/RueWFoLrcF","id":"786867356475752448","lang":"en","created_at":"2016-10-14T09:52:51.000Z","author_id":"116716199","attachments":{"media_keys":["3_786867084508749824"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/7vZtlwICLO","expanded_url":"http://bit.ly/2ekJwmy","display_url":"bit.ly/2ekJwmy"}],"hashtags":[{"start":19,"end":29,"tag":"medicines"},{"start":46,"end":53,"tag":"orphan"},{"start":73,"end":78,"tag":"COMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"786610589065940992","text":"Find out about the #medicines recommended for #orphan designation by the #COMP in October: https://t.co/7vZtlwICLO","id":"786610589065940992","lang":"en","created_at":"2016-10-13T16:52:33.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/cqmINAmJBg","expanded_url":"http://bit.ly/2d9NM7e","display_url":"bit.ly/2d9NM7e"},{"start":107,"end":130,"url":"https://t.co/yJWFuMbwMI","expanded_url":"https://twitter.com/EMA_News/status/786594706079698945/photo/1","display_url":"pic.twitter.com/yJWFuMbwMI"}],"hashtags":[{"start":71,"end":81,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":10,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"786594706079698945","text":"Check out our first mapping of global regulatory initiatives for human #medicines: https://t.co/cqmINAmJBg https://t.co/yJWFuMbwMI","id":"786594706079698945","lang":"en","created_at":"2016-10-13T15:49:26.000Z","author_id":"116716199","attachments":{"media_keys":["3_786594654418571264"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/tiFNvzCBnQ","expanded_url":"http://bit.ly/2dJay5e","display_url":"bit.ly/2dJay5e"}],"hashtags":[{"start":30,"end":40,"tag":"Cabometyx"},{"start":42,"end":55,"tag":"cabozantinib"},{"start":64,"end":73,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"786192578144272385","text":"See the assessment report for #Cabometyx (#cabozantinib), a new #medicine for patients with advanced kidney cancer: https://t.co/tiFNvzCBnQ","id":"786192578144272385","lang":"en","created_at":"2016-10-12T13:11:32.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/1I3DbsFec2","expanded_url":"http://bit.ly/2dhAcgL","display_url":"bit.ly/2dhAcgL"},{"start":123,"end":146,"url":"https://t.co/8Q0WCSIPTF","expanded_url":"https://twitter.com/EMA_News/status/785842760234459137/photo/1","display_url":"pic.twitter.com/8Q0WCSIPTF"}],"hashtags":[{"start":0,"end":7,"tag":"Survey"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"785842760234459137","text":"#Survey results are out: Satisfaction of users with centralised post-authorisation procedures 2015 https://t.co/1I3DbsFec2 https://t.co/8Q0WCSIPTF","id":"785842760234459137","lang":"en","created_at":"2016-10-11T14:01:28.000Z","author_id":"116716199","attachments":{"media_keys":["3_785842652952625157"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":75,"end":98,"url":"https://t.co/IGP5vU8PjA","expanded_url":"http://bit.ly/2dqL3Tj","display_url":"bit.ly/2dqL3Tj"}],"hashtags":[{"start":20,"end":30,"tag":"medicines"},{"start":55,"end":60,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"785501298326114304","text":"The monthly list of #medicines under evaluation by the #CHMP is available: https://t.co/IGP5vU8PjA","id":"785501298326114304","lang":"en","created_at":"2016-10-10T15:24:38.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/OOX3ubms9L","expanded_url":"http://bit.ly/2dFgqib","display_url":"bit.ly/2dFgqib"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":62,"end":72,"tag":"medicines"},{"start":74,"end":79,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"785435900251631616","text":"The #agenda of this week's meeting of our committee for human #medicines (#CHMP) is available: https://t.co/OOX3ubms9L","id":"785435900251631616","lang":"en","created_at":"2016-10-10T11:04:45.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/cCfE5DGilz","expanded_url":"http://bit.ly/2dKyq95","display_url":"bit.ly/2dKyq95"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":6,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"784419818732711936","text":"The highlights from yesterday's meeting of our Management Board have been published: https://t.co/cCfE5DGilz","id":"784419818732711936","lang":"en","created_at":"2016-10-07T15:47:13.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/Th5dqSKNfc","expanded_url":"http://bit.ly/2cZJwlV","display_url":"bit.ly/2cZJwlV"}],"hashtags":[{"start":32,"end":50,"tag":"AdvancedTherapies"},{"start":52,"end":56,"tag":"CAT"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"784418778662768645","text":"The agenda of the Committee for #AdvancedTherapies (#CAT) meeting has just been published https://t.co/Th5dqSKNfc","id":"784418778662768645","lang":"en","created_at":"2016-10-07T15:43:05.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/5jz2Psuyw5","expanded_url":"http://bit.ly/2dR9Yz7","display_url":"bit.ly/2dR9Yz7"},{"start":127,"end":150,"url":"https://t.co/11lFiLchii","expanded_url":"https://twitter.com/EMA_News/status/784390251150278660/photo/1","display_url":"pic.twitter.com/11lFiLchii"}],"hashtags":[{"start":0,"end":5,"tag":"CVMP"},{"start":81,"end":91,"tag":"honeybees"}],"mentions":{},"annotations":[{"start":42,"end":58,"probability":0.3419,"type":"Person","normalized_text":"Varroa destructor"}]},"public_metrics":{"retweet_count":11,"reply_count":1,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"784390251150278660","text":"#CVMP recommended a new treatment against Varroa destructor, the largest pest to #honeybees worldwide. https://t.co/5jz2Psuyw5 https://t.co/11lFiLchii","id":"784390251150278660","lang":"en","created_at":"2016-10-07T13:49:43.000Z","author_id":"116716199","attachments":{"media_keys":["3_784389588349513729"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/JvcctqOETf","expanded_url":"http://bit.ly/2dxvL13","display_url":"bit.ly/2dxvL13"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"784046435859922944","text":"Apply by 7 Nov for a role as scientific officer on our inspections and human medicines pharmacovigilance team: https://t.co/JvcctqOETf","id":"784046435859922944","lang":"en","created_at":"2016-10-06T15:03:31.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/w0CEGTwcO5","expanded_url":"http://bit.ly/2cUOxRw","display_url":"bit.ly/2cUOxRw"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"784045515952492544","text":"We are recruiting experts in stakeholder relations to support  our interaction with patients.  Deadline 7 November: https://t.co/w0CEGTwcO5","id":"784045515952492544","lang":"en","created_at":"2016-10-06T14:59:52.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/06iVudB3Gx","expanded_url":"http://bit.ly/2cWnoc4","display_url":"bit.ly/2cWnoc4"}],"hashtags":[{"start":41,"end":52,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"784041688587173888","text":"Apply for a role as administrator in our #veterinary medicines division. Deadline 7 November: https://t.co/06iVudB3Gx","id":"784041688587173888","lang":"en","created_at":"2016-10-06T14:44:40.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":65,"end":88,"url":"https://t.co/K1weex0rwG","expanded_url":"http://bit.ly/2dKcVlX","display_url":"bit.ly/2dKcVlX"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"783704665632477185","text":"See the agenda for the meeting of our Management Board tomorrow: https://t.co/K1weex0rwG","id":"783704665632477185","lang":"en","created_at":"2016-10-05T16:25:27.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/dwC0S8CPbW","expanded_url":"http://bit.ly/1eSRmZC","display_url":"bit.ly/1eSRmZC"}],"hashtags":[{"start":52,"end":57,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"783333291533463552","text":"We will now also publish agendas and minutes of the #CHMP Organisational Matters (ORGAM) meeting. First agenda here: https://t.co/dwC0S8CPbW","id":"783333291533463552","lang":"en","created_at":"2016-10-04T15:49:44.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/eELm9TZEDR","expanded_url":"http://bit.ly/2dGQzWE","display_url":"bit.ly/2dGQzWE"}],"hashtags":[{"start":0,"end":11,"tag":"Paediatric"},{"start":23,"end":28,"tag":"PDCO"},{"start":56,"end":66,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"783316778483118080","text":"#Paediatric Committee (#PDCO) has agreed 6 new PIPs for #medicines for children under development : https://t.co/eELm9TZEDR","id":"783316778483118080","lang":"en","created_at":"2016-10-04T14:44:07.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/z7Cs3WvOSD","expanded_url":"http://bit.ly/2dNJ3co","display_url":"bit.ly/2dNJ3co"}],"hashtags":[{"start":51,"end":62,"tag":"veterinary"},{"start":63,"end":73,"tag":"medicines"},{"start":85,"end":90,"tag":"CVMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"783261043212574721","text":"See here the agenda for this week's meeting of our #veterinary #medicines committee (#CVMP): https://t.co/z7Cs3WvOSD","id":"783261043212574721","lang":"en","created_at":"2016-10-04T11:02:39.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/kLJg4YRIWB","expanded_url":"http://bit.ly/2dDNTZO","display_url":"bit.ly/2dDNTZO"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":25,"end":32,"tag":"herbal"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"782932188010545153","text":"The #minutes of our July #herbal medicines committee (HMPC) meeting are available: https://t.co/kLJg4YRIWB","id":"782932188010545153","lang":"en","created_at":"2016-10-03T13:15:54.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/tWRuzN8JGl","expanded_url":"http://bit.ly/2d0SccK","display_url":"bit.ly/2d0SccK"}],"hashtags":[{"start":47,"end":65,"tag":"pharmacovigilance"},{"start":77,"end":82,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"781816302658850816","text":"The highlights from this week's meeting of our #pharmacovigilance committee (#PRAC) are available: https://t.co/tWRuzN8JGl","id":"781816302658850816","lang":"en","created_at":"2016-09-30T11:21:46.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/3IkMKcrcxP","expanded_url":"http://bit.ly/2dp9ksy","display_url":"bit.ly/2dp9ksy"}],"hashtags":[{"start":26,"end":35,"tag":"Truberzi"},{"start":37,"end":49,"tag":"eluxadoline"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"781536190440808448","text":"The assessment report for #Truberzi (#eluxadoline), a medicine to treat irritable bowel syndrome, is available: https://t.co/3IkMKcrcxP","id":"781536190440808448","lang":"en","created_at":"2016-09-29T16:48:42.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":121,"end":144,"url":"https://t.co/XpQDOXFQYQ","expanded_url":"http://bit.ly/2cEsrhg","display_url":"bit.ly/2cEsrhg"}],"hashtags":[{"start":30,"end":39,"tag":"Sialanar"},{"start":41,"end":56,"tag":"glycopyrronium"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"781528038693634048","text":"See the assessment report for #Sialanar (#glycopyrronium), a medicine for severe saliva drooling in children &amp; teens https://t.co/XpQDOXFQYQ","id":"781528038693634048","lang":"en","created_at":"2016-09-29T16:16:19.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/ywMHC89gro","expanded_url":"http://bit.ly/2dgXe6M","display_url":"bit.ly/2dgXe6M"}],"hashtags":{},"mentions":{},"annotations":[{"start":36,"end":38,"probability":0.734,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":6,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"781503732651585536","text":"New judicial decisions at odds with EMA’s efforts to allow access to data on medicines: EMA appeals interim measures https://t.co/ywMHC89gro","id":"781503732651585536","lang":"en","created_at":"2016-09-29T14:39:44.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/vsi0B1GTCQ","expanded_url":"http://bit.ly/2cByza2","display_url":"bit.ly/2cByza2"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":74,"end":85,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"781153159301435392","text":"#Consultation open until 31 December on guidance on the use of adjuvanted #veterinary vaccines: https://t.co/vsi0B1GTCQ","id":"781153159301435392","lang":"en","created_at":"2016-09-28T15:26:40.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/KyHm5vQN3Z","expanded_url":"http://bit.ly/2dkmNW6","display_url":"bit.ly/2dkmNW6"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":30,"end":40,"tag":"guideline"},{"start":92,"end":103,"tag":"veterinary"},{"start":104,"end":113,"tag":"vaccines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"781152728244449280","text":"#Consultation on revisions to #guideline on data requirements for multi-strain dossiers for #veterinary #vaccines: https://t.co/KyHm5vQN3Z","id":"781152728244449280","lang":"en","created_at":"2016-09-28T15:24:58.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":13,"end":18,"tag":"EAAD"},{"start":41,"end":48,"tag":"Health"},{"start":58,"end":67,"tag":"EHFG2016"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"},{"start":69,"end":78,"username":"EMA_News","id":"116716199"},{"start":79,"end":87,"username":"EFSA_EU","id":"84582815"},{"start":88,"end":98,"username":"EU_Health","id":"606325697"},{"start":99,"end":115,"username":"innovationunion","id":"786508396245639172"},{"start":116,"end":127,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"781150272928280577","text":"RT @EAAD_EU: #EAAD received the European #Health Award at #EHFG2016! @EMA_News @EFSA_EU @EU_Health @innovationunion @WHO_Europe @V_Andriuka…","id":"781150272928280577","lang":"en","created_at":"2016-09-28T15:15:12.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"781077245276323841"}]},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/VQoM3KdLrK","expanded_url":"http://bit.ly/2dwsxMM","display_url":"bit.ly/2dwsxMM"}],"hashtags":[{"start":41,"end":59,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"780434732718891008","text":"The agenda of this week's meeting of our #pharmacovigilance committee (PRAC) is now available: https://t.co/VQoM3KdLrK","id":"780434732718891008","lang":"en","created_at":"2016-09-26T15:51:54.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/K6BqHcmAkX","expanded_url":"http://bit.ly/2dkSnEs","display_url":"bit.ly/2dkSnEs"}],"hashtags":[{"start":51,"end":60,"tag":"medicine"},{"start":77,"end":90,"tag":"RareDiseases"}],"mentions":[{"start":8,"end":15,"username":"US_FDA","id":"208120290"}],"annotations":{}},"public_metrics":{"retweet_count":36,"reply_count":0,"like_count":13,"quote_count":7},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"780405022936870912","text":"EMA and @US_FDA set up new working group to foster #medicine development for #RareDiseases: https://t.co/K6BqHcmAkX","id":"780405022936870912","lang":"en","created_at":"2016-09-26T13:53:51.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/qpyj234li8","expanded_url":"http://bit.ly/2cMTtpH","display_url":"bit.ly/2cMTtpH"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":20,"end":38,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"779354022121791488","text":"The #minutes of our #pharmacovigilance committee (PRAC) meeting in July are available: https://t.co/qpyj234li8","id":"779354022121791488","lang":"en","created_at":"2016-09-23T16:17:33.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/DEtVYamPSy","expanded_url":"http://bit.ly/2df2Fli","display_url":"bit.ly/2df2Fli"}],"hashtags":[{"start":32,"end":35,"tag":"EU"},{"start":36,"end":45,"tag":"clinical"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":4,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"779305445567725568","text":"Find out facts about the future #EU #clinical trial portal and database: https://t.co/DEtVYamPSy","id":"779305445567725568","lang":"en","created_at":"2016-09-23T13:04:31.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/3MeblYPK9e","expanded_url":"http://bit.ly/2cMkPwd","display_url":"bit.ly/2cMkPwd"}],"hashtags":[{"start":65,"end":75,"tag":"medicines"},{"start":77,"end":82,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"779304086994845696","text":"See the minutes from the July meeting of our committee for human #medicines (#CHMP): https://t.co/3MeblYPK9e","id":"779304086994845696","lang":"en","created_at":"2016-09-23T12:59:07.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/eP1mz0BrUN","expanded_url":"http://bit.ly/2d8qSJO","display_url":"bit.ly/2d8qSJO"},{"start":107,"end":130,"url":"https://t.co/Qr6RrwbarD","expanded_url":"https://twitter.com/EMA_News/status/778597477175980032/photo/1","display_url":"pic.twitter.com/Qr6RrwbarD"}],"hashtags":[{"start":0,"end":11,"tag":"Healthcare"}],"mentions":{},"annotations":[{"start":57,"end":69,"probability":0.6186,"type":"Person","normalized_text":"Gonzalo Calvo"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"778597477175980032","text":"#Healthcare professionals’ working party re-elects prof. Gonzalo Calvo as co-chair https://t.co/eP1mz0BrUN https://t.co/Qr6RrwbarD","id":"778597477175980032","lang":"en","created_at":"2016-09-21T14:11:18.000Z","author_id":"116716199","attachments":{"media_keys":["3_778597390630748161"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/dFFAeXzsKW","expanded_url":"http://bit.ly/2cCI5KP","display_url":"bit.ly/2cCI5KP"},{"start":96,"end":119,"url":"https://t.co/NSoEL9PAC8","expanded_url":"https://twitter.com/EMA_News/status/778577629112918016/photo/1","display_url":"pic.twitter.com/NSoEL9PAC8"}],"hashtags":[{"start":46,"end":52,"tag":"PRIME"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"778577629112918016","text":"Find out which medicines were accepted in our #PRIME scheme this month: https://t.co/dFFAeXzsKW https://t.co/NSoEL9PAC8","id":"778577629112918016","lang":"en","created_at":"2016-09-21T12:52:26.000Z","author_id":"116716199","attachments":{"media_keys":["3_778577602948784128"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/X1LqGtnGP4","expanded_url":"http://bit.ly/2diwKDH","display_url":"bit.ly/2diwKDH"},{"start":106,"end":129,"url":"https://t.co/3mIOWbCUKA","expanded_url":"https://twitter.com/WHO_Europe/status/778567576519663618/photo/1","display_url":"pic.twitter.com/3mIOWbCUKA"}],"hashtags":[{"start":23,"end":47,"tag":"AntimicrobialResistance"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"public_metrics":{"retweet_count":84,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"778569724263358465","text":"RT @WHO_Europe: Why is #AntimicrobialResistance such a big problem? Learn more at https://t.co/X1LqGtnGP4 https://t.co/3mIOWbCUKA","id":"778569724263358465","lang":"en","created_at":"2016-09-21T12:21:02.000Z","author_id":"116716199","attachments":{"media_keys":["3_778567509326913537"]},"referenced_tweets":[{"type":"retweeted","id":"778567576519663618"}]},{"entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/sNZLse6eRW","expanded_url":"http://bit.ly/2clEv79","display_url":"bit.ly/2clEv79"}],"hashtags":[{"start":0,"end":5,"tag":"Zika"},{"start":88,"end":98,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"778540777270116353","text":"#Zika virus infection: no increased risk for patients who take plasma- or urine-derived #medicines: https://t.co/sNZLse6eRW","id":"778540777270116353","lang":"en","created_at":"2016-09-21T10:26:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/MiuKc1BUcx","expanded_url":"http://bit.ly/2d1gV2k","display_url":"bit.ly/2d1gV2k"}],"hashtags":[{"start":66,"end":84,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"778513825528176641","text":"Watch now the live broadcast of the 10th stakeholder forum on the #pharmacovigilance legislation: https://t.co/MiuKc1BUcx","id":"778513825528176641","lang":"en","created_at":"2016-09-21T08:38:54.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":62,"end":69,"tag":"health"},{"start":84,"end":87,"tag":"EU"},{"start":96,"end":108,"tag":"antibiotics"},{"start":109,"end":113,"tag":"AMR"},{"start":114,"end":119,"tag":"UNGA"},{"start":120,"end":127,"tag":"UNGA71"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":45,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"778235500096282625","text":"RT @EU_Health: Antimicrobial resistance is one of the biggest #health threats: what #EU action? #antibiotics #AMR #UNGA #UNGA71 https://t.c…","id":"778235500096282625","lang":"en","created_at":"2016-09-20T14:12:56.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"778209137608056833"}]},{"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/9aUcNB1MQu","expanded_url":"http://bit.ly/2cW2koG","display_url":"bit.ly/2cW2koG"}],"hashtags":[{"start":74,"end":81,"tag":"Herbal"},{"start":102,"end":107,"tag":"HMPC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"777826243337158656","text":"We have published the agenda of the September meeting of our Committee on #Herbal Medicinal Products (#HMPC): https://t.co/9aUcNB1MQu","id":"777826243337158656","lang":"en","created_at":"2016-09-19T11:06:42.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/PRZCtFuep7","expanded_url":"http://bit.ly/2d3CMFn","display_url":"bit.ly/2d3CMFn"}],"hashtags":[{"start":68,"end":73,"tag":"PDCO"}],"mentions":{},"annotations":[{"start":0,"end":14,"probability":0.8493,"type":"Person","normalized_text":"Dr Dirk Mentzer"},{"start":46,"end":65,"probability":0.6633,"type":"Organization","normalized_text":"Paediatric Committee"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"776802530428944384","text":"Dr Dirk Mentzer is re-elected as chair of the Paediatric Committee (#PDCO): https://t.co/PRZCtFuep7","id":"776802530428944384","lang":"en","created_at":"2016-09-16T15:18:50.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":70,"end":93,"url":"https://t.co/HzPv9Owugs","expanded_url":"http://bit.ly/2cBg1cc","display_url":"bit.ly/2cBg1cc"},{"start":94,"end":117,"url":"https://t.co/s7FNGaChmV","expanded_url":"https://twitter.com/EMA_News/status/776742405215285248/photo/1","display_url":"pic.twitter.com/s7FNGaChmV"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":20,"end":30,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":7,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"776742405215285248","text":"#CHMP recommends 11 #medicines for approval at its September meeting: https://t.co/HzPv9Owugs https://t.co/s7FNGaChmV","id":"776742405215285248","lang":"en","created_at":"2016-09-16T11:19:55.000Z","author_id":"116716199","attachments":{"media_keys":["3_776742057343844353"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/Z45b40lZGg","expanded_url":"http://bit.ly/2cBYOAH","display_url":"bit.ly/2cBYOAH"}],"hashtags":[{"start":4,"end":13,"tag":"medicine"},{"start":66,"end":71,"tag":"CHMP"},{"start":97,"end":104,"tag":"Cancer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":1,"like_count":6,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"776741724190306304","text":"New #medicine for soft tissue sarcoma recommended for approval by #CHMP: https://t.co/Z45b40lZGg #Cancer","id":"776741724190306304","lang":"en","created_at":"2016-09-16T11:17:12.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/zxGvvtwQH5","expanded_url":"http://bit.ly/2d57FvU","display_url":"bit.ly/2d57FvU"}],"hashtags":[{"start":4,"end":13,"tag":"medicine"},{"start":92,"end":99,"tag":"cancer"},{"start":125,"end":130,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":5,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"776741379418521600","text":"New #medicine recommended for approval to treat patients with advanced or metastatic breast #cancer: https://t.co/zxGvvtwQH5 #CHMP","id":"776741379418521600","lang":"en","created_at":"2016-09-16T11:15:50.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/alujiNeFT4","expanded_url":"http://bit.ly/2cwLL3v","display_url":"bit.ly/2cwLL3v"}],"hashtags":[{"start":47,"end":58,"tag":"paediatric"},{"start":70,"end":75,"tag":"PDCO"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"776087589858181120","text":"See the agenda for this month’s meeting of our #paediatric committee (#PDCO): https://t.co/alujiNeFT4","id":"776087589858181120","lang":"en","created_at":"2016-09-14T15:57:55.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/QoXPg1r0z3","expanded_url":"http://bit.ly/2cZLAPA","display_url":"bit.ly/2cZLAPA"}],"hashtags":[{"start":62,"end":80,"tag":"pharmacovigilance"}],"mentions":{},"annotations":[{"start":26,"end":28,"probability":0.4918,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"776071090066034689","text":"See the live broadcast of EMA’s 10th stakeholder forum on the #pharmacovigilance legislation on 21 September: https://t.co/QoXPg1r0z3","id":"776071090066034689","lang":"en","created_at":"2016-09-14T14:52:21.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/FIx4WKxBvw","expanded_url":"http://bit.ly/1Gh85BG","display_url":"bit.ly/1Gh85BG"}],"hashtags":[{"start":62,"end":78,"tag":"advancedtherapy"},{"start":80,"end":84,"tag":"CAT"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"775612503619284992","text":"Apply by 30 Sept to represent clinicians in our committee for #advancedtherapy (#CAT): https://t.co/FIx4WKxBvw","id":"775612503619284992","lang":"en","created_at":"2016-09-13T08:30:05.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/F63SB4SWxy","expanded_url":"http://bit.ly/2cTCaVw","display_url":"bit.ly/2cTCaVw"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":69,"end":74,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"775359915158282244","text":"The #agenda for this week's meeting of our human medicine committee (#CHMP) is available: https://t.co/F63SB4SWxy","id":"775359915158282244","lang":"en","created_at":"2016-09-12T15:46:23.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/KaiZo0dQd4","expanded_url":"http://bit.ly/2cjt4jU","display_url":"bit.ly/2cjt4jU"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":56,"end":72,"tag":"advancedtherapy"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"774279856750202880","text":"The #agenda of this week's meeting of our committee for #advancedtherapy (CAT) has been published: https://t.co/KaiZo0dQd4","id":"774279856750202880","lang":"en","created_at":"2016-09-09T16:14:37.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/pGGZUhp3Mc","expanded_url":"http://bit.ly/2ceG8WO","display_url":"bit.ly/2ceG8WO"}],"hashtags":{},"mentions":[{"start":60,"end":64,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"774264781960278016","text":"Change at head of International Affairs: Emer Cooke to join @WHO; Agnès Saint-Raymond to take charge ad interim: https://t.co/pGGZUhp3Mc","id":"774264781960278016","lang":"fr","created_at":"2016-09-09T15:14:43.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/A3zmJsd6iZ","expanded_url":"http://bit.ly/2c4CAJP","display_url":"bit.ly/2c4CAJP"}],"hashtags":[{"start":28,"end":39,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"774202984414707713","text":"Highlights from this week's #veterinary committee (CVMP) meeting have been published: https://t.co/A3zmJsd6iZ","id":"774202984414707713","lang":"en","created_at":"2016-09-09T11:09:10.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/LwrFxTxYnB","expanded_url":"http://bit.ly/2c8o8Lc","display_url":"bit.ly/2c8o8Lc"}],"hashtags":[{"start":22,"end":36,"tag":"antimicrobial"},{"start":49,"end":53,"tag":"AMR"}],"mentions":[{"start":91,"end":98,"username":"US_FDA","id":"208120290"}],"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":5,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"773807992789696512","text":"Find out how we fight #antimicrobial resistance (#AMR) globally together with our partners @US_FDA and PMDA: https://t.co/LwrFxTxYnB","id":"773807992789696512","lang":"en","created_at":"2016-09-08T08:59:36.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/HsSJtpvWP0","expanded_url":"http://bit.ly/2bV9ppG","display_url":"bit.ly/2bV9ppG"},{"start":113,"end":136,"url":"https://t.co/vFsm5RAkmD","expanded_url":"https://twitter.com/EMA_News/status/773798984271921152/photo/1","display_url":"pic.twitter.com/vFsm5RAkmD"}],"hashtags":[{"start":66,"end":77,"tag":"Paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":5,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"773798984271921152","text":"Health professionals &amp; patients associations can register for #Paediatric Committee: https://t.co/HsSJtpvWP0 https://t.co/vFsm5RAkmD","id":"773798984271921152","lang":"en","created_at":"2016-09-08T08:23:48.000Z","author_id":"116716199","attachments":{"media_keys":["3_773798902478897152"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/f7fmjO6urJ","expanded_url":"http://bit.ly/1UC5vBI","display_url":"bit.ly/1UC5vBI"}],"hashtags":[{"start":66,"end":76,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"773796495019610113","text":"One week left to comment on guideline on evaluation of anticancer #medicines: https://t.co/f7fmjO6urJ","id":"773796495019610113","lang":"en","created_at":"2016-09-08T08:13:55.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/1yn0xWTjYI","expanded_url":"http://bit.ly/2c4IR46","display_url":"bit.ly/2c4IR46"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":5,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"773532821382103041","text":"Registration for 8 December workshop on adaptive pathways is now open. Forms to be sent by 1 November: https://t.co/1yn0xWTjYI","id":"773532821382103041","lang":"en","created_at":"2016-09-07T14:46:10.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/SUcSN1i6fE","expanded_url":"http://bit.ly/2bTDzeJ","display_url":"bit.ly/2bTDzeJ"}],"hashtags":[{"start":109,"end":114,"tag":"RC66"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":82,"end":103,"probability":0.5253,"type":"Organization","normalized_text":"Public Health Panorama"}]},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"773516378867376128","text":"RT @WHO_Europe: Evidence informed policy-making in the spotlight - new edition of Public Health Panorama for #RC66 https://t.co/SUcSN1i6fE","id":"773516378867376128","lang":"en","created_at":"2016-09-07T13:40:50.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"773515798589607936"}]},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/ioxmwMHcbB","expanded_url":"http://bit.ly/2csvpqr","display_url":"bit.ly/2csvpqr"}],"hashtags":[{"start":48,"end":57,"tag":"workshop"},{"start":75,"end":86,"tag":"regulatory"},{"start":98,"end":107,"tag":"neonates"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":1,"like_count":4,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"773506628951867392","text":"See the agenda for the second annual scientific #workshop at EMA: Applying #regulatory science to #neonates: https://t.co/ioxmwMHcbB","id":"773506628951867392","lang":"en","created_at":"2016-09-07T13:02:06.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/HsSJtpvWP0","expanded_url":"http://bit.ly/2bV9ppG","display_url":"bit.ly/2bV9ppG"}],"hashtags":[{"start":86,"end":97,"tag":"Paediatric"},{"start":109,"end":114,"tag":"PDCO"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"773167198647058432","text":"Call for expressions of interest open until 31 Oct. to represent civil society in our #Paediatric Committee (#PDCO): https://t.co/HsSJtpvWP0","id":"773167198647058432","lang":"en","created_at":"2016-09-06T14:33:19.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/MctCKzSE0y","expanded_url":"http://bit.ly/2bIKLvh","display_url":"bit.ly/2bIKLvh"}],"hashtags":[{"start":8,"end":13,"tag":"EPAR"},{"start":18,"end":26,"tag":"Aerivio"},{"start":37,"end":48,"tag":"salmeterol"},{"start":51,"end":63,"tag":"fluticasone"},{"start":64,"end":75,"tag":"propionate"},{"start":98,"end":105,"tag":"asthma"},{"start":110,"end":115,"tag":"COPD"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"771751154745303040","text":"See the #EPAR for #Aerivio Spiromax (#salmeterol / #fluticasone #propionate) for the treatment of #asthma and #COPD: https://t.co/MctCKzSE0y","id":"771751154745303040","lang":"en","created_at":"2016-09-02T16:46:28.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/EiOkgy8KiN","expanded_url":"http://bit.ly/2caosvg","display_url":"bit.ly/2caosvg"}],"hashtags":[{"start":52,"end":70,"tag":"Pharmacovigilance"},{"start":98,"end":103,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"771714755199467520","text":"Read the highlights from this week’s meeting of our #Pharmacovigilance Risk Assessment Committee (#PRAC): https://t.co/EiOkgy8KiN","id":"771714755199467520","lang":"en","created_at":"2016-09-02T14:21:50.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/8wxBsZAYq1","expanded_url":"http://bit.ly/2bPgc1v","display_url":"bit.ly/2bPgc1v"}],"hashtags":[{"start":46,"end":55,"tag":"Cinqaero"},{"start":57,"end":68,"tag":"reslizumab"},{"start":73,"end":82,"tag":"medicine"},{"start":92,"end":99,"tag":"asthma"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"771680985670885376","text":"See the European public assessment report for #Cinqaero (#reslizumab), a #medicine to treat #asthma: https://t.co/8wxBsZAYq1","id":"771680985670885376","lang":"en","created_at":"2016-09-02T12:07:38.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/EKkLhrK8yi","expanded_url":"https://www.pscp.tv/w/apgPijI2MTAyMHwxak1KZ3JsTGRReUdMaWCssPnpB1d8UkOcQCA-nZt06tLKuSKUuHAMHh3od1w=","display_url":"pscp.tv/w/apgPijI2MTAy…"}],"hashtags":[{"start":17,"end":27,"tag":"Periscope"},{"start":74,"end":84,"tag":"ZikaVirus"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":159,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"771679583611543552","text":"RT @WHO: LIVE on #Periscope: PRESS CONFERENCE: WHO Emergency Committee on #ZikaVirus  https://t.co/EKkLhrK8yi","id":"771679583611543552","lang":"en","created_at":"2016-09-02T12:02:04.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"771678838862610433"}]},{"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/krST8ll4L7","expanded_url":"http://bit.ly/2bZ14DN","display_url":"bit.ly/2bZ14DN"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":30,"end":40,"tag":"guideline"},{"start":91,"end":98,"tag":"herbal"},{"start":99,"end":109,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"771666204087889920","text":"#Consultation on revisions to #guideline on non-clinical documentation in applications for #herbal #medicines  https://t.co/krST8ll4L7","id":"771666204087889920","lang":"en","created_at":"2016-09-02T11:08:54.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/HGgm4wzD66","expanded_url":"http://bit.ly/2bVwAk7","display_url":"bit.ly/2bVwAk7"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":31,"end":41,"tag":"guideline"},{"start":95,"end":102,"tag":"herbal"},{"start":103,"end":114,"tag":"monographs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"771371128812146688","text":"#Consultation opens on revised #guideline on assessment of clinical safety and efficacy for EU #herbal #monographs: https://t.co/HGgm4wzD66","id":"771371128812146688","lang":"en","created_at":"2016-09-01T15:36:23.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/WyJ4jNThWJ","expanded_url":"http://bit.ly/2cfo8dX","display_url":"bit.ly/2cfo8dX"}],"hashtags":[{"start":44,"end":54,"tag":"medicines"},{"start":58,"end":67,"tag":"children"},{"start":82,"end":93,"tag":"paediatric"},{"start":105,"end":110,"tag":"PDCO"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"771331409705332736","text":"Find out about new PIPs for  development of #medicines in #children agreed by our #paediatric committee (#PDCO): https://t.co/WyJ4jNThWJ","id":"771331409705332736","lang":"en","created_at":"2016-09-01T12:58:33.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/HmH3NIjaQG","expanded_url":"http://bit.ly/1UOPhaB","display_url":"bit.ly/1UOPhaB"}],"hashtags":[{"start":4,"end":14,"tag":"EMABasics"},{"start":15,"end":24,"tag":"training"},{"start":36,"end":45,"tag":"patients"},{"start":50,"end":61,"tag":"healthcare"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"771026871266009088","text":"New #EMABasics #training videos for #patients and #healthcare professionals have been made available: https://t.co/HmH3NIjaQG","id":"771026871266009088","lang":"en","created_at":"2016-08-31T16:48:25.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":80,"end":91,"tag":"gonorrhoea"}],"mentions":[{"start":3,"end":16,"username":"ECDC_HIVAIDS","id":"2182569746"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"771011235059998721","text":"RT @ECDC_HIVAIDS: Susceptibility of gonococci to 2 of the recommended drugs for #gonorrhoea  treatment has shown signs of improvement. http…","id":"771011235059998721","lang":"en","created_at":"2016-08-31T15:46:17.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"771009936033771520"}]},{"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/OiNUceJasZ","expanded_url":"http://europa.eu/!Pb63hk","display_url":"europa.eu/!Pb63hk"}],"hashtags":[{"start":107,"end":110,"tag":"EU"},{"start":111,"end":118,"tag":"health"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"770917926996180992","text":"RT @EU_Health: Have you checked our easy to read summaries of scientific opinions? https://t.co/OiNUceJasZ #EU #health https://t.co/Zi6VC1d…","id":"770917926996180992","lang":"en","created_at":"2016-08-31T09:35:31.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"770914139728408576"}]},{"entities":{"urls":[{"start":65,"end":88,"url":"https://t.co/1tfCXUXmRS","expanded_url":"http://bit.ly/2acvRHV","display_url":"bit.ly/2acvRHV"},{"start":105,"end":128,"url":"https://t.co/IAi80WSBnh","expanded_url":"https://twitter.com/EMA_News/status/770913070373675008/photo/1","display_url":"pic.twitter.com/IAi80WSBnh"}],"hashtags":[{"start":89,"end":96,"tag":"ITjobs"},{"start":97,"end":104,"tag":"EUjobs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"770913070373675008","text":"Apply by 8 Sept for a role as Solution Architect/Technical Lead: https://t.co/1tfCXUXmRS #ITjobs #EUjobs https://t.co/IAi80WSBnh","id":"770913070373675008","lang":"en","created_at":"2016-08-31T09:16:13.000Z","author_id":"116716199","attachments":{"media_keys":["3_770908036298862592"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/f7fmjO6urJ","expanded_url":"http://bit.ly/1UC5vBI","display_url":"bit.ly/1UC5vBI"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":22,"end":32,"tag":"guideline"},{"start":61,"end":71,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"770898946604593152","text":"#Consultation open on #guideline on evaluation of anticancer #medicines: https://t.co/f7fmjO6urJ","id":"770898946604593152","lang":"en","created_at":"2016-08-31T08:20:06.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/k7xOdYli07","expanded_url":"http://bit.ly/2bToSGE","display_url":"bit.ly/2bToSGE"}],"hashtags":[{"start":14,"end":21,"tag":"agenda"},{"start":53,"end":71,"tag":"pharmacovigilance"},{"start":83,"end":88,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"770665594970570752","text":"Check out the #agenda for this week’s meeting of our #pharmacovigilance committee (#PRAC) : https://t.co/k7xOdYli07","id":"770665594970570752","lang":"en","created_at":"2016-08-30T16:52:50.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/230qAaetL3","expanded_url":"http://bit.ly/2bvRYxG","display_url":"bit.ly/2bvRYxG"},{"start":106,"end":129,"url":"https://t.co/oS6TmasMvI","expanded_url":"https://twitter.com/ECDC_EU/status/770637408329011200/photo/1","display_url":"pic.twitter.com/oS6TmasMvI"}],"hashtags":[{"start":30,"end":51,"tag":"AntibioticResistance"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":66,"end":67,"probability":0.7589,"type":"Place","normalized_text":"EU"}]},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"770664268219899905","text":"RT @ECDC_EU: Good progress in #AntibioticResistance monitoring in EU laboratories https://t.co/230qAaetL3 https://t.co/oS6TmasMvI","id":"770664268219899905","lang":"en","created_at":"2016-08-30T16:47:34.000Z","author_id":"116716199","attachments":{"media_keys":["3_770552136459546624"]},"referenced_tweets":[{"type":"retweeted","id":"770637408329011200"}]},{"entities":{"urls":[{"start":50,"end":73,"url":"https://t.co/hS5ZXJH0V4","expanded_url":"http://goo.gl/BZRf4n","display_url":"goo.gl/BZRf4n"},{"start":74,"end":97,"url":"https://t.co/2l2IPjbQnI","expanded_url":"https://twitter.com/WHO/status/770270670668398592/photo/1","display_url":"pic.twitter.com/2l2IPjbQnI"}],"hashtags":[{"start":28,"end":49,"tag":"AntibioticResistance"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"public_metrics":{"retweet_count":805,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"770576088737218564","text":"RT @WHO: Birth in a time of #AntibioticResistance https://t.co/hS5ZXJH0V4 https://t.co/2l2IPjbQnI","id":"770576088737218564","lang":"en","created_at":"2016-08-30T10:57:10.000Z","author_id":"116716199","attachments":{"media_keys":["3_770270480414679040"]},"referenced_tweets":[{"type":"retweeted","id":"770270670668398592"}]},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/7gqlvgrmrw","expanded_url":"http://bit.ly/2blp26L","display_url":"bit.ly/2blp26L"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":40,"end":58,"tag":"pharmacovigilance"},{"start":70,"end":75,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"769180167537295360","text":"The #minutes of the June meeting of our #pharmacovigilance committee (#PRAC) are available: https://t.co/7gqlvgrmrw","id":"769180167537295360","lang":"en","created_at":"2016-08-26T14:30:17.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":69,"end":92,"url":"https://t.co/eRvGnxhVBh","expanded_url":"http://bit.ly/1zp7JIe","display_url":"bit.ly/1zp7JIe"},{"start":109,"end":132,"url":"https://t.co/4cIs4pCvzi","expanded_url":"https://twitter.com/EMA_News/status/769111398399868928/photo/1","display_url":"pic.twitter.com/4cIs4pCvzi"}],"hashtags":[{"start":28,"end":43,"tag":"DataManagement"},{"start":93,"end":100,"tag":"ITjobs"},{"start":101,"end":108,"tag":"EUjobs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"769111398399868928","text":"We are looking for a Master #DataManagement Architect. DDL: 19/09/16 https://t.co/eRvGnxhVBh #ITjobs #EUjobs https://t.co/4cIs4pCvzi","id":"769111398399868928","lang":"en","created_at":"2016-08-26T09:57:01.000Z","author_id":"116716199","attachments":{"media_keys":["3_767762247833837570"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/8bnMnM3FUL","expanded_url":"http://bit.ly/2biXRK1","display_url":"bit.ly/2biXRK1"}],"hashtags":[{"start":51,"end":61,"tag":"Medicinal"},{"start":121,"end":126,"tag":"COMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"768833687152685057","text":"Check out the minutes for the Committee for Orphan #Medicinal Products meeting (14-16 June 2016) https://t.co/8bnMnM3FUL #COMP","id":"768833687152685057","lang":"en","created_at":"2016-08-25T15:33:29.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":61,"end":84,"url":"https://t.co/iirhmvM7Xh","expanded_url":"http://bit.ly/1E2MV0f","display_url":"bit.ly/1E2MV0f"},{"start":85,"end":108,"url":"https://t.co/hvvzZJBJdU","expanded_url":"https://twitter.com/EMA_News/status/768722090845319169/photo/1","display_url":"pic.twitter.com/hvvzZJBJdU"}],"hashtags":[{"start":21,"end":26,"tag":"SMEs"}],"mentions":{},"annotations":[{"start":8,"end":10,"probability":0.3537,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"768722090845319169","text":"See how EMA supports #SMEs to obtain marketing authorisation https://t.co/iirhmvM7Xh https://t.co/hvvzZJBJdU","id":"768722090845319169","lang":"en","created_at":"2016-08-25T08:10:03.000Z","author_id":"116716199","attachments":{"media_keys":["3_768490836107624448"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/saKdZgK3nr","expanded_url":"http://bit.ly/1UDhVbs","display_url":"bit.ly/1UDhVbs"}],"hashtags":[{"start":25,"end":35,"tag":"ZikaVirus"},{"start":36,"end":41,"tag":"maps"},{"start":81,"end":86,"tag":"Zika"}],"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"768481611738386432","text":"RT @ECDC_Outbreaks: ECDC #ZikaVirus #maps updated today with the latest on local #Zika transmission https://t.co/saKdZgK3nr https://t.co/Pt…","id":"768481611738386432","lang":"en","created_at":"2016-08-24T16:14:28.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"768479037564026880"}]},{"entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/eg5739DiKV","expanded_url":"https://ec.europa.eu/research/horizonprize/index.cfm?lg=en&pg=prizes","display_url":"ec.europa.eu/research/horiz…"},{"start":110,"end":133,"url":"https://t.co/uJoHde3ZUV","expanded_url":"https://twitter.com/EU_H2020/status/766885071479386112","display_url":"twitter.com/EU_H2020/statu…"}],"hashtags":[{"start":44,"end":57,"tag":"HorizonPrize"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"768450036715913217","text":"RT @EU_H2020: Take a look at the many other #HorizonPrize challenges still open -&gt; https://t.co/eg5739DiKV https://t.co/uJoHde3ZUV","id":"768450036715913217","lang":"en","created_at":"2016-08-24T14:09:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"768432808150925312"}]},{"entities":{"urls":{},"hashtags":[{"start":25,"end":30,"tag":"Zika"},{"start":116,"end":128,"tag":"infographic"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":63,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"768381578087174144","text":"RT @ECDC_EU: Do you know #Zika can be also transmitted 1) sexually 2) mother-to-child 3) during blood donations See #infographic https://t.…","id":"768381578087174144","lang":"en","created_at":"2016-08-24T09:36:58.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"768118609897934848"}]},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/b5ugkGFJyD","expanded_url":"http://bit.ly/1UicqyP","display_url":"bit.ly/1UicqyP"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":37,"end":48,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"768378585228816384","text":"#Consultation on reflection paper on #veterinary non-spontaneous adverse event reports, incl. internet/social media: https://t.co/b5ugkGFJyD","id":"768378585228816384","lang":"en","created_at":"2016-08-24T09:25:05.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/yvOxMs7wbA","expanded_url":"http://bit.ly/1qZstHj","display_url":"bit.ly/1qZstHj"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":127,"end":131,"tag":"ICH"},{"start":132,"end":142,"tag":"guideline"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"768367568432357376","text":"#Consultation opens on Q&amp;A on toxicokinetics: assessment of systemic exposure in toxicity studies: https://t.co/yvOxMs7wbA #ICH #guideline","id":"768367568432357376","lang":"en","created_at":"2016-08-24T08:41:18.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/k6TIuaezGu","expanded_url":"http://bit.ly/2bdGXPr","display_url":"bit.ly/2bdGXPr"},{"start":112,"end":135,"url":"https://t.co/YLFEF0yHK3","expanded_url":"https://twitter.com/EMA_News/status/768360988605231104/photo/1","display_url":"pic.twitter.com/YLFEF0yHK3"}],"hashtags":[{"start":14,"end":24,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":8,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"768360988605231104","text":"Regulation of #medicines relies on best expertise. Find about EMA’s network of experts: https://t.co/k6TIuaezGu https://t.co/YLFEF0yHK3","id":"768360988605231104","lang":"en","created_at":"2016-08-24T08:15:09.000Z","author_id":"116716199","attachments":{"media_keys":["3_768084363179331584"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":79,"end":102,"url":"https://t.co/AIgTrcfGLS","expanded_url":"http://bit.ly/2bwpiou","display_url":"bit.ly/2bwpiou"},{"start":103,"end":126,"url":"https://t.co/yYE6SyCQDU","expanded_url":"https://twitter.com/EMA_News/status/767994888176607232/photo/1","display_url":"pic.twitter.com/yYE6SyCQDU"}],"hashtags":[{"start":37,"end":50,"tag":"PublicHealth"},{"start":74,"end":77,"tag":"EU"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":5,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"767994888176607232","text":"How does Article 58 help EMA address #PublicHealth challenges outside the #EU? https://t.co/AIgTrcfGLS https://t.co/yYE6SyCQDU","id":"767994888176607232","lang":"en","created_at":"2016-08-23T08:00:24.000Z","author_id":"116716199","attachments":{"media_keys":["3_767759413671292928"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":70,"end":93,"url":"https://t.co/aO8RQuDmUY","expanded_url":"http://bit.ly/2bbvD3a","display_url":"bit.ly/2bbvD3a"}],"hashtags":[{"start":47,"end":58,"tag":"Paediatric"},{"start":94,"end":99,"tag":"PDCO"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"767678538925350912","text":"See the minutes from the July’s meeting of our #Paediatric Committee: https://t.co/aO8RQuDmUY #PDCO","id":"767678538925350912","lang":"en","created_at":"2016-08-22T11:03:21.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/JfdZNaN0rW","expanded_url":"http://bit.ly/2bzABLq","display_url":"bit.ly/2bzABLq"}],"hashtags":[{"start":47,"end":56,"tag":"workshop"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"767664266333814784","text":"Register for our medical literature monitoring #workshop until 9 September: https://t.co/JfdZNaN0rW","id":"767664266333814784","lang":"en","created_at":"2016-08-22T10:06:38.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/MlBoAfvAjS","expanded_url":"http://dlvr.it/M58w1j","display_url":"dlvr.it/M58w1j"},{"start":115,"end":138,"url":"https://t.co/JMnbs2tD8f","expanded_url":"https://twitter.com/innovationunion/status/767642747712839680/photo/1","display_url":"pic.twitter.com/JMnbs2tD8f"}],"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"},{"start":97,"end":114,"tag":"EUBudget4Results"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"767644808563286016","text":"RT @innovationunion: #ResearchHeadlines - Re-educating the immune system https://t.co/MlBoAfvAjS #EUBudget4Results https://t.co/JMnbs2tD8f","id":"767644808563286016","lang":"en","created_at":"2016-08-22T08:49:19.000Z","author_id":"116716199","attachments":{"media_keys":["3_767642745905123329"]},"referenced_tweets":[{"type":"retweeted","id":"767642747712839680"}]},{"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/eRvGnx0kJJ","expanded_url":"http://bit.ly/1zp7JIe","display_url":"bit.ly/1zp7JIe"},{"start":115,"end":138,"url":"https://t.co/yBlb31c7Wb","expanded_url":"https://twitter.com/EMA_News/status/766589946807353344/photo/1","display_url":"pic.twitter.com/yBlb31c7Wb"}],"hashtags":[{"start":107,"end":114,"tag":"EUjobs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"766589946807353344","text":"Join us, we are looking for a Solution Architect/Technical Lead. Deadline: 8/09/16 https://t.co/eRvGnx0kJJ #EUjobs https://t.co/yBlb31c7Wb","id":"766589946807353344","lang":"en","created_at":"2016-08-19T10:57:40.000Z","author_id":"116716199","attachments":{"media_keys":["3_766589867069505536"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":66,"end":89,"url":"https://t.co/ldfmTSbQlM","expanded_url":"http://bit.ly/2b3eNa5","display_url":"bit.ly/2b3eNa5"},{"start":90,"end":113,"url":"https://t.co/sdvRINaEqp","expanded_url":"https://twitter.com/ECDC_EU/status/766233112342847489/photo/1","display_url":"pic.twitter.com/sdvRINaEqp"}],"hashtags":[{"start":20,"end":30,"tag":"ZikaVirus"},{"start":53,"end":65,"tag":"infographic"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"766268704472662019","text":"RT @ECDC_EU: How is #ZikaVirus transmitted? New ECDC #infographic https://t.co/ldfmTSbQlM https://t.co/sdvRINaEqp","id":"766268704472662019","lang":"en","created_at":"2016-08-18T13:41:10.000Z","author_id":"116716199","attachments":{"media_keys":["3_766231283513102336"]},"referenced_tweets":[{"type":"retweeted","id":"766233112342847489"}]},{"entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/jEP1g8Tqon","expanded_url":"http://bit.ly/2boNMzM","display_url":"bit.ly/2boNMzM"}],"hashtags":[{"start":41,"end":52,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"766217803997339650","text":"The agenda of this week's meeting of our #paediatric committee (PDCO) has been published: https://t.co/jEP1g8Tqon","id":"766217803997339650","lang":"en","created_at":"2016-08-18T10:18:54.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":75,"end":98,"url":"https://t.co/nBtHH4fhXI","expanded_url":"http://bit.ly/2beZLhL","display_url":"bit.ly/2beZLhL"},{"start":99,"end":122,"url":"https://t.co/qCRgorBuiy","expanded_url":"https://twitter.com/EMA_News/status/766202632528654336/photo/1","display_url":"pic.twitter.com/qCRgorBuiy"}],"hashtags":[{"start":0,"end":21,"tag":"AntibioticResistance"}],"mentions":{},"annotations":[{"start":52,"end":54,"probability":0.471,"type":"Person","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":35,"reply_count":0,"like_count":12,"quote_count":2},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"766202632528654336","text":"#AntibioticResistance is a serious threat. See what EMA does to combat it: https://t.co/nBtHH4fhXI https://t.co/qCRgorBuiy","id":"766202632528654336","lang":"en","created_at":"2016-08-18T09:18:37.000Z","author_id":"116716199","attachments":{"media_keys":["3_766202609329926144"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/b5ugkGFJyD","expanded_url":"http://bit.ly/1UicqyP","display_url":"bit.ly/1UicqyP"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":37,"end":48,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"766018535969566720","text":"#Consultation on reflection paper on #veterinary non-spontaneous adverse event reports, incl. internet/social media: https://t.co/b5ugkGFJyD","id":"766018535969566720","lang":"en","created_at":"2016-08-17T21:07:05.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":33,"end":56,"url":"https://t.co/MJWkjPTFbm","expanded_url":"http://bit.ly/1RNe7kK","display_url":"bit.ly/1RNe7kK"},{"start":57,"end":80,"url":"https://t.co/DT5fpIzbcz","expanded_url":"https://twitter.com/EMA_News/status/765909482132078592/photo/1","display_url":"pic.twitter.com/DT5fpIzbcz"}],"hashtags":[{"start":6,"end":12,"tag":"PRIME"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.3043,"type":"Person","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"765909482132078592","text":"EMA’s #PRIME scheme at a glance: https://t.co/MJWkjPTFbm https://t.co/DT5fpIzbcz","id":"765909482132078592","lang":"en","created_at":"2016-08-17T13:53:45.000Z","author_id":"116716199","attachments":{"media_keys":["3_765909410120097792"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/dtl5RO3Ypc","expanded_url":"http://bit.ly/2aWRPOo","display_url":"bit.ly/2aWRPOo"}],"hashtags":[{"start":36,"end":45,"tag":"workshop"},{"start":68,"end":75,"tag":"cancer"},{"start":90,"end":100,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":7,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"765585181474484224","text":"Save the date and register now! EMA #workshop to discuss innovative #cancer immunotherapy #medicines: https://t.co/dtl5RO3Ypc","id":"765585181474484224","lang":"en","created_at":"2016-08-16T16:25:05.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/DK9C3C4zyV","expanded_url":"https://youtu.be/mwPNRH12NIo","display_url":"youtu.be/mwPNRH12NIo"}],"hashtags":[{"start":25,"end":40,"tag":"datamanagement"},{"start":87,"end":97,"tag":"medicines"},{"start":124,"end":132,"tag":"webinar"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"765551937978761216","text":"Check out how our master #datamanagement services will ensure better identification of #medicines:  https://t.co/DK9C3C4zyV #webinar","id":"765551937978761216","lang":"en","created_at":"2016-08-16T14:12:59.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/U6hy4UsT85","expanded_url":"http://bit.ly/18P5cgv","display_url":"bit.ly/18P5cgv"},{"start":114,"end":137,"url":"https://t.co/ztaVSASNaD","expanded_url":"https://twitter.com/EMA_News/status/765486112018169856/photo/1","display_url":"pic.twitter.com/ztaVSASNaD"}],"hashtags":[{"start":40,"end":50,"tag":"medicines"},{"start":76,"end":79,"tag":"EU"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":16,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"765486112018169856","text":"Centralised marketing authorisation for #medicines – why does it matter for #EU citizens? https://t.co/U6hy4UsT85 https://t.co/ztaVSASNaD","id":"765486112018169856","lang":"en","created_at":"2016-08-16T09:51:25.000Z","author_id":"116716199","attachments":{"media_keys":["3_765486054451318784"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/yvOxMs7wbA","expanded_url":"http://bit.ly/1qZstHj","display_url":"bit.ly/1qZstHj"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":127,"end":131,"tag":"ICH"},{"start":132,"end":142,"tag":"guideline"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"765459835940995072","text":"#Consultation opens on Q&amp;A on toxicokinetics: assessment of systemic exposure in toxicity studies: https://t.co/yvOxMs7wbA #ICH #guideline","id":"765459835940995072","lang":"en","created_at":"2016-08-16T08:07:01.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":49,"end":72,"url":"https://t.co/8p4hh1b7L0","expanded_url":"http://bit.ly/2aThb5h","display_url":"bit.ly/2aThb5h"},{"start":73,"end":96,"url":"https://t.co/fni4YlvD70","expanded_url":"https://twitter.com/EMA_News/status/765171365670301697/photo/1","display_url":"pic.twitter.com/fni4YlvD70"}],"hashtags":[{"start":15,"end":26,"tag":"veterinary"},{"start":27,"end":36,"tag":"vaccines"},{"start":44,"end":47,"tag":"EU"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"765171365670301697","text":"Why do we need #veterinary #vaccines in the #EU? https://t.co/8p4hh1b7L0 https://t.co/fni4YlvD70","id":"765171365670301697","lang":"en","created_at":"2016-08-15T13:00:44.000Z","author_id":"116716199","attachments":{"media_keys":["3_765114518942937088"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":70,"end":93,"url":"https://t.co/jg1LCC2NQO","expanded_url":"http://bit.ly/2aVfCEJ","display_url":"bit.ly/2aVfCEJ"}],"hashtags":[{"start":58,"end":68,"tag":"medicines"},{"start":94,"end":112,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":11,"quote_count":1},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"765112584483790848","text":"How to better monitor and manage the safety of biological #medicines? https://t.co/jg1LCC2NQO #pharmacovigilance","id":"765112584483790848","lang":"en","created_at":"2016-08-15T09:07:09.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"VeroWirtz","id":"2670240932"},{"start":117,"end":126,"username":"EMA_News","id":"116716199"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"764052087533481986","text":"RT @VeroWirtz: Desire for greater info entails continuous evolution in the communication of information on medicines @EMA_News https://t.co…","id":"764052087533481986","lang":"en","created_at":"2016-08-12T10:53:07.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"764043864885727234"}]},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/RzbtipI7jz","expanded_url":"http://bit.ly/1USkSao","display_url":"bit.ly/1USkSao"}],"hashtags":[{"start":28,"end":36,"tag":"measles"},{"start":84,"end":94,"tag":"Vaccinate"}],"mentions":[{"start":3,"end":12,"username":"ECDC_VPD","id":"186471638"}],"annotations":{}},"public_metrics":{"retweet_count":57,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"764035275240660992","text":"RT @ECDC_VPD: A person with #measles can infect 12–18 previously uninfected people. #Vaccinate to protect\nhttps://t.co/RzbtipI7jz https://t…","id":"764035275240660992","lang":"en","created_at":"2016-08-12T09:46:19.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"764030472900927488"}]},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/Jk3nC8f7OC","expanded_url":"http://bit.ly/1rczPr2","display_url":"bit.ly/1rczPr2"}],"hashtags":[{"start":110,"end":118,"tag":"ehealth"},{"start":119,"end":127,"tag":"DSMdata"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":77,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"764031079409868804","text":"RT @EU_Health: 46% of Europeans go online to seek info about health &amp; diseases 🏥 https://t.co/Jk3nC8f7OC  #ehealth #DSMdata @DSMeu https://…","id":"764031079409868804","lang":"en","created_at":"2016-08-12T09:29:38.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"764013614248275972"}]},{"entities":{"urls":[{"start":51,"end":74,"url":"https://t.co/KRsK2uRxXB","expanded_url":"http://bit.ly/1jSNOgk","display_url":"bit.ly/1jSNOgk"},{"start":75,"end":98,"url":"https://t.co/mZxH8192Zy","expanded_url":"https://twitter.com/EMA_News/status/764022310554574849/photo/1","display_url":"pic.twitter.com/mZxH8192Zy"}],"hashtags":[{"start":37,"end":40,"tag":"EU"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":8,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"764022310554574849","text":"Info about us - now available in all #EU languages https://t.co/KRsK2uRxXB https://t.co/mZxH8192Zy","id":"764022310554574849","lang":"en","created_at":"2016-08-12T08:54:48.000Z","author_id":"116716199","attachments":{"media_keys":["3_764020243060576256"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":63,"end":86,"url":"https://t.co/7hC0pq9eC3","expanded_url":"http://bit.ly/2bf1Xos","display_url":"bit.ly/2bf1Xos"},{"start":87,"end":110,"url":"https://t.co/7rchHdwN8H","expanded_url":"https://twitter.com/EMA_News/status/764008616563052544/photo/1","display_url":"pic.twitter.com/7rchHdwN8H"}],"hashtags":[{"start":23,"end":41,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":8,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"764008616563052544","text":"Achievements of the EU #pharmacovigilance system over 3 years: https://t.co/7hC0pq9eC3 https://t.co/7rchHdwN8H","id":"764008616563052544","lang":"en","created_at":"2016-08-12T08:00:23.000Z","author_id":"116716199","attachments":{"media_keys":["3_763772336621383680"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":42,"end":65,"url":"https://t.co/7hC0pqqQ0D","expanded_url":"http://bit.ly/2bf1Xos","display_url":"bit.ly/2bf1Xos"},{"start":66,"end":89,"url":"https://t.co/74NRxtEHPU","expanded_url":"https://twitter.com/EMA_News/status/763709315215654912/photo/1","display_url":"pic.twitter.com/74NRxtEHPU"}],"hashtags":[{"start":0,"end":18,"tag":"Pharmacovigilance"},{"start":26,"end":29,"tag":"EU"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":12,"quote_count":2},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"763709315215654912","text":"#Pharmacovigilance in the #EU since 2012: https://t.co/7hC0pqqQ0D https://t.co/74NRxtEHPU","id":"763709315215654912","lang":"en","created_at":"2016-08-11T12:11:04.000Z","author_id":"116716199","attachments":{"media_keys":["3_763708183022018564"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":51,"end":74,"url":"https://t.co/9Bd8hH7wS5","expanded_url":"http://bit.ly/2aNsx8B","display_url":"bit.ly/2aNsx8B"}],"hashtags":[{"start":34,"end":39,"tag":"data"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"763687416511291393","text":"Check out our new GMP guidance on #data integrity: https://t.co/9Bd8hH7wS5","id":"763687416511291393","lang":"en","created_at":"2016-08-11T10:44:03.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"Jordi_Falco","id":"2715091074"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"763382021938745345","text":"@Jordi_Falco There is only the report  and the image outlines one of the key findings of this report.","id":"763393096981815297","lang":"en","created_at":"2016-08-10T15:14:32.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"763386294378586113"}],"in_reply_to_user_id":"2715091074"},{"entities":{"urls":[{"start":61,"end":84,"url":"https://t.co/7hC0pq9eC3","expanded_url":"http://bit.ly/2bf1Xos","display_url":"bit.ly/2bf1Xos"},{"start":85,"end":108,"url":"https://t.co/EE0QribE3l","expanded_url":"https://twitter.com/EMA_News/status/763382021938745345/photo/1","display_url":"pic.twitter.com/EE0QribE3l"}],"hashtags":[{"start":23,"end":41,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":25,"reply_count":1,"like_count":13,"quote_count":6},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"763382021938745345","text":"Achievements of the EU #pharmacovigilance system since 2012: https://t.co/7hC0pq9eC3 https://t.co/EE0QribE3l","id":"763382021938745345","lang":"en","created_at":"2016-08-10T14:30:31.000Z","author_id":"116716199","attachments":{"media_keys":["3_763379717831532544"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/Mz8q4p69iF","expanded_url":"http://ow.ly/Gjrb3036gFQ","display_url":"ow.ly/Gjrb3036gFQ"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"763379165114560512","text":"RT @MHRAgovuk: Reporting defective medicines extremely important. Read our blog on reporting dos &amp; don'ts: https://t.co/Mz8q4p69iF https://…","id":"763379165114560512","lang":"en","created_at":"2016-08-10T14:19:10.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"763333859182256128"}]},{"entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/Ogm94PPiRv","expanded_url":"http://bit.ly/2b806S9","display_url":"bit.ly/2b806S9"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":121,"end":139,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":7,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"763041678559023108","text":"#Consultation opens on signal detection from spontaneous reports of suspected adverse reactions: https://t.co/Ogm94PPiRv #pharmacovigilance","id":"763041678559023108","lang":"en","created_at":"2016-08-09T15:58:07.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/RFg2m4w7d6","expanded_url":"http://bit.ly/2aLX9rJ","display_url":"bit.ly/2aLX9rJ"}],"hashtags":[{"start":9,"end":22,"tag":"consultation"},{"start":75,"end":85,"tag":"medicines"},{"start":111,"end":129,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"762996980612161536","text":"Start of #consultation on management and reporting of adverse reactions to #medicines: https://t.co/RFg2m4w7d6 #pharmacovigilance","id":"762996980612161536","lang":"en","created_at":"2016-08-09T13:00:30.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/JcDdZ8l0Ji","expanded_url":"http://bit.ly/2aIHThk","display_url":"bit.ly/2aIHThk"}],"hashtags":[{"start":22,"end":32,"tag":"medicines"},{"start":61,"end":66,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":10,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"762992732415680512","text":"List of the new human #medicines submitted for evaluation by #CHMP has been published: https://t.co/JcDdZ8l0Ji","id":"762992732415680512","lang":"en","created_at":"2016-08-09T12:43:37.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/QP3TFoRM6V","expanded_url":"http://bit.ly/2aIFCD3","display_url":"bit.ly/2aIFCD3"},{"start":105,"end":128,"url":"https://t.co/xgbluX2D9w","expanded_url":"https://twitter.com/EMA_News/status/762990486021955584/photo/1","display_url":"pic.twitter.com/xgbluX2D9w"}],"hashtags":[{"start":30,"end":40,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"762990486021955584","text":"The latest issue of our human #medicines highlights newsletter is now available: https://t.co/QP3TFoRM6V https://t.co/xgbluX2D9w","id":"762990486021955584","lang":"en","created_at":"2016-08-09T12:34:42.000Z","author_id":"116716199","attachments":{"media_keys":["3_762990451976798210"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/WO9a6VCmwU","expanded_url":"http://bit.ly/2aGEE7r","display_url":"bit.ly/2aGEE7r"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":74,"end":92,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"762944368210685952","text":"#Consultation opens until 14 October on signal management as part of good #pharmacovigilance practices: https://t.co/WO9a6VCmwU","id":"762944368210685952","lang":"en","created_at":"2016-08-09T09:31:26.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/PkWxUzrBfS","expanded_url":"http://europa.eu/!fc79NU","display_url":"europa.eu/!fc79NU"}],"hashtags":[{"start":47,"end":56,"tag":"medicine"},{"start":57,"end":64,"tag":"safety"},{"start":68,"end":71,"tag":"EU"},{"start":96,"end":110,"tag":"patientsafety"},{"start":111,"end":129,"tag":"pharmacovigilance"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"762670911627616260","text":"RT @EU_Health: Report on activities to monitor #medicine #safety in #EU https://t.co/PkWxUzrBfS #patientsafety #pharmacovigilance https://t…","id":"762670911627616260","lang":"en","created_at":"2016-08-08T15:24:49.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"762663433909243904"}]},{"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/y5DixLEXWf","expanded_url":"http://bit.ly/2aDwc9p","display_url":"bit.ly/2aDwc9p"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":41,"end":52,"tag":"injections"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"761569793250103296","text":"#Consultation on production of water for #injections using non-distillation methods, open until 4 November: https://t.co/y5DixLEXWf","id":"761569793250103296","lang":"en","created_at":"2016-08-05T14:29:22.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/mH4wTWDDjY","expanded_url":"http://bit.ly/2azBJ32","display_url":"bit.ly/2azBJ32"}],"hashtags":[{"start":22,"end":32,"tag":"medicines"},{"start":117,"end":130,"tag":"transparency"}],"mentions":[{"start":83,"end":92,"username":"TGAgovau","id":"3800463014"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":1,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"761501354321928192","text":"Making information on #medicines more easily available: a joint article by EMA and @TGAgovau https://t.co/mH4wTWDDjY #transparency","id":"761501354321928192","lang":"en","created_at":"2016-08-05T09:57:25.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":43,"end":66,"url":"https://t.co/BII1Z6JRvC","expanded_url":"https://youtu.be/1X8RkxzEN5I","display_url":"youtu.be/1X8RkxzEN5I"}],"hashtags":[{"start":20,"end":31,"tag":"veterinary"},{"start":32,"end":41,"tag":"vaccines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"761478132045983744","text":"Why do we need more #veterinary #vaccines: https://t.co/BII1Z6JRvC","id":"761478132045983744","lang":"en","created_at":"2016-08-05T08:25:08.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/8p4hh1b7L0","expanded_url":"http://bit.ly/2aThb5h","display_url":"bit.ly/2aThb5h"}],"hashtags":[{"start":44,"end":55,"tag":"veterinary"},{"start":56,"end":65,"tag":"vaccines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"761222752564973570","text":"What can we do to encourage availability of #veterinary #vaccines: https://t.co/8p4hh1b7L0","id":"761222752564973570","lang":"en","created_at":"2016-08-04T15:30:21.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/5mpliBwgBO","expanded_url":"http://bit.ly/2aFyvX2","display_url":"bit.ly/2aFyvX2"}],"hashtags":[{"start":26,"end":37,"tag":"Bortezomib"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"761210913814876160","text":"The assessment report for #Bortezomib Sun (bortezomib), a generic medicine for multiple myeloma has been published: https://t.co/5mpliBwgBO","id":"761210913814876160","lang":"en","created_at":"2016-08-04T14:43:19.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/HScbfyMIsC","expanded_url":"http://bit.ly/2agZuu4","display_url":"bit.ly/2agZuu4"}],"hashtags":[{"start":15,"end":19,"tag":"ISO"},{"start":56,"end":66,"tag":"medicinal"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"761111962402955264","text":"Webinar on new #ISO standards for the identification of #medicinal products to take place on 4 August: https://t.co/HScbfyMIsC","id":"761111962402955264","lang":"en","created_at":"2016-08-04T08:10:07.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/V0wFGmrZzr","expanded_url":"http://bit.ly/2azRwtK","display_url":"bit.ly/2azRwtK"}],"hashtags":[{"start":18,"end":23,"tag":"SMEs"},{"start":67,"end":78,"tag":"regulatory"},{"start":95,"end":105,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"760861575452307457","text":"See our quarterly #SMEs newsletter providing information on the EU #regulatory environment for #medicines: https://t.co/V0wFGmrZzr","id":"760861575452307457","lang":"en","created_at":"2016-08-03T15:35:10.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":74,"end":97,"url":"https://t.co/Ziwmn6h2XW","expanded_url":"http://bit.ly/2aPrLde","display_url":"bit.ly/2aPrLde"}],"hashtags":[{"start":98,"end":115,"tag":"adaptivepathways"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":35,"reply_count":0,"like_count":12,"quote_count":4},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"760794862216241152","text":"The final report on the adaptive pathways pilot project is now available: https://t.co/Ziwmn6h2XW #adaptivepathways","id":"760794862216241152","lang":"en","created_at":"2016-08-03T11:10:04.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/1cvlSSby2I","expanded_url":"http://bit.ly/2apiYcx","display_url":"bit.ly/2apiYcx"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"760153154281406464","text":"Comment invited on guidance on clinical investigation of recombinant and human plasma-derived factor VIII  products: https://t.co/1cvlSSby2I","id":"760153154281406464","lang":"en","created_at":"2016-08-01T16:40:09.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/SDiJk4ybEx","expanded_url":"http://bit.ly/2aCV9AP","display_url":"bit.ly/2aCV9AP"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":73,"end":88,"tag":"CysticFibrosis"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"760113488555638784","text":"#Consultation opens on guidance on the development of medicines to treat #CysticFibrosis. Comments by 31 October: https://t.co/SDiJk4ybEx","id":"760113488555638784","lang":"en","created_at":"2016-08-01T14:02:32.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/pfvIvFVeDw","expanded_url":"http://bit.ly/2aJ4BW0","display_url":"bit.ly/2aJ4BW0"}],"hashtags":[{"start":126,"end":139,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"760113054377910273","text":"Comment invited on guideline on the development of medicines for the treatment of ulcerative colitis: https://t.co/pfvIvFVeDw #consultation","id":"760113054377910273","lang":"en","created_at":"2016-08-01T14:00:49.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/FtUpDfDHDr","expanded_url":"http://bit.ly/2apQXVC","display_url":"bit.ly/2apQXVC"}],"hashtags":[{"start":26,"end":41,"tag":"bioequivalence"},{"start":73,"end":86,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"760106614628061185","text":"Five new product-specific #bioequivalence guidelines released for public #consultation: https://t.co/FtUpDfDHDr","id":"760106614628061185","lang":"en","created_at":"2016-08-01T13:35:13.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/on1jQFj6ID","expanded_url":"http://bit.ly/2apPhLW","display_url":"bit.ly/2apPhLW"}],"hashtags":[{"start":0,"end":13,"tag":"consultation"}],"mentions":{},"annotations":[{"start":89,"end":93,"probability":0.3898,"type":"Other","normalized_text":"Crohn"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"760098178972651520","text":"#consultation open on guideline on the development of new medicines for the treatment of Crohn’s disease: https://t.co/on1jQFj6ID","id":"760098178972651520","lang":"en","created_at":"2016-08-01T13:01:42.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/Ywwm1eeOMN","expanded_url":"http://bit.ly/2apzXi9","display_url":"bit.ly/2apzXi9"}],"hashtags":[{"start":15,"end":25,"tag":"medicines"},{"start":35,"end":48,"tag":"tuberculosis"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"760069151293661184","text":"Development of #medicines to treat #tuberculosis: comments on draft guidance invited until 31 January 2017: https://t.co/Ywwm1eeOMN","id":"760069151293661184","lang":"en","created_at":"2016-08-01T11:06:21.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/mfDMaUcR4o","expanded_url":"http://bit.ly/2amtu85","display_url":"bit.ly/2amtu85"}],"hashtags":[{"start":0,"end":13,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"759072835004428288","text":"#consultation on review of EMA guidelines to implement 3Rs (replacement, reduction and refinement of animal testing) https://t.co/mfDMaUcR4o","id":"759072835004428288","lang":"en","created_at":"2016-07-29T17:07:21.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/Xlv9t3rbZZ","expanded_url":"http://bit.ly/2ahQ7Z1","display_url":"bit.ly/2ahQ7Z1"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"759069053004705793","text":"The minutes of the June's meeting of our Management Board are available: https://t.co/Xlv9t3rbZZ","id":"759069053004705793","lang":"en","created_at":"2016-07-29T16:52:19.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/9DLUR1lGJM","expanded_url":"http://horizon-magazine.eu/article/public-should-be-heart-21st-century-science-commissioner-moedas_en.html#.V5t0i4jCdsY.twitter","display_url":"horizon-magazine.eu/article/public…"}],"hashtags":{},"mentions":[{"start":96,"end":109,"username":"HorizonMagEU","id":"3355129101"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"759046417184808960","text":"Public should be at heart of 21st-century science – Commissioner Moedas https://t.co/9DLUR1lGJM @HorizonMagEU","id":"759046417184808960","lang":"en","created_at":"2016-07-29T15:22:22.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/kQnX032rch","expanded_url":"http://bit.ly/2awj6d3","display_url":"bit.ly/2awj6d3"}],"hashtags":[{"start":0,"end":13,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"759040667700039680","text":"#consultation open on guideline on use of physiologically-based pharmacokinetic (PBPK) modelling in drug development https://t.co/kQnX032rch","id":"759040667700039680","lang":"en","created_at":"2016-07-29T14:59:32.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/BtOaEFZMHs","expanded_url":"http://bit.ly/2a4Mn0n","display_url":"bit.ly/2a4Mn0n"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"759025920720015361","text":"#Consultation open until 13 Aug on guidance on dissolution specification for generic oral immediate release products https://t.co/BtOaEFZMHs","id":"759025920720015361","lang":"en","created_at":"2016-07-29T14:00:56.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/mVpq4gvhYc","expanded_url":"http://bit.ly/29vPHSP","display_url":"bit.ly/29vPHSP"}],"hashtags":[{"start":24,"end":33,"tag":"accounts"},{"start":62,"end":77,"tag":"administration"},{"start":125,"end":137,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"759014416666890240","text":"Apply for a position as #accounts receivable assistant in our #administration division, by 5 August: https://t.co/mVpq4gvhYc #recruitment","id":"759014416666890240","lang":"en","created_at":"2016-07-29T13:15:13.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/64n4lEBpP3","expanded_url":"http://bit.ly/29xSRzH","display_url":"bit.ly/29xSRzH"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":57,"end":61,"tag":"ICH"},{"start":66,"end":76,"tag":"guideline"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"759014305597526016","text":"#Consultation open until 12 Aug on strategy to implement #ICH Q3D #guideline for elemental impurities in EU context: https://t.co/64n4lEBpP3","id":"759014305597526016","lang":"en","created_at":"2016-07-29T13:14:46.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/7Tt5SYONhC","expanded_url":"http://bit.ly/2aB3PKZ","display_url":"bit.ly/2aB3PKZ"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758955790774390784","text":"Non-clinical and clinical module of new guideline on influenza vaccines has been adopted and published: https://t.co/7Tt5SYONhC","id":"758955790774390784","lang":"en","created_at":"2016-07-29T09:22:15.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/Izuh2wRAcx","expanded_url":"http://bit.ly/2af5lm7","display_url":"bit.ly/2af5lm7"}],"hashtags":[{"start":72,"end":82,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758719126537904128","text":"Comments invited by 31 October on guidance on clinical investigation of #medicines for bipolar disorder. https://t.co/Izuh2wRAcx","id":"758719126537904128","lang":"en","created_at":"2016-07-28T17:41:50.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/HScbfyv7B4","expanded_url":"http://bit.ly/2agZuu4","display_url":"bit.ly/2agZuu4"}],"hashtags":[{"start":0,"end":8,"tag":"Webinar"},{"start":16,"end":20,"tag":"ISO"},{"start":57,"end":67,"tag":"medicinal"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":5,"quote_count":4},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758673239929479168","text":"#Webinar on new #ISO standards for the identification of #medicinal products to take place on 4 August: https://t.co/HScbfyv7B4","id":"758673239929479168","lang":"en","created_at":"2016-07-28T14:39:30.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/Jec8KN03k8","expanded_url":"http://bit.ly/2a6Yg1o","display_url":"bit.ly/2a6Yg1o"}],"hashtags":[{"start":79,"end":88,"tag":"medicine"},{"start":98,"end":108,"tag":"Hepatitis"}],"mentions":{},"annotations":[{"start":42,"end":49,"probability":0.3195,"type":"Person","normalized_text":"Zepatier"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758664858900586497","text":"We've published the assessment report for Zepatier (elbasvir / grazoprevir), a #medicine to treat #Hepatitis C: https://t.co/Jec8KN03k8","id":"758664858900586497","lang":"en","created_at":"2016-07-28T14:06:12.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/jRbfAVEyi4","expanded_url":"http://bit.ly/2ak1NKg","display_url":"bit.ly/2ak1NKg"}],"hashtags":[{"start":29,"end":39,"tag":"guideline"},{"start":69,"end":78,"tag":"diabetes"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758662626826153984","text":"Concept paper on revision of #guideline on clinical investigation of #diabetes medicines. Comment until end October: https://t.co/jRbfAVEyi4","id":"758662626826153984","lang":"en","created_at":"2016-07-28T13:57:20.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/lyUiOIaf11","expanded_url":"http://bit.ly/2ac7xai","display_url":"bit.ly/2ac7xai"}],"hashtags":[{"start":71,"end":80,"tag":"medicine"},{"start":98,"end":108,"tag":"Hepatitis"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758637124270907392","text":"Assessment report available for  Epclusa (sofosbuvir / velpatasvir), a #medicine to treat chronic #Hepatitis C: https://t.co/lyUiOIaf11","id":"758637124270907392","lang":"lt","created_at":"2016-07-28T12:15:59.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/1tfCXUFM0k","expanded_url":"http://bit.ly/2acvRHV","display_url":"bit.ly/2acvRHV"}],"hashtags":[{"start":128,"end":135,"tag":"ITjobs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758591592315912192","text":"Apply by 8 Sept for a role as Solution Architect/Technical Lead in our Information Management Division: https://t.co/1tfCXUFM0k #ITjobs","id":"758591592315912192","lang":"en","created_at":"2016-07-28T09:15:04.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":79,"end":89,"tag":"hepatitis"},{"start":115,"end":127,"tag":"WorldHepDay"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758575863608774656","text":"RT @WHO_Europe: More than 400 people across the European Region die from viral #hepatitis-related causes every day #WorldHepDay https://t.c…","id":"758575863608774656","lang":"en","created_at":"2016-07-28T08:12:34.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"758572048662794240"}]},{"entities":{"urls":{},"hashtags":[{"start":87,"end":97,"tag":"hepatitis"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758572860017344512","text":"RT @WHO_Europe: An estimated 13+ million people in the European Region are living with #hepatitis B infection, over 15 million with chronic…","id":"758572860017344512","lang":"en","created_at":"2016-07-28T08:00:38.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"758569631460298752"}]},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/UzkLI4zask","expanded_url":"http://bit.ly/2a9uERT","display_url":"bit.ly/2a9uERT"}],"hashtags":[{"start":27,"end":32,"tag":"EPAR"},{"start":38,"end":44,"tag":"Qtern"},{"start":46,"end":58,"tag":"saxagliptin"},{"start":61,"end":75,"tag":"dapagliflozin"},{"start":98,"end":107,"tag":"diabetes"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758310574694473728","text":"See the assessment report (#EPAR) for #Qtern (#saxagliptin / #dapagliflozin), a medicine to treat #diabetes: https://t.co/UzkLI4zask","id":"758310574694473728","lang":"en","created_at":"2016-07-27T14:38:24.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/DO6wuHHG09","expanded_url":"http://bit.ly/2ah9r8n","display_url":"bit.ly/2ah9r8n"},{"start":96,"end":119,"url":"https://t.co/MOprYYaiBR","expanded_url":"https://twitter.com/EMA_News/status/758298142177714179/photo/1","display_url":"pic.twitter.com/MOprYYaiBR"}],"hashtags":[{"start":46,"end":52,"tag":"PRIME"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":1,"like_count":7,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758298142177714179","text":"Find out which medicines were accepted in our #PRIME scheme this month: https://t.co/DO6wuHHG09 https://t.co/MOprYYaiBR","id":"758298142177714179","lang":"en","created_at":"2016-07-27T13:49:00.000Z","author_id":"116716199","attachments":{"media_keys":["3_758297741533573120"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/9R7NkOL8jM","expanded_url":"http://bit.ly/2alV85Y","display_url":"bit.ly/2alV85Y"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":7,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758275187318132736","text":"See workshop report on demonstrating significant benefit of orphan medicines: concept, methodology, impact on access https://t.co/9R7NkOL8jM","id":"758275187318132736","lang":"en","created_at":"2016-07-27T12:17:47.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/IMWJrBCB5P","expanded_url":"http://bit.ly/2awoCyK","display_url":"bit.ly/2awoCyK"}],"hashtags":[{"start":29,"end":38,"tag":"colistin"},{"start":83,"end":104,"tag":"antibioticresistance"},{"start":129,"end":140,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":7,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"758255526694252544","text":"Updated advice on the use of #colistin in animals: countries to reduce use to curb #antibioticresistance https://t.co/IMWJrBCB5P #veterinary","id":"758255526694252544","lang":"en","created_at":"2016-07-27T10:59:39.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/uhigvW5Onn","expanded_url":"http://bit.ly/ECDC_antibiotic_use","display_url":"bit.ly/ECDC_antibioti…"}],"hashtags":[{"start":24,"end":27,"tag":"EU"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"public_metrics":{"retweet_count":36,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757968108741066752","text":"RT @ECDC_EU: Comment on #EU guidelines on prudent use of antimicrobials. Public consultation opens today https://t.co/uhigvW5Onn  #antibiot…","id":"757968108741066752","lang":"en","created_at":"2016-07-26T15:57:34.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"757962522045648896"}]},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/O041Ku57AU","expanded_url":"http://bit.ly/2aHIb3Q","display_url":"bit.ly/2aHIb3Q"}],"hashtags":[{"start":59,"end":70,"tag":"pemetrexed"},{"start":75,"end":83,"tag":"generic"},{"start":98,"end":107,"tag":"medicine"}],"mentions":{},"annotations":[{"start":32,"end":51,"probability":0.3638,"type":"Organization","normalized_text":"Pemetrexed Fresenius"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757967859674935300","text":"Assessment report available for Pemetrexed Fresenius Kabi\n(#pemetrexed), a #generic of the cancer #medicine Alimta: https://t.co/O041Ku57AU","id":"757967859674935300","lang":"en","created_at":"2016-07-26T15:56:34.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/eOjWZbfToU","expanded_url":"https://shar.es/1Zgs8o","display_url":"shar.es/1Zgs8o"}],"hashtags":[{"start":81,"end":95,"tag":"certification"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"},{"start":125,"end":135,"username":"ShareThis","id":"14116807"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757905609350152193","text":"RT @edqm_news: Have your say in preparing the EDQM's international conference on #certification! https://t.co/eOjWZbfToU via @sharethis #CE…","id":"757905609350152193","lang":"en","created_at":"2016-07-26T11:49:13.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"757870673016528896"}]},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/of65RsBE5i","expanded_url":"http://bit.ly/1Rt2AbK","display_url":"bit.ly/1Rt2AbK"}],"hashtags":[{"start":95,"end":106,"tag":"veterinary"},{"start":107,"end":116,"tag":"vaccines"}],"mentions":{},"annotations":[{"start":23,"end":40,"probability":0.1729,"type":"Other","normalized_text":"VICH GL50 Criteria"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757863446977339392","text":"One week to comment on VICH GL50 Criteria to waive animal batch safety testing for inactivated #veterinary #vaccines https://t.co/of65RsBE5i","id":"757863446977339392","lang":"en","created_at":"2016-07-26T09:01:40.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/SNOp3LLNwR","expanded_url":"http://bit.ly/1LJXS5g","display_url":"bit.ly/1LJXS5g"}],"hashtags":[{"start":94,"end":105,"tag":"veterinary"},{"start":106,"end":115,"tag":"vaccines"}],"mentions":{},"annotations":[{"start":28,"end":36,"probability":0.2689,"type":"Person","normalized_text":"VICH GL55"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757862372157616128","text":"One week left to comment on VICH GL55: Criteria to waive animal batch safety testing for live #veterinary #vaccines: https://t.co/SNOp3LLNwR","id":"757862372157616128","lang":"en","created_at":"2016-07-26T08:57:24.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/Poq9JyabII","expanded_url":"http://bit.ly/2ae5eWq","display_url":"bit.ly/2ae5eWq"}],"hashtags":[{"start":0,"end":9,"tag":"Comments"},{"start":42,"end":49,"tag":"herbal"},{"start":106,"end":119,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757606601427652608","text":"#Comments invited until 31 October on the #herbal monograph on Allium sativum L.: https://t.co/Poq9JyabII #consultation","id":"757606601427652608","lang":"en","created_at":"2016-07-25T16:01:04.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/djx5fQsVKO","expanded_url":"http://bit.ly/29V69eS","display_url":"bit.ly/29V69eS"}],"hashtags":[{"start":53,"end":60,"tag":"Herbal"},{"start":81,"end":86,"tag":"HMPC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757606525003259904","text":"See report from the July meeting of our Committee on #Herbal Medicinal Products (#HMPC): https://t.co/djx5fQsVKO","id":"757606525003259904","lang":"en","created_at":"2016-07-25T16:00:45.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/d5n8o5LqMr","expanded_url":"http://bit.ly/2a64KTX","display_url":"bit.ly/2a64KTX"}],"hashtags":[{"start":19,"end":29,"tag":"guideline"},{"start":56,"end":67,"tag":"veterinary"},{"start":68,"end":78,"tag":"medicines"},{"start":118,"end":131,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757606227509645313","text":"Comment on a draft #guideline on higher-tier testing of #veterinary #medicines to dung fauna: https://t.co/d5n8o5LqMr #consultation","id":"757606227509645313","lang":"en","created_at":"2016-07-25T15:59:34.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/4Oc2q4CB66","expanded_url":"http://bit.ly/29V4y8F","display_url":"bit.ly/29V4y8F"}],"hashtags":[{"start":0,"end":11,"tag":"Veterinary"},{"start":23,"end":36,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757605676076113923","text":"#Veterinary medicines: #consultation on a guideline on approach towards harmonisation of withdrawal periods: https://t.co/4Oc2q4CB66","id":"757605676076113923","lang":"en","created_at":"2016-07-25T15:57:23.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/Dyf27nqJk0","expanded_url":"http://bit.ly/2aojOMr","display_url":"bit.ly/2aojOMr"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":46,"end":53,"tag":"herbal"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757561886514810881","text":"#Consultation is open until 31 October on the #herbal monograph on Glycine max (L.) Merr.: https://t.co/Dyf27nqJk0","id":"757561886514810881","lang":"en","created_at":"2016-07-25T13:03:23.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/XaqK0XW5EE","expanded_url":"http://bit.ly/2ank24A","display_url":"bit.ly/2ank24A"}],"hashtags":[{"start":29,"end":40,"tag":"veterinary"},{"start":55,"end":70,"tag":"tumorigenicity"},{"start":90,"end":97,"tag":"ADVENT"},{"start":123,"end":136,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757561010660204545","text":"Questions on stem cell-based #veterinary medicines and #tumorigenicity to be discussed by #ADVENT: https://t.co/XaqK0XW5EE #consultation","id":"757561010660204545","lang":"en","created_at":"2016-07-25T12:59:54.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/8DMDRAq3NB","expanded_url":"http://bit.ly/2a5AcS3","display_url":"bit.ly/2a5AcS3"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":31,"end":38,"tag":"ADVENT"},{"start":58,"end":69,"tag":"veterinary"},{"start":98,"end":105,"tag":"safety"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757560759434022912","text":"#Consultation on questions for #ADVENT on stem cell-based #veterinary medicines and target animal #safety: https://t.co/8DMDRAq3NB","id":"757560759434022912","lang":"en","created_at":"2016-07-25T12:58:54.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/EUlbmT9PaR","expanded_url":"http://bit.ly/2aFj1CI","display_url":"bit.ly/2aFj1CI"}],"hashtags":[{"start":9,"end":22,"tag":"consultation"},{"start":60,"end":71,"tag":"veterinary"},{"start":79,"end":94,"tag":"anticoccidials"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757543126848401408","text":"Start of #consultation on revisions to the guideline on the #veterinary use of #anticoccidials in poultry: https://t.co/EUlbmT9PaR","id":"757543126848401408","lang":"en","created_at":"2016-07-25T11:48:50.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/n8gli3CcUb","expanded_url":"http://bit.ly/2a7hAuV","display_url":"bit.ly/2a7hAuV"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":76,"end":90,"tag":"antimicrobial"},{"start":91,"end":102,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"757542987413020672","text":"#Consultation on revised guidance on summary of product characteristics for #antimicrobial #veterinary medicines: https://t.co/n8gli3CcUb","id":"757542987413020672","lang":"en","created_at":"2016-07-25T11:48:17.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/XFPGifF7xw","expanded_url":"http://bit.ly/29YKEa1","display_url":"bit.ly/29YKEa1"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"756513250272051200","text":"The #minutes of the June meeting of our committee for advanced therapies (CAT) are published: https://t.co/XFPGifF7xw","id":"756513250272051200","lang":"en","created_at":"2016-07-22T15:36:28.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/MhnG7m78OS","expanded_url":"http://bit.ly/2a2LzVC","display_url":"bit.ly/2a2LzVC"}],"hashtags":[{"start":19,"end":29,"tag":"medicines"},{"start":46,"end":53,"tag":"orphan"},{"start":73,"end":78,"tag":"COMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"756508042242428929","text":"Find out about the #medicines recommended for #orphan designation by the #COMP in July:\nhttps://t.co/MhnG7m78OS","id":"756508042242428929","lang":"en","created_at":"2016-07-22T15:15:47.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/OFda8hhyi5","expanded_url":"http://bit.ly/2a0NCvQ","display_url":"bit.ly/2a0NCvQ"}],"hashtags":[{"start":6,"end":15,"tag":"medicine"},{"start":20,"end":24,"tag":"HIV"},{"start":116,"end":121,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":31,"reply_count":1,"like_count":12,"quote_count":4},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"756447212268294144","text":"First #medicine for #HIV pre-exposure prophylaxis (PrEP) recommended for approval in the EU https://t.co/OFda8hhyi5 #CHMP","id":"756447212268294144","lang":"en","created_at":"2016-07-22T11:14:04.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/0eVi1y2gS7","expanded_url":"http://bit.ly/29Yflfk","display_url":"bit.ly/29Yflfk"}],"hashtags":[{"start":4,"end":14,"tag":"medicines"},{"start":45,"end":52,"tag":"kidney"},{"start":88,"end":93,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":3,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"756446474741874688","text":"Two #medicines for the treatment of advanced #kidney cancer recommended for approval by #CHMP https://t.co/0eVi1y2gS7","id":"756446474741874688","lang":"en","created_at":"2016-07-22T11:11:08.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/37rSPiK3aQ","expanded_url":"http://bit.ly/29YwSrV","display_url":"bit.ly/29YwSrV"},{"start":107,"end":130,"url":"https://t.co/wPOjVL29L5","expanded_url":"https://twitter.com/EMA_News/status/756445773873680384/photo/1","display_url":"pic.twitter.com/wPOjVL29L5"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":19,"end":29,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":3,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"756445773873680384","text":"#CHMP recommends 8 #medicines for approval at July meeting – check out highlights: https://t.co/37rSPiK3aQ https://t.co/wPOjVL29L5","id":"756445773873680384","lang":"en","created_at":"2016-07-22T11:08:21.000Z","author_id":"116716199","attachments":{"media_keys":["3_756438763564306432"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/GE0AMD3m1x","expanded_url":"http://bit.ly/20iLFAl","display_url":"bit.ly/20iLFAl"}],"hashtags":[{"start":8,"end":18,"tag":"guideline"},{"start":22,"end":32,"tag":"medicines"},{"start":42,"end":52,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"756409464178212864","text":"Revised #guideline on #medicines to treat #Alzheimer’s disease and other dementias - one week left to comment: https://t.co/GE0AMD3m1x","id":"756409464178212864","lang":"en","created_at":"2016-07-22T08:44:04.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/mVpq4gdH6E","expanded_url":"http://bit.ly/29vPHSP","display_url":"bit.ly/29vPHSP"}],"hashtags":[{"start":24,"end":33,"tag":"accounts"},{"start":62,"end":77,"tag":"administration"},{"start":125,"end":137,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"756408994063941632","text":"Apply for a position as #accounts receivable assistant in our #administration division, by 5 August: https://t.co/mVpq4gdH6E #recruitment","id":"756408994063941632","lang":"en","created_at":"2016-07-22T08:42:12.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/oIIF33C7vP","expanded_url":"http://bit.ly/1NCTvK5","display_url":"bit.ly/1NCTvK5"}],"hashtags":[{"start":16,"end":29,"tag":"Consultation"},{"start":69,"end":83,"tag":"antibacterial"},{"start":84,"end":94,"tag":"medicines"},{"start":99,"end":110,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"756408700361990144","text":"One week to go: #Consultation on need for addendum on development of #antibacterial #medicines for #paediatric use: https://t.co/oIIF33C7vP","id":"756408700361990144","lang":"en","created_at":"2016-07-22T08:41:02.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/uFTvmeJmzN","expanded_url":"http://bit.ly/1YW5M2e","display_url":"bit.ly/1YW5M2e"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"756407572522004480","text":"1 week left to comment: reflection paper on collecting + reporting information on off-label use in pharmacovigilance https://t.co/uFTvmeJmzN","id":"756407572522004480","lang":"en","created_at":"2016-07-22T08:36:33.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/xqX7M16vSJ","expanded_url":"http://bit.ly/2abzzV3","display_url":"bit.ly/2abzzV3"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":70,"end":85,"tag":"clinicaltrials"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":3,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"756083549409771520","text":"#Consultation opens on proposals to revise guidance on first-in-human #clinicaltrials; comments until 30 Sept: https://t.co/xqX7M16vSJ","id":"756083549409771520","lang":"en","created_at":"2016-07-21T11:09:00.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/hlnswhRc6s","expanded_url":"http://bit.ly/29N7SyX","display_url":"bit.ly/29N7SyX"}],"hashtags":[{"start":58,"end":69,"tag":"veterinary"},{"start":81,"end":86,"tag":"CVMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"755750108755587076","text":"See the minutes from the June meeting of the committee on #veterinary medicines (#CVMP): https://t.co/hlnswhRc6s","id":"755750108755587076","lang":"en","created_at":"2016-07-20T13:04:01.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/QovOfsXz0u","expanded_url":"http://bit.ly/29TgYPE","display_url":"bit.ly/29TgYPE"}],"hashtags":[{"start":43,"end":54,"tag":"Paediatric"},{"start":66,"end":71,"tag":"PDCO"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"755713382397935616","text":"The agenda for this month’s meeting of our #Paediatric Committee (#PDCO) is now available: https://t.co/QovOfsXz0u","id":"755713382397935616","lang":"en","created_at":"2016-07-20T10:38:05.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/JQuHcZnWfi","expanded_url":"http://bit.ly/2a94CiM","display_url":"bit.ly/2a94CiM"}],"hashtags":[{"start":129,"end":136,"tag":"ITjobs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"755422707018235904","text":"We have extended until 19 September our deadline to apply for a job as master data management architect: https://t.co/JQuHcZnWfi #ITjobs","id":"755422707018235904","lang":"en","created_at":"2016-07-19T15:23:03.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/QJFKFlEneJ","expanded_url":"http://bit.ly/2a7rSRH","display_url":"bit.ly/2a7rSRH"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":69,"end":74,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"755372919195332608","text":"The #agenda for this week's meeting of our human medicine committee (#CHMP) is available: https://t.co/QJFKFlEneJ","id":"755372919195332608","lang":"en","created_at":"2016-07-19T12:05:12.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/i6BhrHh9qy","expanded_url":"http://bit.ly/29Vpvjp","display_url":"bit.ly/29Vpvjp"}],"hashtags":[{"start":42,"end":51,"tag":"Zinbryta"},{"start":53,"end":64,"tag":"daclizumab"},{"start":69,"end":78,"tag":"medicine"},{"start":83,"end":101,"tag":"MultipleSclerosis"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"755358031039332352","text":"We've published the assessment report for #Zinbryta\n(#daclizumab), a #medicine for #MultipleSclerosis: https://t.co/i6BhrHh9qy","id":"755358031039332352","lang":"en","created_at":"2016-07-19T11:06:03.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/j1GhsMWdqe","expanded_url":"http://bit.ly/2a50yA4","display_url":"bit.ly/2a50yA4"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":5,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"754966072399433728","text":"EU post-authorisation studies (PAS) register has been upgraded to improve searching and data management: https://t.co/j1GhsMWdqe","id":"754966072399433728","lang":"en","created_at":"2016-07-18T09:08:32.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/eW7pAoYZJ1","expanded_url":"http://bit.ly/29Ogvfa","display_url":"bit.ly/29Ogvfa"}],"hashtags":[{"start":62,"end":73,"tag":"veterinary"},{"start":85,"end":90,"tag":"CVMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"753958596195545088","text":"See the highlights from the July meeting of our committee for #veterinary medicines (#CVMP): https://t.co/eW7pAoYZJ1","id":"753958596195545088","lang":"en","created_at":"2016-07-15T14:25:11.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/o01WDlXTvg","expanded_url":"http://bit.ly/29J2psH","display_url":"bit.ly/29J2psH"}],"hashtags":[{"start":0,"end":5,"tag":"CVMP"},{"start":32,"end":43,"tag":"veterinary"},{"start":53,"end":62,"tag":"Velactis"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"753957859189198848","text":"#CVMP recommends suspending the #veterinary medicine #Velactis (cabergoline) after reports of serious side effects: https://t.co/o01WDlXTvg","id":"753957859189198848","lang":"en","created_at":"2016-07-15T14:22:16.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/NfKOkWjh9d","expanded_url":"http://bit.ly/29BhXPy","display_url":"bit.ly/29BhXPy"}],"hashtags":[{"start":57,"end":64,"tag":"herbal"},{"start":65,"end":76,"tag":"monographs"},{"start":116,"end":129,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"753897260648398848","text":"Submit scientific data for the systematic review of four #herbal #monographs by 15 October: https://t.co/NfKOkWjh9d #consultation","id":"753897260648398848","lang":"en","created_at":"2016-07-15T10:21:28.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":53,"end":76,"url":"https://t.co/C4YblDLm4z","expanded_url":"http://bit.ly/29zsydH","display_url":"bit.ly/29zsydH"}],"hashtags":{},"mentions":[{"start":0,"end":7,"username":"oltra_","id":"174688807"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"753348355984617472","text":"@oltra_ \nEMA concluded this review in November 2015: https://t.co/C4YblDLm4z","id":"753630037430177792","lang":"en","created_at":"2016-07-14T16:39:37.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"753625445384409088"}],"in_reply_to_user_id":"174688807"},{"entities":{"urls":[{"start":57,"end":80,"url":"https://t.co/C4YblDLm4z","expanded_url":"http://bit.ly/29zsydH","display_url":"bit.ly/29zsydH"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"DES_Journal","id":"260926865"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":2,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"753348355984617472","text":"@DES_Journal EMA concluded this review in November 2015: https://t.co/C4YblDLm4z","id":"753619212158074880","lang":"en","created_at":"2016-07-14T15:56:36.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"753348355984617472"}],"in_reply_to_user_id":"260926865"},{"entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/UcsAPM2BMv","expanded_url":"http://bit.ly/29zq3Ia","display_url":"bit.ly/29zq3Ia"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":77,"end":81,"tag":"CAT"}],"mentions":{},"annotations":[{"start":43,"end":74,"probability":0.2318,"type":"Organization","normalized_text":"Committee for Advanced Therapies"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"753612783376330752","text":"The #agenda of this month’s meeting of our Committee for Advanced Therapies (#CAT) is available: https://t.co/UcsAPM2BMv","id":"753612783376330752","lang":"en","created_at":"2016-07-14T15:31:03.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":120,"end":143,"url":"https://t.co/NdOJ1ST8Ox","expanded_url":"http://bit.ly/2a0imzm","display_url":"bit.ly/2a0imzm"}],"hashtags":[{"start":13,"end":27,"tag":"EndolucinBeta"},{"start":109,"end":119,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"753555233444392960","text":"EPAR out for #EndolucinBeta which  contains lutetium (177Lu) chloride &amp; is used for radiolabelling other #medicines https://t.co/NdOJ1ST8Ox","id":"753555233444392960","lang":"en","created_at":"2016-07-14T11:42:22.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/seQoJHzfwV","expanded_url":"http://bit.ly/29EgYwH","display_url":"bit.ly/29EgYwH"}],"hashtags":[{"start":42,"end":52,"tag":"Zavicefta"},{"start":84,"end":98,"tag":"antibacterial"},{"start":99,"end":108,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"753552230972854272","text":"We've published the assessment report for #Zavicefta (ceftazidime/avibactam), a new #antibacterial #medicine https://t.co/seQoJHzfwV","id":"753552230972854272","lang":"en","created_at":"2016-07-14T11:30:26.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/pIs7GjPmMc","expanded_url":"http://bit.ly/28KqDS7","display_url":"bit.ly/28KqDS7"}],"hashtags":[{"start":96,"end":103,"tag":"ITjobs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"753149183729819649","text":"We are recruiting a master data management architect, apply by 21 July: https://t.co/pIs7GjPmMc #ITjobs","id":"753149183729819649","lang":"en","created_at":"2016-07-13T08:48:52.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/Fg0kRDFIl7","expanded_url":"http://bit.ly/28Ky5g6","display_url":"bit.ly/28Ky5g6"}],"hashtags":[{"start":123,"end":135,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":1,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"753142986897317890","text":"Apply now for our position as media and PR officer in our Stakeholders and Communication division: https://t.co/Fg0kRDFIl7 #recruitment","id":"753142986897317890","lang":"en","created_at":"2016-07-13T08:24:15.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":59,"end":82,"url":"https://t.co/FDoB4UzRyc","expanded_url":"http://bit.ly/28Kr3Ys","display_url":"bit.ly/28Kr3Ys"}],"hashtags":[{"start":37,"end":43,"tag":"legal"},{"start":83,"end":95,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"753142127056396288","text":"Apply by 21 July for our position as #legal administrator: https://t.co/FDoB4UzRyc #recruitment","id":"753142127056396288","lang":"en","created_at":"2016-07-13T08:20:50.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/wp2RdqQ4o6","expanded_url":"http://bit.ly/28L9afy","display_url":"bit.ly/28L9afy"}],"hashtags":[{"start":117,"end":129,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"753141493775339520","text":"We're recruiting an information management specialist for our information centre activities: https://t.co/wp2RdqQ4o6 #recruitment","id":"753141493775339520","lang":"en","created_at":"2016-07-13T08:18:19.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/E1f24Qm8S9","expanded_url":"http://bit.ly/29AMwJZ","display_url":"bit.ly/29AMwJZ"}],"hashtags":[{"start":8,"end":15,"tag":"ENCePP"},{"start":69,"end":90,"tag":"pharmacoepidemiology"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"752886757662699520","text":"Revised #ENCePP checklist for study protocols, supporting quality of #pharmacoepidemiology studies: https://t.co/E1f24Qm8S9","id":"752886757662699520","lang":"en","created_at":"2016-07-12T15:26:05.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/O8G1R6aUkP","expanded_url":"http://bit.ly/29G7THk","display_url":"bit.ly/29G7THk"}],"hashtags":[{"start":12,"end":19,"tag":"ENCePP"},{"start":57,"end":78,"tag":"pharmacoepidemiology"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"752885273038495744","text":"The revised #ENCePP guide on methodological standards in #pharmacoepidemiology is now available: https://t.co/O8G1R6aUkP","id":"752885273038495744","lang":"en","created_at":"2016-07-12T15:20:11.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/64n4lEBpP3","expanded_url":"http://bit.ly/29xSRzH","display_url":"bit.ly/29xSRzH"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":44,"end":48,"tag":"ICH"},{"start":53,"end":63,"tag":"guideline"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"752812320825282560","text":"#Consultation open on strategy to implement #ICH Q3D #guideline for elemental impurities in the European context: https://t.co/64n4lEBpP3","id":"752812320825282560","lang":"en","created_at":"2016-07-12T10:30:18.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":77,"end":100,"url":"https://t.co/GysnJJ6ngr","expanded_url":"http://bit.ly/29E652i","display_url":"bit.ly/29E652i"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"752805424521416704","text":"Find out about EMA's key achievements in 2015 in our annual activity report: https://t.co/GysnJJ6ngr","id":"752805424521416704","lang":"en","created_at":"2016-07-12T10:02:54.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/07BpP7kJvk","expanded_url":"http://bit.ly/29tfU0F","display_url":"bit.ly/29tfU0F"}],"hashtags":[{"start":62,"end":70,"tag":"Odefsey"},{"start":85,"end":94,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"751465955281231874","text":"A summary of the European public assessment report (EPAR) for #Odefsey, an antiviral #medicine, is available now: https://t.co/07BpP7kJvk","id":"751465955281231874","lang":"en","created_at":"2016-07-08T17:20:19.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/1rhUfFgyT9","expanded_url":"http://bit.ly/1RY814z","display_url":"bit.ly/1RY814z"},{"start":120,"end":143,"url":"https://t.co/ukquwNFv8V","expanded_url":"http://bit.ly/29tdUFP","display_url":"bit.ly/29tdUFP"}],"hashtags":[{"start":0,"end":9,"tag":"Patients"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":9,"quote_count":2},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"751450109766926337","text":"#Patients, consumers, carers: get involved in EMA activities. Check out our webpage https://t.co/1rhUfFgyT9 and Q&amp;A https://t.co/ukquwNFv8V","id":"751450109766926337","lang":"en","created_at":"2016-07-08T16:17:22.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/pJ7ElEb3Cb","expanded_url":"http://bit.ly/29zNK4w","display_url":"bit.ly/29zNK4w"}],"hashtags":[{"start":82,"end":92,"tag":"Medicinal"},{"start":103,"end":108,"tag":"HMPC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"751441703903649792","text":"We have just published the agenda for the next meeting of the Committee on Herbal #Medicinal Products (#HMPC) https://t.co/pJ7ElEb3Cb","id":"751441703903649792","lang":"en","created_at":"2016-07-08T15:43:57.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":61,"end":84,"url":"https://t.co/Gt2fV51nZU","expanded_url":"http://bit.ly/29DzQ1z","display_url":"bit.ly/29DzQ1z"}],"hashtags":[{"start":23,"end":33,"tag":"medicines"},{"start":54,"end":59,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"751434050800324608","text":"Find out about the new #medicines under evaluation by #CHMP: https://t.co/Gt2fV51nZU","id":"751434050800324608","lang":"en","created_at":"2016-07-08T15:13:33.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/TWEX6pDBy3","expanded_url":"http://bit.ly/29rJCY5","display_url":"bit.ly/29rJCY5"}],"hashtags":[{"start":0,"end":5,"tag":"PRAC"},{"start":34,"end":41,"tag":"cancer"},{"start":42,"end":51,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"751420459040772096","text":"#PRAC has concluded its review of #cancer #medicine Zydelig and issued updated recommendations for use: https://t.co/TWEX6pDBy3","id":"751420459040772096","lang":"en","created_at":"2016-07-08T14:19:32.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/sXmfyvKTIv","expanded_url":"http://bit.ly/29GgCLo","display_url":"bit.ly/29GgCLo"}],"hashtags":[{"start":65,"end":83,"tag":"pharmacovigilance"},{"start":95,"end":100,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"751419851441307648","text":"We have published the highlights from this week’s meeting of our #pharmacovigilance committee (#PRAC): https://t.co/sXmfyvKTIv","id":"751419851441307648","lang":"en","created_at":"2016-07-08T14:17:07.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/JSex5IKXPK","expanded_url":"http://bit.ly/29pSLgW","display_url":"bit.ly/29pSLgW"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"751088980045750273","text":"The #minutes of the May meeting of our committee for advanced therapies (CAT) are now available: https://t.co/JSex5IKXPK","id":"751088980045750273","lang":"en","created_at":"2016-07-07T16:22:22.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/WSpTvNnluO","expanded_url":"http://bit.ly/29jVsCg","display_url":"bit.ly/29jVsCg"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":33,"tag":"guideline"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"751020969301512193","text":"#Consultation on draft #guideline on clinical evaluation of direct acting antivirals to treat chronic hepatitis: https://t.co/WSpTvNnluO","id":"751020969301512193","lang":"en","created_at":"2016-07-07T11:52:07.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/biMoY8Hhov","expanded_url":"http://bit.ly/29yyOad","display_url":"bit.ly/29yyOad"}],"hashtags":[{"start":43,"end":50,"tag":"orphan"},{"start":51,"end":60,"tag":"medicine"},{"start":72,"end":77,"tag":"COMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"750981303244361728","text":"We've published the agenda of this month's #orphan #medicine committee (#COMP) meeting:  https://t.co/biMoY8Hhov","id":"750981303244361728","lang":"en","created_at":"2016-07-07T09:14:29.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/FDoB4URsWM","expanded_url":"http://bit.ly/28Kr3Ys","display_url":"bit.ly/28Kr3Ys"}],"hashtags":[{"start":28,"end":34,"tag":"legal"},{"start":92,"end":104,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"750964997942050816","text":"Apply now for a position as #legal administrator. Deadline 21 July: https://t.co/FDoB4URsWM #recruitment","id":"750964997942050816","lang":"en","created_at":"2016-07-07T08:09:42.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/pIs7GjPmMc","expanded_url":"http://bit.ly/28KqDS7","display_url":"bit.ly/28KqDS7"}],"hashtags":[{"start":96,"end":103,"tag":"ITjobs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"750964293370310656","text":"We are recruiting a master data management architect. Apply by 21 July: https://t.co/pIs7GjPmMc #ITjobs","id":"750964293370310656","lang":"en","created_at":"2016-07-07T08:06:54.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/wp2RdqQ4o6","expanded_url":"http://bit.ly/28L9afy","display_url":"bit.ly/28L9afy"}],"hashtags":[{"start":123,"end":135,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"750964059047100416","text":"Two weeks left to apply for a role as information management specialist in our information centre: https://t.co/wp2RdqQ4o6 #recruitment","id":"750964059047100416","lang":"en","created_at":"2016-07-07T08:05:58.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/Fg0kRDFIl7","expanded_url":"http://bit.ly/28Ky5g6","display_url":"bit.ly/28Ky5g6"}],"hashtags":[{"start":128,"end":140,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"750963250200805377","text":"Apply by 21 July for a position as media and PR officer in our Stakeholders and Communication division: https://t.co/Fg0kRDFIl7 #recruitment","id":"750963250200805377","lang":"en","created_at":"2016-07-07T08:02:45.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/clNnKPj7jo","expanded_url":"http://bit.ly/29y2r8t","display_url":"bit.ly/29y2r8t"}],"hashtags":[{"start":44,"end":55,"tag":"veterinary"},{"start":69,"end":78,"tag":"medicine"},{"start":79,"end":88,"tag":"Sevocalm"},{"start":90,"end":102,"tag":"sevoflurane"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"750669081603346432","text":"We have published the assessment report for #veterinary anaesthetic  #medicine #Sevocalm (#sevoflurane): https://t.co/clNnKPj7jo","id":"750669081603346432","lang":"en","created_at":"2016-07-06T12:33:50.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/mVpq4gdH6E","expanded_url":"http://bit.ly/29vPHSP","display_url":"bit.ly/29vPHSP"}],"hashtags":[{"start":24,"end":33,"tag":"accounts"},{"start":62,"end":77,"tag":"administration"},{"start":125,"end":137,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"750604759682383872","text":"Apply for a position as #accounts receivable assistant in our #administration division, by 5 August: https://t.co/mVpq4gdH6E #recruitment","id":"750604759682383872","lang":"en","created_at":"2016-07-06T08:18:14.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/CKfFauq5xC","expanded_url":"http://bit.ly/29eXv6o","display_url":"bit.ly/29eXv6o"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":42,"end":60,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"750011623948124160","text":"The #agenda of this week's meeting of our #pharmacovigilance committee (PRAC) is available: https://t.co/CKfFauq5xC","id":"750011623948124160","lang":"en","created_at":"2016-07-04T17:01:20.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/Py7d8g68sK","expanded_url":"http://bit.ly/29dE9OC","display_url":"bit.ly/29dE9OC"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"750000880896868353","text":"Report on March workshop on immunogenicity assessment of biotechnology-derived therapeutic proteins is available: https://t.co/Py7d8g68sK","id":"750000880896868353","lang":"en","created_at":"2016-07-04T16:18:39.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/UuUla5TQxV","expanded_url":"http://bit.ly/29eeBS9","display_url":"bit.ly/29eeBS9"}],"hashtags":[{"start":45,"end":56,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"749959526489751553","text":"Find out about medicines granted opinions on #paediatric investigation plans by our paediatric committee in June: https://t.co/UuUla5TQxV","id":"749959526489751553","lang":"en","created_at":"2016-07-04T13:34:19.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/yUcwSN7hwu","expanded_url":"http://bit.ly/1WpJJne","display_url":"bit.ly/1WpJJne"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":49,"end":60,"tag":"paediatric"},{"start":81,"end":93,"tag":"Respiratory"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"749902369052356608","text":"#Consultation open until 11 July on Inventory of #paediatric therapeutic needs - #Respiratory: https://t.co/yUcwSN7hwu","id":"749902369052356608","lang":"en","created_at":"2016-07-04T09:47:11.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/VAGIfvwK1K","expanded_url":"http://bit.ly/29hr3DK","display_url":"bit.ly/29hr3DK"}],"hashtags":[{"start":19,"end":23,"tag":"CAT"},{"start":110,"end":115,"tag":"ATMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"748917259985354756","text":"Find out about the #CAT's recommendations on advanced therapy classification in June: https://t.co/VAGIfvwK1K #ATMP","id":"748917259985354756","lang":"en","created_at":"2016-07-01T16:32:43.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/81MeCjcHF0","expanded_url":"http://bit.ly/2982DsS","display_url":"bit.ly/2982DsS"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":39,"end":57,"tag":"pharmacovigilance"},{"start":69,"end":74,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":4,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"748898383897690113","text":"The #minutes of the May meeting of our #pharmacovigilance committee (#PRAC) are now available: https://t.co/81MeCjcHF0","id":"748898383897690113","lang":"en","created_at":"2016-07-01T15:17:43.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/QxUaEtM0M4","expanded_url":"http://bit.ly/295HGxT","display_url":"bit.ly/295HGxT"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":84,"end":94,"tag":"medicines"},{"start":98,"end":113,"tag":"clinicaltrials"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"748891544929853440","text":"#Consultation on guideline on requirements for quality documentation for biological #medicines in #clinicaltrials: https://t.co/QxUaEtM0M4","id":"748891544929853440","lang":"en","created_at":"2016-07-01T14:50:32.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/irMvyucNpW","expanded_url":"http://bit.ly/297YQkR","display_url":"bit.ly/297YQkR"}],"hashtags":[{"start":31,"end":40,"tag":"academia"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":1,"like_count":8,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"748559544222158848","text":"Strengthening interaction with #academia - EMA consults academia in preparation of a framework of collaboration: https://t.co/irMvyucNpW","id":"748559544222158848","lang":"en","created_at":"2016-06-30T16:51:17.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/GPIjf0Deuf","expanded_url":"http://bit.ly/298FRm6","display_url":"bit.ly/298FRm6"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":41,"end":48,"tag":"orphan"},{"start":49,"end":59,"tag":"medicines"},{"start":71,"end":76,"tag":"COMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"748533232421994496","text":"The #minutes from the May meeting of our #orphan #medicines committee (#COMP) are available: https://t.co/GPIjf0Deuf","id":"748533232421994496","lang":"en","created_at":"2016-06-30T15:06:44.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":53,"end":76,"url":"https://t.co/Y4ox5SFQAj","expanded_url":"http://bit.ly/297xn2r","display_url":"bit.ly/297xn2r"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"748506063658455040","text":"EMA multiannual work programme to 2020 is available: https://t.co/Y4ox5SFQAj","id":"748506063658455040","lang":"en","created_at":"2016-06-30T13:18:46.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":38,"end":61,"url":"https://t.co/60eZBRKzBC","expanded_url":"http://bit.ly/29ccfI9","display_url":"bit.ly/29ccfI9"},{"start":62,"end":85,"url":"https://t.co/QKJGkL1W0w","expanded_url":"https://twitter.com/EMA_News/status/748153435518795777/photo/1","display_url":"pic.twitter.com/QKJGkL1W0w"}],"hashtags":[{"start":16,"end":22,"tag":"PRIME"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"748153435518795777","text":"Updated data on #PRIME are available: https://t.co/60eZBRKzBC https://t.co/QKJGkL1W0w","id":"748153435518795777","lang":"en","created_at":"2016-06-29T13:57:33.000Z","author_id":"116716199","attachments":{"media_keys":["3_748153395144499200"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/yUcwSN7hwu","expanded_url":"http://bit.ly/1WpJJne","display_url":"bit.ly/1WpJJne"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":49,"end":60,"tag":"paediatric"},{"start":81,"end":93,"tag":"Respiratory"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":1,"like_count":1,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"747470816514838528","text":"#Consultation open until 11 July on Inventory of #paediatric therapeutic needs - #Respiratory: https://t.co/yUcwSN7hwu","id":"747470816514838528","lang":"en","created_at":"2016-06-27T16:45:04.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/gZrVjrORNu","expanded_url":"http://bit.ly/28ZxUmZ","display_url":"bit.ly/28ZxUmZ"}],"hashtags":[{"start":72,"end":83,"tag":"veterinary"},{"start":119,"end":132,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"747467046070460416","text":"Comments invited on guideline on user safety for topically administered #veterinary medicines: https://t.co/gZrVjrORNu #consultation","id":"747467046070460416","lang":"en","created_at":"2016-06-27T16:30:05.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/mQFMBShpxV","expanded_url":"http://bit.ly/28YPNPf","display_url":"bit.ly/28YPNPf"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"747463969779101696","text":"#Consultation on questions to be addressed in relation to stem cell therapies for animals and extraneous agents: https://t.co/mQFMBShpxV","id":"747463969779101696","lang":"en","created_at":"2016-06-27T16:17:52.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/MtzCEMd6zP","expanded_url":"http://bit.ly/28XimPK","display_url":"bit.ly/28XimPK"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":4,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"747370167622053888","text":"Follow our workshop on Thurs 30 June on the role of single-arm trials in the authorisation of new cancer medicines: https://t.co/MtzCEMd6zP","id":"747370167622053888","lang":"en","created_at":"2016-06-27T10:05:08.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/k6LdGxKy0s","expanded_url":"http://bit.ly/28RPSoz","display_url":"bit.ly/28RPSoz"}],"hashtags":[{"start":14,"end":25,"tag":"veterinary"},{"start":26,"end":35,"tag":"medicine"},{"start":36,"end":45,"tag":"Velactis"},{"start":47,"end":59,"tag":"cabergoline"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"746338699865133056","text":"EMA reviewing #veterinary #medicine #Velactis (#cabergoline) following reports of serious adverse events in cattle: https://t.co/k6LdGxKy0s","id":"746338699865133056","lang":"en","created_at":"2016-06-24T13:46:27.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"ZacharyBrennan","id":"605657704"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"746291041913966592","text":"@ZacharyBrennan Please contact the press office for your query.","id":"746306966490865664","lang":"en","created_at":"2016-06-24T11:40:21.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"746298156363583492"}],"in_reply_to_user_id":"605657704"},{"entities":{"urls":[{"start":58,"end":81,"url":"https://t.co/VU0pV8VVIm","expanded_url":"http://bit.ly/28RDrGA","display_url":"bit.ly/28RDrGA"}],"hashtags":[{"start":51,"end":56,"tag":"CHMP"},{"start":82,"end":92,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":1,"like_count":3,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"746304036341702656","text":"New cell-based therapy recommended for approval by #CHMP: https://t.co/VU0pV8VVIm #medicines","id":"746304036341702656","lang":"en","created_at":"2016-06-24T11:28:42.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/lZEGB0Jb1Q","expanded_url":"http://bit.ly/28R6lq6","display_url":"bit.ly/28R6lq6"},{"start":111,"end":134,"url":"https://t.co/iutJ1IOVPe","expanded_url":"https://twitter.com/EMA_News/status/746302623528132608/photo/1","display_url":"pic.twitter.com/iutJ1IOVPe"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":23,"end":33,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":4,"quote_count":4},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"746302623528132608","text":"#CHMP recommends 6 new #medicines for approval at June meeting – check out highlights: https://t.co/lZEGB0Jb1Q https://t.co/iutJ1IOVPe","id":"746302623528132608","lang":"en","created_at":"2016-06-24T11:23:05.000Z","author_id":"116716199","attachments":{"media_keys":["3_746302071595474945"]},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"ZacharyBrennan","id":"605657704"},{"start":16,"end":26,"username":"MHRApress","id":"330990243"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"746291041913966592","text":"@ZacharyBrennan @MHRApress It is too early to foresee the implications. Focus is on our mission to protect public health.","id":"746296859891761153","lang":"en","created_at":"2016-06-24T11:00:11.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"746291041913966592"}],"in_reply_to_user_id":"605657704"},{"entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/JYmnFP1e5u","expanded_url":"http://bit.ly/28PGUH9","display_url":"bit.ly/28PGUH9"}],"hashtags":[{"start":41,"end":52,"tag":"paediatric"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"746259223311425536","text":"The agenda of this week's meeting of our #paediatric committee (PDCO) has been published: https://t.co/JYmnFP1e5u","id":"746259223311425536","lang":"en","created_at":"2016-06-24T08:30:38.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/kxvpHkmeNt","expanded_url":"http://bit.ly/28Sl35t","display_url":"bit.ly/28Sl35t"}],"hashtags":{},"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":10,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"745985316201332736","text":"Find out about our interactions with patients, consumers and healthcare professionals in 2015: https://t.co/kxvpHkmeNt","id":"745985316201332736","lang":"en","created_at":"2016-06-23T14:22:13.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/vCjlI0SThF","expanded_url":"http://bit.ly/28T014Y","display_url":"bit.ly/28T014Y"}],"hashtags":[{"start":19,"end":29,"tag":"medicines"},{"start":46,"end":53,"tag":"orphan"},{"start":73,"end":78,"tag":"COMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"745978966834561024","text":"Find out about the #medicines recommended for #orphan designation by the #COMP in June: https://t.co/vCjlI0SThF","id":"745978966834561024","lang":"en","created_at":"2016-06-23T13:56:59.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/0XC0HAP364","expanded_url":"http://bit.ly/28NHu7F","display_url":"bit.ly/28NHu7F"}],"hashtags":[{"start":41,"end":51,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"745657724516581376","text":"Check our new regulatory pages on herbal #medicines: It's been designed to help users find info more easily: https://t.co/0XC0HAP364","id":"745657724516581376","lang":"en","created_at":"2016-06-22T16:40:29.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/B1pp0aCxIz","expanded_url":"http://bit.ly/28NqfFs","display_url":"bit.ly/28NqfFs"}],"hashtags":[{"start":8,"end":12,"tag":"FDA"},{"start":68,"end":76,"tag":"patient"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.3667,"type":"Person","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":25,"reply_count":1,"like_count":17,"quote_count":3},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"745635142727774208","text":"EMA and #FDA establish new working group to share best practices on #patient engagement: https://t.co/B1pp0aCxIz","id":"745635142727774208","lang":"en","created_at":"2016-06-22T15:10:45.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/wp2RdqQ4o6","expanded_url":"http://bit.ly/28L9afy","display_url":"bit.ly/28L9afy"}],"hashtags":[{"start":117,"end":129,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"745242614555881473","text":"We're recruiting an information management specialist for our information centre activities: https://t.co/wp2RdqQ4o6 #recruitment","id":"745242614555881473","lang":"en","created_at":"2016-06-21T13:10:59.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":59,"end":82,"url":"https://t.co/FDoB4URsWM","expanded_url":"http://bit.ly/28Kr3Ys","display_url":"bit.ly/28Kr3Ys"}],"hashtags":[{"start":37,"end":43,"tag":"legal"},{"start":83,"end":95,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"745241945971298304","text":"Apply by 21 July for our position as #legal administrator: https://t.co/FDoB4URsWM #recruitment","id":"745241945971298304","lang":"en","created_at":"2016-06-21T13:08:20.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/pIs7GjPmMc","expanded_url":"http://bit.ly/28KqDS7","display_url":"bit.ly/28KqDS7"}],"hashtags":[{"start":96,"end":103,"tag":"ITjobs"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"745240597401866240","text":"We are recruiting a master data management architect, apply by 21 July: https://t.co/pIs7GjPmMc #ITjobs","id":"745240597401866240","lang":"en","created_at":"2016-06-21T13:02:58.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/Fg0kRDFIl7","expanded_url":"http://bit.ly/28Ky5g6","display_url":"bit.ly/28Ky5g6"}],"hashtags":[{"start":123,"end":135,"tag":"recruitment"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"745237562093088768","text":"Apply now for our position as media and PR officer in our Stakeholders and Communication division: https://t.co/Fg0kRDFIl7 #recruitment","id":"745237562093088768","lang":"en","created_at":"2016-06-21T12:50:55.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/KwqHING64L","expanded_url":"http://bit.ly/28In4gY","display_url":"bit.ly/28In4gY"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"744876937215115264","text":"The #agenda of this week's meeting of our committee for human medicines (CHMP) is available: https://t.co/KwqHING64L","id":"744876937215115264","lang":"en","created_at":"2016-06-20T12:57:55.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/zcQtMzDe0W","expanded_url":"http://bit.ly/1UneBl3","display_url":"bit.ly/1UneBl3"}],"hashtags":[{"start":76,"end":81,"tag":"CVMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743821122894970880","text":"The minutes from the May meeting of our committee for veterinary medicines (#CVMP) are now published: https://t.co/zcQtMzDe0W","id":"743821122894970880","lang":"en","created_at":"2016-06-17T15:02:29.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/eI6YXQ5gbd","expanded_url":"http://bit.ly/1Ung7n5","display_url":"bit.ly/1Ung7n5"}],"hashtags":[{"start":80,"end":85,"tag":"CVMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743820719134478336","text":"Highlights from this month’s meeting of our committee for veterinary medicines (#CVMP) are available on our website: https://t.co/eI6YXQ5gbd","id":"743820719134478336","lang":"en","created_at":"2016-06-17T15:00:53.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/KGkAnhTswY","expanded_url":"http://bit.ly/23g8N0e","display_url":"bit.ly/23g8N0e"}],"hashtags":{},"mentions":{},"annotations":[{"start":44,"end":65,"probability":0.3152,"type":"Other","normalized_text":"EMA’s Management Board"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743811105680691200","text":"See the highlights from the June meeting of EMA’s Management Board: https://t.co/KGkAnhTswY","id":"743811105680691200","lang":"en","created_at":"2016-06-17T14:22:41.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/sLhLSo5MQK","expanded_url":"http://bit.ly/21q8ZZf","display_url":"bit.ly/21q8ZZf"}],"hashtags":[{"start":77,"end":81,"tag":"CAT"}],"mentions":{},"annotations":[{"start":43,"end":74,"probability":0.3155,"type":"Organization","normalized_text":"Committee for Advanced Therapies"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743751164940820482","text":"The agenda for this month’s meeting of our Committee for Advanced Therapies (#CAT) is now available: https://t.co/sLhLSo5MQK","id":"743751164940820482","lang":"en","created_at":"2016-06-17T10:24:30.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/btvYDC8ZEb","expanded_url":"http://bit.ly/1Q8Du54","display_url":"bit.ly/1Q8Du54"}],"hashtags":[{"start":40,"end":50,"tag":"medicines"},{"start":81,"end":86,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743488955606261760","text":"Find out about the applications for new #medicines currently under evaluation by #CHMP: https://t.co/btvYDC8ZEb","id":"743488955606261760","lang":"en","created_at":"2016-06-16T17:02:35.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/6LviGa17rB","expanded_url":"http://bit.ly/1UB0NAD","display_url":"bit.ly/1UB0NAD"}],"hashtags":[{"start":59,"end":69,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":1},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743487996045975553","text":"Involving general practitioners in regulatory decisions on #medicines: check out the report from our April workshop https://t.co/6LviGa17rB","id":"743487996045975553","lang":"en","created_at":"2016-06-16T16:58:46.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/6fMYu1KQd6","expanded_url":"http://bit.ly/1XYoIkC","display_url":"bit.ly/1XYoIkC"}],"hashtags":[{"start":8,"end":25,"tag":"adaptivepathways"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":4,"quote_count":2},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743468699911331840","text":"What is #adaptivepathways? We just published our response to a letter from a group of scientists: https://t.co/6fMYu1KQd6","id":"743468699911331840","lang":"en","created_at":"2016-06-16T15:42:05.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/l1mxseVpVq","expanded_url":"http://europa.eu/!Wd47xK","display_url":"europa.eu/!Wd47xK"}],"hashtags":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"public_metrics":{"retweet_count":46,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"Twitter Web Client","conversation_id":"743392479030968320","text":"RT @EU_Commission: Lack of awareness on antimicrobial resistance ➡️ need to intensify EU action https://t.co/l1mxseVpVq https://t.co/mPyidZ…","id":"743392479030968320","lang":"en","created_at":"2016-06-16T10:39:13.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"743389108421033984"}]},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/KhEDFEStqN","expanded_url":"http://europa.eu/!Wd47xK","display_url":"europa.eu/!Wd47xK"}],"hashtags":[{"start":38,"end":50,"tag":"antibiotics"},{"start":71,"end":74,"tag":"EU"},{"start":84,"end":88,"tag":"AMR"},{"start":89,"end":103,"tag":"Eurobarometer"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743392318984699904","text":"RT @EU_Health: Info on correct use of #antibiotics only reached 1/3 of #EU citizens #AMR #Eurobarometer https://t.co/KhEDFEStqN https://t.c…","id":"743392318984699904","lang":"en","created_at":"2016-06-16T10:38:35.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"743389101974499328"}]},{"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/KhEDFEStqN","expanded_url":"http://europa.eu/!Wd47xK","display_url":"europa.eu/!Wd47xK"}],"hashtags":[{"start":72,"end":84,"tag":"antibiotics"},{"start":103,"end":107,"tag":"AMR"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":39,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743392290815762433","text":"RT @EU_Health: Consumption dropped 6% last 7 yrs, but 1/3 citizens took #antibiotics in last 12 months #AMR https://t.co/KhEDFEStqN https:/…","id":"743392290815762433","lang":"en","created_at":"2016-06-16T10:38:28.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"743388505406050304"}]},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/KhEDFEStqN","expanded_url":"http://europa.eu/!Wd47xK","display_url":"europa.eu/!Wd47xK"}],"hashtags":[{"start":19,"end":22,"tag":"EU"},{"start":40,"end":52,"tag":"antibiotics"},{"start":109,"end":123,"tag":"Eurobarometer"},{"start":124,"end":128,"tag":"AMR"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"public_metrics":{"retweet_count":61,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743392265381494784","text":"RT @EU_Health: 57% #EU citizens unaware #antibiotics are ineffective against viruses https://t.co/KhEDFEStqN #Eurobarometer #AMR https://t.…","id":"743392265381494784","lang":"en","created_at":"2016-06-16T10:38:22.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"743387427964846080"}]},{"entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/vB9P05z1yi","expanded_url":"http://bit.ly/1YrxndF","display_url":"bit.ly/1YrxndF"}],"hashtags":[{"start":54,"end":65,"tag":"veterinary"},{"start":66,"end":76,"tag":"medicines"},{"start":78,"end":83,"tag":"CVMP"}],"mentions":{},"annotations":[{"start":0,"end":11,"probability":0.9985,"type":"Person","normalized_text":"David Murphy"},{"start":25,"end":36,"probability":0.5127,"type":"Organization","normalized_text":"Chair of EMA"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743115177487372288","text":"David Murphy elected new Chair of EMA’s committee for #veterinary #medicines (#CVMP): https://t.co/vB9P05z1yi","id":"743115177487372288","lang":"en","created_at":"2016-06-15T16:17:19.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/NgVyM1L6dD","expanded_url":"http://bit.ly/1VYPS8Z","display_url":"bit.ly/1VYPS8Z"}],"hashtags":[{"start":52,"end":59,"tag":"Herbal"},{"start":80,"end":85,"tag":"HMPC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743017674922467332","text":"The report from the May meeting of our Committee on #Herbal Medicinal Products (#HMPC) is now published: https://t.co/NgVyM1L6dD","id":"743017674922467332","lang":"en","created_at":"2016-06-15T09:49:52.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/3zpQRwqblA","expanded_url":"http://bit.ly/261QZHT","display_url":"bit.ly/261QZHT"}],"hashtags":[{"start":57,"end":64,"tag":"herbal"},{"start":65,"end":76,"tag":"monographs"},{"start":121,"end":134,"tag":"consultation"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"743002169553620992","text":"Submit scientific data for the systematic review of five #herbal #monographs until 15 September: https://t.co/3zpQRwqblA #consultation","id":"743002169553620992","lang":"en","created_at":"2016-06-15T08:48:16.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":66,"end":89,"url":"https://t.co/57uft98oEh","expanded_url":"http://bit.ly/260yUtC","display_url":"bit.ly/260yUtC"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742773276305395712","text":"The #agenda of this week's Management Board meeting is available: https://t.co/57uft98oEh","id":"742773276305395712","lang":"en","created_at":"2016-06-14T17:38:43.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"CTTI_Trials","id":"755163601"},{"start":69,"end":78,"username":"EMA_News","id":"116716199"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742745264344174592","text":"RT @CTTI_Trials: 10 yrs of Patients &amp; Consumers Working Party at @EMA_News. CTTI helps @FDA_Patient_Net launch similar initiative https://t…","id":"742745264344174592","lang":"en","created_at":"2016-06-14T15:47:25.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"742737539925053440"}]},{"entities":{"urls":{},"hashtags":[{"start":113,"end":120,"tag":"PCWP10"}],"mentions":{},"annotations":[{"start":18,"end":29,"probability":0.8309,"type":"Person","normalized_text":"Noel Wathion"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742744069353447424","text":"Dep Exec Director Noel Wathion highlights importance of incorporating patients' preferences in scientific review #PCWP10","id":"742744069353447424","lang":"en","created_at":"2016-06-14T15:42:40.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":115,"end":124,"tag":"patients"},{"start":125,"end":132,"tag":"PCWP10"}],"mentions":{},"annotations":[{"start":23,"end":35,"probability":0.9871,"type":"Person","normalized_text":"Nathalie Bere"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742741082463731712","text":"Looking to the future: Nathalie Bere highlights importance of engaging with young people and input from individual #patients #PCWP10","id":"742741082463731712","lang":"en","created_at":"2016-06-14T15:30:48.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":122,"end":131,"tag":"patients"},{"start":132,"end":139,"tag":"PCWP10"}],"mentions":[{"start":13,"end":19,"username":"EATGx","id":"273916420"}],"annotations":[{"start":0,"end":11,"probability":0.9896,"type":"Person","normalized_text":"David Haerry"},{"start":80,"end":82,"probability":0.4232,"type":"Person","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742728644615884801","text":"David Haerry @EATGx: PCWP has matured a lot and keeps its good spirit &amp; energy; EMA has made a tangible difference to #patients #PCWP10","id":"742728644615884801","lang":"en","created_at":"2016-06-14T14:41:22.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":98,"end":105,"tag":"PCWP10"}],"mentions":[{"start":17,"end":26,"username":"eurordis","id":"26993786"}],"annotations":[{"start":0,"end":10,"probability":0.9737,"type":"Person","normalized_text":"Lise Murphy"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742726067895578624","text":"Lise Murphy from @eurordis: PCWP has developed into a hub; interaction is increasing and maturing #PCWP10","id":"742726067895578624","lang":"en","created_at":"2016-06-14T14:31:08.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":91,"end":98,"tag":"PCWP10"}],"mentions":[{"start":1,"end":17,"username":"IlariaPassarani","id":"1106659014"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742715612284260352","text":".@IlariaPassarani: PCWP is more than a cosmetic exercise. It is a real commitment from EMA #PCWP10","id":"742715612284260352","lang":"en","created_at":"2016-06-14T13:49:35.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":46,"end":55,"tag":"patients"},{"start":121,"end":128,"tag":"PCWP10"}],"mentions":[{"start":21,"end":30,"username":"eurordis","id":"26993786"}],"annotations":[{"start":0,"end":14,"probability":0.9765,"type":"Person","normalized_text":"François Houyez"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742714073264054273","text":"François Houyez from @eurordis: engaging with #patients with mutual respect, listening and credibility has been achieved #PCWP10","id":"742714073264054273","lang":"en","created_at":"2016-06-14T13:43:28.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":{},"hashtags":[{"start":87,"end":97,"tag":"medicines"},{"start":103,"end":112,"tag":"patients"},{"start":113,"end":120,"tag":"PCWP10"}],"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9595,"type":"Person","normalized_text":"Guido Rasi"}]},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":8,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742706611010076672","text":"Guido Rasi: We need to explore new ways to address, drive and steer the development of #medicines with #patients #PCWP10","id":"742706611010076672","lang":"en","created_at":"2016-06-14T13:13:49.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/7f0lppEsCZ","expanded_url":"http://bit.ly/25WYTCb","display_url":"bit.ly/25WYTCb"}],"hashtags":[{"start":53,"end":62,"tag":"patients"},{"start":133,"end":140,"tag":"PCWP10"}],"mentions":{},"annotations":[{"start":0,"end":14,"probability":0.9879,"type":"Person","normalized_text":"Isabelle Moulon"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742704111087460352","text":"Isabelle Moulon opens 10th anniversary PCWP meeting: #patients now provide input at all levels of EMA's work https://t.co/7f0lppEsCZ #PCWP10","id":"742704111087460352","lang":"en","created_at":"2016-06-14T13:03:53.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/7f0lppEsCZ","expanded_url":"http://bit.ly/25WYTCb","display_url":"bit.ly/25WYTCb"}],"hashtags":[{"start":32,"end":41,"tag":"patients"},{"start":46,"end":56,"tag":"consumers"},{"start":131,"end":138,"tag":"PCWP10"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":9,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742632086780170240","text":"10th anniversary meeting of our #patients and #consumers working party (PCWP): Live broadcast today at 2pm https://t.co/7f0lppEsCZ #PCWP10","id":"742632086780170240","lang":"en","created_at":"2016-06-14T08:17:41.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/ZjXLvB2uLY","expanded_url":"http://bit.ly/1Pp33sU","display_url":"bit.ly/1Pp33sU"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":28,"end":39,"tag":"veterinary"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742392384223346688","text":"The #agenda for this week's #veterinary medicines committee (CVMP) is available: https://t.co/ZjXLvB2uLY","id":"742392384223346688","lang":"en","created_at":"2016-06-13T16:25:12.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/jkdd1P8DfB","expanded_url":"http://bit.ly/1Pop2Af","display_url":"bit.ly/1Pop2Af"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":41,"end":48,"tag":"herbal"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"742330663001591808","text":"The #minutes of the April meeting of our #herbal medicines committee (HMPC) are available: https://t.co/jkdd1P8DfB","id":"742330663001591808","lang":"en","created_at":"2016-06-13T12:19:56.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/8FLiISsrdP","expanded_url":"http://bit.ly/1XL85IX","display_url":"bit.ly/1XL85IX"}],"hashtags":[{"start":32,"end":41,"tag":"patients"},{"start":132,"end":139,"tag":"PCWP10"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"741259858511548417","text":"10th anniversary meeting of our #patients and consumers working party to be broadcast live on Tues,14 June: https://t.co/8FLiISsrdP #PCWP10","id":"741259858511548417","lang":"en","created_at":"2016-06-10T13:24:56.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/WOOb0tdpZs","expanded_url":"http://bit.ly/24F7ua9","display_url":"bit.ly/24F7ua9"}],"hashtags":[{"start":61,"end":79,"tag":"pharmacovigilance"},{"start":91,"end":96,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"741225323728150529","text":"We've published the highlights of this week's meeting of our #pharmacovigilance committee (#PRAC): https://t.co/WOOb0tdpZs","id":"741225323728150529","lang":"en","created_at":"2016-06-10T11:07:43.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/UJBOQclLbR","expanded_url":"http://bit.ly/21bXe8x","display_url":"bit.ly/21bXe8x"}],"hashtags":[{"start":43,"end":50,"tag":"orphan"},{"start":51,"end":60,"tag":"medicine"},{"start":72,"end":77,"tag":"COMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"741208336322994176","text":"We've published the agenda of this month's #orphan #medicine committee (#COMP) meeting: https://t.co/UJBOQclLbR","id":"741208336322994176","lang":"en","created_at":"2016-06-10T10:00:13.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/I1uzgIouDh","expanded_url":"http://bit.ly/28pqmi5","display_url":"bit.ly/28pqmi5"}],"hashtags":[{"start":57,"end":67,"tag":"medicines"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"741199664544927744","text":"Use of central repository for submitting PSURs for human #medicines in the EU mandatory from 13 June 2016: https://t.co/I1uzgIouDh","id":"741199664544927744","lang":"en","created_at":"2016-06-10T09:25:45.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":43,"end":66,"url":"https://t.co/rMxJXL615X","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"Improbabologue","id":"3246466673"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"740841623475654656","text":"@Improbabologue Please send your query  at https://t.co/rMxJXL615X so we can reply in full.","id":"740895783847858176","lang":"en","created_at":"2016-06-09T13:18:14.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"740841623475654656"}],"in_reply_to_user_id":"3246466673"},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/kQkO8HyBob","expanded_url":"http://bit.ly/1WGfZCz","display_url":"bit.ly/1WGfZCz"}],"hashtags":[{"start":42,"end":51,"tag":"Galafold"},{"start":53,"end":64,"tag":"migalastat"},{"start":69,"end":78,"tag":"medicine"},{"start":83,"end":89,"tag":"Fabry"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":2,"like_count":5,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"740874328347168768","text":"We've published the assessment report for #Galafold (#migalastat), a #medicine for #Fabry disease: https://t.co/kQkO8HyBob","id":"740874328347168768","lang":"en","created_at":"2016-06-09T11:52:59.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/mPGyGFLYvH","expanded_url":"http://bit.ly/1YfOvDe","display_url":"bit.ly/1YfOvDe"}],"hashtags":[{"start":42,"end":50,"tag":"Flixabi"},{"start":52,"end":63,"tag":"infliximab"},{"start":68,"end":79,"tag":"biosimilar"},{"start":98,"end":107,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"740841275931435008","text":"We've published the assessment report for #Flixabi\n(#infliximab), a #biosimilar anti-inflammatory #medicine: https://t.co/mPGyGFLYvH","id":"740841275931435008","lang":"en","created_at":"2016-06-09T09:41:39.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/2lzmDvU3K1","expanded_url":"http://bit.ly/1TVEqWW","display_url":"bit.ly/1TVEqWW"}],"hashtags":[{"start":42,"end":53,"tag":"Strimvelis"},{"start":85,"end":92,"tag":"immune"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"740553701505536005","text":"We’ve published the assessment report for #Strimvelis, a gene therapy for ultra-rare #immune disorder in children: https://t.co/2lzmDvU3K1","id":"740553701505536005","lang":"en","created_at":"2016-06-08T14:38:55.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/nJKQJWTWgZ","expanded_url":"http://bit.ly/24zoYog","display_url":"bit.ly/24zoYog"}],"hashtags":[{"start":32,"end":45,"tag":"Palonosetron"},{"start":64,"end":73,"tag":"medicine"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":4,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"740550389402116096","text":"Assessment report published for #Palonosetron Accord, a generic #medicine to prevent nausea and vomiting: https://t.co/nJKQJWTWgZ","id":"740550389402116096","lang":"en","created_at":"2016-06-08T14:25:46.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/7vb8ZBgFcq","expanded_url":"http://bit.ly/1Ulk6xw","display_url":"bit.ly/1Ulk6xw"}],"hashtags":[{"start":87,"end":97,"tag":"medicines"},{"start":133,"end":138,"tag":"ATMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"738689926015942656","text":"Read our workshop report detailing proposals to foster development of advanced therapy #medicines in the EU: https://t.co/7vb8ZBgFcq #ATMP","id":"738689926015942656","lang":"en","created_at":"2016-06-03T11:12:57.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/h70aS3ip6q","expanded_url":"http://bit.ly/22C1hMT","display_url":"bit.ly/22C1hMT"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":43,"end":50,"tag":"orphan"},{"start":51,"end":61,"tag":"medicines"},{"start":73,"end":78,"tag":"COMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"738659346754719744","text":"The #minutes from the April meeting of our #orphan #medicines committee (#COMP) are available: https://t.co/h70aS3ip6q","id":"738659346754719744","lang":"en","created_at":"2016-06-03T09:11:26.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":59,"end":82,"url":"https://t.co/RA3IY9cni5","expanded_url":"http://bit.ly/1U0a1Km","display_url":"bit.ly/1U0a1Km"}],"hashtags":[{"start":22,"end":30,"tag":"minutes"},{"start":44,"end":49,"tag":"PRAC"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"738427025585807360","text":"We have published the #minutes of our April #PRAC meeting: https://t.co/RA3IY9cni5","id":"738427025585807360","lang":"en","created_at":"2016-06-02T17:48:16.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/5vGyZMKfSp","expanded_url":"http://bit.ly/22A0fkn","display_url":"bit.ly/22A0fkn"}],"hashtags":[{"start":0,"end":11,"tag":"Paediatric"},{"start":53,"end":63,"tag":"medicines"},{"start":86,"end":95,"tag":"children"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"738370698775810048","text":"#Paediatric committee (PDCO) agrees six new PIPs for #medicines under development for #children https://t.co/5vGyZMKfSp","id":"738370698775810048","lang":"en","created_at":"2016-06-02T14:04:27.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/VVJXXkJQtc","expanded_url":"http://bit.ly/1t3B2ms","display_url":"bit.ly/1t3B2ms"}],"hashtags":[{"start":4,"end":13,"tag":"guidance"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":1,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"738362639433224192","text":"New #guidance on RMP submissions and on the classification of changes to marketing authorisation post authorisation: https://t.co/VVJXXkJQtc","id":"738362639433224192","lang":"en","created_at":"2016-06-02T13:32:26.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/eAfMQXbHlN","expanded_url":"http://bit.ly/285jJkN","display_url":"bit.ly/285jJkN"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"738319053052379136","text":"The #minutes of the April meeting of our committee for advanced therapies (CAT) are now available: https://t.co/eAfMQXbHlN","id":"738319053052379136","lang":"en","created_at":"2016-06-02T10:39:14.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":45,"end":68,"url":"https://t.co/6a4jOtG7Lq","expanded_url":"http://bit.ly/22xB8P4","display_url":"bit.ly/22xB8P4"},{"start":69,"end":92,"url":"https://t.co/aql81qS9NV","expanded_url":"https://twitter.com/EMA_News/status/737996983168815104/photo/1","display_url":"pic.twitter.com/aql81qS9NV"}],"hashtags":[{"start":20,"end":26,"tag":"PRIME"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":6,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"737996983168815104","text":"First statistics on #PRIME are now released: https://t.co/6a4jOtG7Lq https://t.co/aql81qS9NV","id":"737996983168815104","lang":"en","created_at":"2016-06-01T13:19:26.000Z","author_id":"116716199","attachments":{"media_keys":["3_737996700443369473"]},"referenced_tweets":{}},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/GMkYMi8qIs","expanded_url":"http://bit.ly/1Uu9cZb","display_url":"bit.ly/1Uu9cZb"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":43,"end":54,"tag":"guidelines"},{"start":58,"end":79,"tag":"radiopharmaceuticals"},{"start":84,"end":95,"tag":"diagnostic"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"737995547341131776","text":"#Consultation open on three new scientific #guidelines on #radiopharmaceuticals and #diagnostic agents: https://t.co/GMkYMi8qIs","id":"737995547341131776","lang":"en","created_at":"2016-06-01T13:13:44.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/JaGKsCuQGx","expanded_url":"http://bit.ly/1UgLmNz","display_url":"bit.ly/1UgLmNz"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":59,"end":70,"tag":"Paediatric"},{"start":82,"end":87,"tag":"PDCO"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"737983978129477632","text":"We've published the #minutes from the April meeting of our #Paediatric committee (#PDCO): https://t.co/JaGKsCuQGx","id":"737983978129477632","lang":"en","created_at":"2016-06-01T12:27:46.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/YcP9mjcd8V","expanded_url":"http://bit.ly/1sLcdv1","display_url":"bit.ly/1sLcdv1"}],"hashtags":[{"start":9,"end":17,"tag":"minutes"},{"start":68,"end":78,"tag":"medicines"},{"start":80,"end":85,"tag":"CHMP"}],"mentions":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"possibly_sensitive":false,"source":"TweetDeck","conversation_id":"737977416962977792","text":"View the #minutes from the April meeting of our committee for human #medicines (#CHMP): https://t.co/YcP9mjcd8V","id":"737977416962977792","lang":"en","created_at":"2016-06-01T12:01:41.000Z","author_id":"116716199","attachments":{"media_keys":{}},"referenced_tweets":{}}]
